data_2lkn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CD ' ' HG1' ' A' ' 79' ' ' THR 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 CA--C 1.564 1.987 0 N-CA-C 114.579 0.954 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.47 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 15' ' ' LYS . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.47 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.568 2.21 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.433 HD13 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.564 2.007 0 N-CA-C 114.511 0.927 . . . . 0.0 114.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.41 ' O ' ' SD ' ' A' ' 60' ' ' MET . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.428 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.428 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.569 2.258 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HD3' ' HG1' ' A' ' 79' ' ' THR . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.568 2.22 0 N-CA-C 114.437 0.899 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.436 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.413 ' HG1' ' HD3' ' A' ' 15' ' ' LYS . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.563 1.93 0 N-CA-C 114.151 0.789 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.564 ' HG1' ' HA ' ' A' ' 159' ' ' SER . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.564 ' HA ' ' HG1' ' A' ' 32' ' ' THR . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 114.134 0.782 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.462 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.545 ' H ' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.565 2.046 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.548 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.918 0 CA-C-O 121.857 0.69 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD12 ' HZ2' ' A' ' 15' ' ' LYS . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HZ2' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.569 2.263 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.436 ' HD1' ' HG ' ' A' ' 53' ' ' SER . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.424 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HG ' ' HD1' ' A' ' 37' ' ' HIS . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 HG22 ' SD ' ' A' ' 152' ' ' MET . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.424 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 119.426 -0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' MET . . . . . 0.414 ' SD ' HG22 ' A' ' 76' ' ' ILE . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 . . . . . 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 CA--C 1.565 2.06 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HB3' ' HZ3' ' A' ' 15' ' ' LYS . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.564 1.977 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.567 2.172 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HZ2' ' HH ' ' A' ' 163' ' ' TYR . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.622 ' HH ' ' HZ2' ' A' ' 66' ' ' LYS . 3.3 p90 . . . . . 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 CA--C 1.569 2.268 0 N-CA-C 113.703 0.617 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' O ' ' SD ' ' A' ' 60' ' ' MET . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.568 2.194 0 N-CA-C 114.136 0.783 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.426 HD13 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 . . . . . 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.567 2.171 0 N-CA-C 113.568 0.565 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.415 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.486 HD13 ' HZ1' ' A' ' 15' ' ' LYS . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HZ1' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.567 2.143 0 CA-C-O 120.862 0.276 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HZ2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.621 ' HG1' ' HG2' ' A' ' 61' ' ' GLU . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.621 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.568 HG13 ' HZ2' ' A' ' 33' ' ' LYS . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 CA--C 1.563 1.972 0 CA-C-O 121.473 0.53 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.417 ' HG1' ' HG3' ' A' ' 61' ' ' GLU . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.576 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' HG3' ' HG1' ' A' ' 35' ' ' THR . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 . . . . . 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 CA--C 1.569 2.259 0 N-CA-C 113.7 0.615 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.562 1.889 0 N-CA-C 112.939 0.323 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.56 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.56 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -141.19 101.95 4.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -86.36 -39.94 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.183 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.51 -43.57 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 119.915 1.234 . . . . 0.0 113.786 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CD ' ' HG1' ' A' ' 79' ' ' THR 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -143.68 143.84 31.6 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.98 -165.05 30.28 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.526 -1.216 . . . . 0.0 115.509 169.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.73 139.73 30.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.128 -1.036 . . . . 0.0 109.803 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.22 114.7 37.97 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.831 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 -169.46 0.73 Allowed 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.884 2.389 . . . . 0.0 114.579 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.47 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 15' ' ' LYS . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.47 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -57.08 -27.25 61.58 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -77.89 -55.74 5.07 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.08 0.952 . . . . 0.0 112.249 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -85.08 -58.36 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -160.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.18 -30.37 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.042 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.37 -2.36 1.47 Allowed 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.12 -46.9 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 161.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.96 67.12 0.03 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.012 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 63.54 109.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.748 1.219 . . . . 0.0 113.439 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.293 1.1 m-20 60.79 155.46 0.11 Allowed Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.69 -66.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 123.087 2.525 . . . . 0.0 114.138 -173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp -67.45 -33.81 75.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.49 -57.39 10.07 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.76 83.07 0.32 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 165.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -94.0 72.58 4.07 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.833 0.825 . . . . 0.0 109.968 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -170.66 140.51 1.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.677 0.791 . . . . 0.0 109.252 -165.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -95.99 87.03 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.6 m -135.16 75.82 1.59 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.87 0.843 . . . . 0.0 108.95 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.59 -68.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.34 63.64 0.21 Allowed Glycine 0 CA--C 1.541 1.687 0 CA-C-N 118.594 0.634 . . . . 0.0 112.916 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.6 t -144.11 105.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.64 128.26 9.36 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.148 0.499 . . . . 0.0 109.977 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.256 2.5 mp0 69.63 77.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.776 1.23 . . . . 0.0 111.606 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.2 tpt -157.83 108.52 2.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.04 97.88 9.6 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -150.97 131.11 13.5 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.12 114.91 23.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 167.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 t -74.36 -65.74 0.81 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.462 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.5 m 68.32 101.75 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.676 1.19 . . . . 0.0 112.384 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.65 135.94 36.12 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.526 0.679 . . . . 0.0 111.556 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.44 85.21 0.05 OUTLIER Glycine 0 N--CA 1.476 1.323 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -87.17 157.15 19.42 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.805 0.812 . . . . 0.0 111.012 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.33 -21.26 11.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 164.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.35 -53.13 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 119.425 1.011 . . . . 0.0 113.25 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -73.99 137.94 43.81 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -151.49 145.68 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 110.455 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -90.54 143.08 27.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.447 0.641 . . . . 0.0 110.785 167.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.279 1.038 . . . . 0.0 110.171 -177.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.419 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.78 133.03 49.31 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.291 0.636 . . . . 0.0 111.496 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -81.63 -40.36 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.409 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -50.56 -42.79 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 120.205 1.366 . . . . 0.0 113.761 165.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -104.2 84.84 2.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.48 -137.33 9.27 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 111.94 -2.391 . . . . 0.0 113.32 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.6 139.46 52.27 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.993 0.917 . . . . 0.0 111.407 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.54 130.53 94.75 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.532 -1.223 . . . . 0.0 113.924 -166.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.42 -144.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 123.488 2.792 . . . . 0.0 113.891 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.433 HD13 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.81 -24.24 49.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -82.36 -55.71 4.34 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.99 0.916 . . . . 0.0 112.174 160.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -82.89 -62.54 1.57 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.499 0.72 . . . . 0.0 112.593 -162.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -58.49 -31.12 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.5 -13.14 37.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.75 -47.78 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 120.411 1.46 . . . . 0.0 114.356 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.4 30.13 0.02 OUTLIER Glycine 0 CA--C 1.548 2.138 0 CA-C-O 118.282 -1.288 . . . . 0.0 115.724 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -147.68 119.42 8.06 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.138 1.469 . . . . 0.0 108.301 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -83.2 152.09 64.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.9 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.5 -61.52 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.189 2.593 . . . . 0.0 114.926 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -71.15 -64.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.19 0.904 . . . . 0.0 112.003 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 52.68 66.76 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.056 1.342 . . . . 0.0 114.602 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.46 -82.37 1.52 Allowed Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.991 -0.338 . . . . 0.0 112.625 -169.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 62.75 80.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.752 1.221 . . . . 0.0 113.098 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.01 99.45 3.46 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -96.11 144.22 26.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.562 0.745 . . . . 0.0 111.232 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.3 175.86 7.96 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.65 -58.66 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.15 50.01 1.7 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-N 119.219 0.918 . . . . 0.0 115.191 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -148.96 114.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.72 85.07 1.1 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -158.81 104.79 1.77 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.7 tpt -146.57 -69.76 0.25 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.344 0.657 . . . . 0.0 109.709 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.56 93.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.637 1.175 . . . . 0.0 110.527 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -77.26 119.29 20.71 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.267 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -80.15 142.58 34.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -89.01 119.67 29.74 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.204 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m -90.14 103.06 15.77 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.166 0.508 . . . . 0.0 110.88 -173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.82 147.03 49.83 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.964 0.905 . . . . 0.0 108.825 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.73 67.51 0.18 Allowed Glycine 0 N--CA 1.48 1.581 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.151 167.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -149.17 147.59 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 -18.26 12.57 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -85.62 -47.18 10.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.079 1.309 . . . . 0.0 113.089 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -74.53 151.9 39.42 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -137.48 146.52 44.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.648 163.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -102.96 122.4 44.52 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.97 0.89 . . . . 0.0 110.547 -171.199 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -116.94 105.23 12.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 mm -76.14 -40.47 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 123.322 0.649 . . . . 0.0 112.215 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm -48.2 -46.0 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 125.353 1.461 . . . . 0.0 114.26 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 145.61 44.85 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.77 -148.93 22.03 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.698 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.814 0.846 . . . . 0.0 110.078 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.45 114.29 36.93 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.142 170.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.16 -166.09 0.36 Allowed 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.921 2.414 . . . . 0.0 114.511 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.41 ' O ' ' SD ' ' A' ' 60' ' ' MET . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.428 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.428 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.71 -29.57 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -77.62 -56.04 4.85 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 118.759 0.708 . . . . 0.0 112.259 158.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -83.62 -63.18 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.127 0.876 . . . . 0.0 112.252 -158.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -59.82 -22.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.57 -8.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -47.61 -50.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 157.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.83 -91.78 0.08 OUTLIER Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -130.11 167.74 17.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.901 1.334 . . . . 0.0 111.5 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.33 159.04 43.3 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -61.12 -48.54 9.88 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.392 2.728 . . . . 0.0 116.56 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 mt -92.47 -46.31 7.71 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.886 164.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 106.24 3.29 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 119.554 1.07 . . . . 0.0 110.734 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.54 -88.04 0.51 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.476 -0.625 . . . . 0.0 111.685 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.334 75.3 mt-30 66.69 -91.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.411 1.084 . . . . 0.0 111.837 -169.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -78.72 130.75 36.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.429 0.692 . . . . 0.0 110.408 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -83.19 115.67 22.03 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.322 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.37 -69.68 0.69 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.97 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.33 94.83 5.44 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.762 0.71 . . . . 0.0 109.578 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.49 -86.63 0.12 Allowed Glycine 0 N--CA 1.478 1.482 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.2 t 72.71 97.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 125.118 1.367 . . . . 0.0 108.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 110.68 3.48 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.238 -165.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -136.75 112.5 9.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.96 153.92 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.547 0.739 . . . . 0.0 111.543 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -85.99 93.48 8.97 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -133.47 127.93 34.35 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -77.9 123.23 26.51 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.056 0.543 . . . . 0.0 110.946 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.1 t -89.19 101.18 13.84 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.25 0.548 . . . . 0.0 109.743 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.4 t -135.05 -74.51 0.46 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.9 tp 74.37 132.81 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.713 1.205 . . . . 0.0 113.998 164.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.42 95.03 0.11 Allowed Glycine 0 N--CA 1.476 1.355 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -120.04 110.74 17.03 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -13.66 61.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 -45.64 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.409 1.004 . . . . 0.0 113.327 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -71.42 170.68 12.73 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -78.73 104.38 9.31 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -105.79 134.86 48.23 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.657 0.783 . . . . 0.0 109.468 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.072 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.34 . . . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.21 116.17 18.76 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.7 mm -93.31 -48.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 118.543 -0.742 . . . . 0.0 110.869 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.46 -41.09 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.803 1.183 . . . . 0.0 113.662 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -117.1 136.74 52.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.42 -114.59 4.16 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.81 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.43 160.43 41.59 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.881 0.848 . . . . 0.0 110.861 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.52 126.04 81.62 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.724 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.53 -160.78 0.13 Allowed 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.118 2.545 . . . . 0.0 113.249 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.65 -28.91 61.62 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -82.53 -55.01 4.73 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.483 0.713 . . . . 0.0 112.23 161.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -84.61 -62.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.876 0.762 . . . . 0.0 111.875 -159.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -60.36 -28.52 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.889 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -12.68 3.5 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 118.778 2.881 . . . . 0.0 118.778 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.77 -48.54 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.58 66.48 0.15 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.788 -0.451 . . . . 0.0 113.741 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.267 3.2 mmmp? 70.01 163.32 0.24 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 167.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 151.11 86.02 Favored Pre-proline 0 CA--C 1.571 1.782 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.8 -47.73 2.49 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.383 2.722 . . . . 0.0 115.635 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.24 -44.66 87.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.85 98.01 4.07 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.143 0.883 . . . . 0.0 109.752 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.32 76.73 1.13 Allowed Glycine 0 CA--C 1.543 1.835 0 CA-C-O 119.406 -0.663 . . . . 0.0 113.895 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -126.83 111.78 14.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 166.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.64 100.36 12.89 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -115.2 143.65 44.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.429 0.692 . . . . 0.0 111.898 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.03 179.23 7.46 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 76.1 m -68.37 115.16 7.48 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.419 0.687 . . . . 0.0 112.455 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.47 54.72 6.55 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.0 t -145.08 103.28 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.84 116.4 1.66 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 69.21 91.83 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.607 1.163 . . . . 0.0 111.508 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.2 ptm -147.09 122.51 10.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.29 110.02 12.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.83 -62.81 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.469 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.1 135.38 50.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.965 0.802 . . . . 0.0 109.79 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -91.4 113.86 26.24 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.215 0.606 . . . . 0.0 110.751 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.2 t -89.69 159.09 17.28 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.404 0.682 . . . . 0.0 111.504 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.454 0.4 OUTLIER 84.75 143.83 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 125.573 1.549 . . . . 0.0 113.511 177.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.49 96.76 0.13 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -132.69 116.71 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.58 -6.15 59.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -90.48 -47.01 7.97 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.847 1.203 . . . . 0.0 112.523 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -71.14 143.79 50.45 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? 68.28 96.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.514 1.125 . . . . 0.0 111.364 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -81.59 132.95 35.32 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.495 0.665 . . . . 0.0 111.794 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -170.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.64 119.43 21.88 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 163.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.6 mt -81.23 -39.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 118.396 -0.812 . . . . 0.0 112.201 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm -48.99 -45.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 120.277 1.398 . . . . 0.0 113.729 164.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HD3' ' HG1' ' A' ' 79' ' ' THR . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -134.38 141.26 46.8 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.02 -138.66 20.31 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 115.047 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.37 147.31 24.82 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.824 0.85 . . . . 0.0 111.957 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -92.86 109.97 42.62 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.018 163.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.45 -155.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.175 2.584 . . . . 0.0 114.437 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.436 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.413 ' HG1' ' HD3' ' A' ' 15' ' ' LYS . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER -56.55 -29.06 61.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -79.98 -53.41 6.76 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 123.815 0.846 . . . . 0.0 112.666 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -83.22 -61.51 1.83 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.575 0.75 . . . . 0.0 112.776 -159.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.68 -32.56 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.18 -3.5 1.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 118.951 2.945 . . . . 0.0 118.951 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.29 -47.94 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 159.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.61 59.75 0.28 Allowed Glycine 0 CA--C 1.539 1.547 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.663 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 32.2 mmmt 63.7 174.82 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.77 152.19 87.16 Favored Pre-proline 0 CA--C 1.573 1.841 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.61 -49.11 6.06 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.303 2.668 . . . . 0.0 117.052 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.22 -69.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.704 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.342 9.8 pt-20 56.56 -170.69 0.09 Allowed 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.77 105.99 2.38 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 155.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -76.26 94.44 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.074 0.55 . . . . 0.0 111.936 -162.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -173.24 95.75 0.11 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -158.76 93.74 1.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.2 t -142.08 65.85 1.36 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 160.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.1 t -169.21 -67.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.87 0.868 . . . . 0.0 109.631 -171.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.72 -92.97 0.83 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.362 -0.688 . . . . 0.0 112.725 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.88 100.02 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.27 70.76 0.93 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.427 0.632 . . . . 0.0 109.76 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -146.49 126.99 14.1 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -163.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 70.73 97.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.801 1.241 . . . . 0.0 111.229 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.83 93.76 9.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.45 132.39 13.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -159.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -83.56 98.48 9.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.2 t -81.35 114.66 20.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.08 0.552 . . . . 0.0 110.043 -175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.6 p -101.18 155.14 18.19 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.125 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.11 145.02 56.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.6 84.76 0.06 OUTLIER Glycine 0 N--CA 1.476 1.32 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -142.59 147.79 36.44 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.52 -20.67 11.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 164.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.49 -49.5 21.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -74.79 136.08 41.66 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -150.16 103.68 3.2 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.59 124.91 51.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.772 -176.399 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.57 109.32 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mm -83.81 -40.2 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.173 0.589 . . . . 0.0 112.275 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -50.95 -47.13 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.688 1.195 . . . . 0.0 113.415 165.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -96.49 -93.16 0.21 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 -109.2 3.0 Favored Glycine 0 N--CA 1.479 1.525 0 CA-C-N 117.861 0.3 . . . . 0.0 113.696 -164.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.46 138.24 33.41 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.868 0.842 . . . . 0.0 111.278 -167.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -85.04 110.51 28.94 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.331 -1.318 . . . . 0.0 107.674 166.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -176.23 2.26 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.739 2.293 . . . . 0.0 114.151 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.564 ' HG1' ' HA ' ' A' ' 159' ' ' SER . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.84 -29.21 54.56 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -80.88 -57.38 3.57 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.669 0.788 . . . . 0.0 112.252 160.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -82.01 -61.0 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.817 0.735 . . . . 0.0 112.899 -159.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -54.18 -35.43 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.68 10.62 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.46 -42.8 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.92 -83.74 0.05 OUTLIER Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.518 -0.601 . . . . 0.0 111.62 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -78.66 129.46 34.76 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 0.0 112.183 -173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.95 139.35 26.42 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.728 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.55 -47.37 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 123.472 2.781 . . . . 0.0 115.524 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -66.03 -41.79 90.47 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.85 -51.98 66.9 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.73 -96.53 0.26 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.008 -0.884 . . . . 0.0 112.539 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.364 6.0 pt20 45.41 79.34 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.253 54.6 ttt85 68.96 91.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.923 -166.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -82.7 134.15 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.492 0.717 . . . . 0.0 111.301 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.6 p -124.09 -53.76 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.833 0.853 . . . . 0.0 112.763 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 27.3 p -95.11 125.73 39.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 119.2 0.909 . . . . 0.0 110.512 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.61 -74.89 0.56 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.994 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.437 3.5 m 72.02 124.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 125.408 1.483 . . . . 0.0 114.669 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.65 173.56 6.41 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.03 0.919 . . . . 0.0 111.392 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -64.39 -47.1 80.51 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 13.1 ttt 61.06 66.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.89 1.276 . . . . 0.0 113.845 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -138.3 85.04 2.07 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -145.98 87.44 1.76 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -151.54 39.64 0.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.4 m -154.26 95.55 1.84 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -155.54 104.08 2.35 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.08 146.98 27.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.88 0.848 . . . . 0.0 111.298 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.05 86.47 0.06 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -163.97 131.19 3.31 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.696 0.76 . . . . 0.0 110.917 -163.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.27 -12.88 3.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.1 -52.05 5.65 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.216 1.371 . . . . 0.0 112.487 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.564 ' HA ' ' HG1' ' A' ' 32' ' ' THR . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -72.12 170.63 13.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -75.88 101.62 5.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -91.45 130.18 37.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.456 0.646 . . . . 0.0 110.377 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.71 110.69 19.49 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.7 mm -87.74 -44.11 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.509 -169.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -52.61 -40.95 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 120.684 1.584 . . . . 0.0 113.694 167.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.54 152.12 51.02 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.92 -158.34 52.08 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 113.374 -1.739 . . . . 0.0 115.97 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.0 146.24 25.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.641 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.0 116.7 49.19 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 117.391 -1.29 . . . . 0.0 110.257 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.54 -158.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.929 2.42 . . . . 0.0 114.134 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.462 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -23.21 34.76 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -82.37 -59.55 2.5 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.467 0.707 . . . . 0.0 111.989 160.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -79.02 -60.46 2.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.973 0.509 . . . . 0.0 112.188 -160.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.34 -38.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.8 -8.24 4.6 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.897 2.925 . . . . 0.0 118.897 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.2 -41.16 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.42 -81.04 0.06 OUTLIER Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -83.92 118.22 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.629 0.728 . . . . 0.0 111.21 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.52 151.41 38.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.378 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.99 -50.59 1.02 Allowed 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.475 2.783 . . . . 0.0 115.709 -170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.74 -42.13 15.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 165.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.69 104.84 7.41 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.645 1.111 . . . . 0.0 110.547 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.45 80.39 0.78 Allowed Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.585 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.96 -66.0 0.95 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.128 0.571 . . . . 0.0 110.422 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -75.03 -66.8 0.71 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.524 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.5 m80 72.83 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.822 1.249 . . . . 0.0 112.16 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 42.8 t -143.24 133.91 25.13 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.293 0.637 . . . . 0.0 110.335 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.4 t 68.68 92.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.079 1.352 . . . . 0.0 112.63 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.76 11.52 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.384 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.294 11.0 m 36.16 91.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 166.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 107.5 3.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.04 110.42 20.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -112.14 75.21 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.797 0.808 . . . . 0.0 110.031 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -157.82 115.19 2.98 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -119.08 128.6 54.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.392 0.615 . . . . 0.0 110.493 -168.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -148.24 93.67 2.2 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 170.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.6 m -128.14 92.6 3.48 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 168.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.8 m -133.78 -70.07 0.53 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.194 -167.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mp 73.33 127.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.75 1.22 . . . . 0.0 110.837 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.52 87.99 0.07 OUTLIER Glycine 0 N--CA 1.476 1.306 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -137.31 153.19 50.33 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.023 0.916 . . . . 0.0 109.15 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.36 -10.8 10.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -90.37 -45.14 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.751 1.16 . . . . 0.0 113.259 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -72.9 145.28 46.96 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.331 7.3 pt20 64.25 161.14 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -104.2 123.01 46.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 158.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 122.223 1.011 . . . . 0.0 108.329 179.649 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.34 0.59 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.5 118.18 23.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.37 -40.91 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -47.9 -45.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 125.09 1.356 . . . . 0.0 114.467 164.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.545 ' H ' ' HZ2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -122.31 139.23 54.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.97 -132.93 11.59 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.027 -0.988 . . . . 0.0 115.034 166.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.07 149.64 28.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.397 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.26 112.88 52.47 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.063 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.66 -165.95 0.35 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.863 2.375 . . . . 0.0 114.407 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.548 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -25.81 40.06 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -79.52 -56.09 4.57 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 123.787 0.835 . . . . 0.0 112.349 161.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -88.46 -56.13 3.44 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -160.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.99 -31.89 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -5.12 2.04 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.6 -48.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 160.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.83 -88.8 0.44 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 170.92 15.94 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.046 0.927 . . . . 0.0 112.182 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.22 143.68 77.29 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 123.524 0.73 . . . . 0.0 111.225 171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.89 -59.99 0.13 Allowed 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 122.867 2.378 . . . . 0.0 115.756 -163.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mp -83.63 -68.85 0.68 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.937 0.79 . . . . 0.0 110.975 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.321 13.2 pt-20 46.48 40.41 8.08 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.13 82.71 0.32 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.715 -159.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -72.81 112.65 9.03 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.449 0.624 . . . . 0.0 111.779 -169.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.59 108.02 6.51 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -106.94 142.23 36.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.382 0.673 . . . . 0.0 112.206 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.6 p -84.07 -67.6 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.948 164.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.2 p -88.6 -64.42 1.15 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.88 0.763 . . . . 0.0 112.323 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.87 92.46 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.2 t -104.61 95.14 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.76 127.14 3.54 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -171.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 76.7 mm-40 74.3 100.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.723 1.209 . . . . 0.0 111.038 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.54 111.72 23.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -84.54 108.54 17.36 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 -156.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.05 92.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.02 1.328 . . . . 0.0 113.103 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -127.88 83.53 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p -161.76 96.71 1.04 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.6 m -126.71 101.07 6.47 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.94 147.78 25.61 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.801 0.81 . . . . 0.0 112.548 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.2 81.83 0.05 OUTLIER Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -168.65 131.02 1.34 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.759 0.79 . . . . 0.0 110.246 -164.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -131.38 -16.25 3.11 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 164.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.53 -46.17 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 120.065 1.302 . . . . 0.0 113.172 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -69.51 140.08 53.9 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 64.74 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.35 1.06 . . . . 0.0 113.039 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.03 125.07 33.15 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.238 0.542 . . . . 0.0 110.004 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -174.049 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -92.97 159.26 15.4 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 110.598 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 mm -75.1 -43.06 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.793 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm -51.59 -42.3 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 120.187 1.358 . . . . 0.0 113.296 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -90.13 -65.0 1.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.83 -160.47 14.14 Favored Glycine 0 CA--C 1.546 1.979 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.54 149.79 22.02 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.498 0.719 . . . . 0.0 110.751 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.82 120.14 80.31 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.291 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.67 -179.92 5.61 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 122.911 2.407 . . . . 0.0 113.647 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -57.66 -21.25 38.9 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -83.41 -56.5 3.72 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 118.89 0.768 . . . . 0.0 111.863 156.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -80.27 -60.16 2.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -160.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.9 mm -54.55 -41.47 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -3.31 5.99 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.5 p -59.97 -40.35 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 168.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.38 -80.33 0.05 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -75.8 119.01 19.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.494 0.718 . . . . 0.0 111.326 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.17 154.8 36.96 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 172.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.11 -35.91 31.51 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.901 2.401 . . . . 0.0 116.013 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.75 -70.73 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.012 0.824 . . . . 0.0 110.273 164.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.298 0.6 OUTLIER 64.92 -166.34 0.23 Allowed 'General case' 0 CA--C 1.572 1.823 0 C-N-CA 124.583 1.153 . . . . 0.0 113.175 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.23 99.73 2.27 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 111.032 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -81.5 111.9 18.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.188 0.595 . . . . 0.0 109.95 -168.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.263 98.6 mtt180 66.28 89.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.589 1.156 . . . . 0.0 111.056 -166.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -90.32 127.73 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.778 0.831 . . . . 0.0 110.961 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.26 -59.67 2.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.1 m -79.59 -69.09 0.61 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.846 0.748 . . . . 0.0 112.173 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 175.23 89.63 0.08 OUTLIER Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.32 87.83 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.91 107.32 2.31 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -100.48 112.73 25.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -164.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 67.8 mtt -94.93 107.92 19.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -154.67 131.78 10.98 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.6 -56.0 7.52 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 74.32 134.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.835 1.254 . . . . 0.0 112.691 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.6 p -79.29 98.82 6.82 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.195 0.522 . . . . 0.0 110.182 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.8 m -89.23 135.84 33.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.714 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.432 0.4 OUTLIER 62.91 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -175.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.72 83.78 0.05 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.01 134.57 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 110.694 -161.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.76 -12.33 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -92.12 -48.0 6.95 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.413 1.46 . . . . 0.0 113.025 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -73.46 118.39 16.36 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 57.33 85.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.317 1.047 . . . . 0.0 113.028 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -103.79 105.63 15.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.483 1.197 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 -171.159 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.055 0.455 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 140.17 40.27 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.76 167.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.269 23.7 mt -78.4 -44.51 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.665 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.35 -39.69 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.963 1.711 . . . . 0.0 114.134 167.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD12 ' HZ2' ' A' ' 15' ' ' LYS . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HZ2' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 138.92 44.08 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.86 -168.2 17.97 Favored Glycine 0 CA--C 1.543 1.833 0 CA-C-O 122.419 1.01 . . . . 0.0 115.23 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.77 141.89 28.24 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.425 -0.888 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -84.12 115.12 58.55 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.608 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.85 -164.05 0.19 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 123.062 2.508 . . . . 0.0 115.11 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.436 ' HD1' ' HG ' ' A' ' 53' ' ' SER . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.424 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HG ' ' HD1' ' A' ' 37' ' ' HIS . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 HG22 ' SD ' ' A' ' 152' ' ' MET . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.424 ' HH ' ' HG1' ' A' ' 40' ' ' THR . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.98 -24.18 37.0 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -83.65 -56.13 3.89 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.881 0.872 . . . . 0.0 112.192 160.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -82.36 -59.18 2.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -161.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.57 -34.95 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.919 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.71 2.48 2.48 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 p -49.86 -45.49 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 162.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.82 0.09 OUTLIER Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.0 -0.889 . . . . 0.0 113.453 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 62.84 132.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.066 1.346 . . . . 0.0 114.58 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 62.16 163.12 0.11 Allowed Pre-proline 0 CA--C 1.577 2.005 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 166.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -52.1 0.99 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.022 2.481 . . . . 0.0 115.556 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.14 -86.16 0.2 Allowed 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 36.02 68.03 0.26 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.51 59.9 9.93 Favored Glycine 0 CA--C 1.549 2.201 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.23 117.72 29.2 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.126 0.963 . . . . 0.0 111.686 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -94.6 -51.91 4.53 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.49 0.716 . . . . 0.0 112.286 165.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.253 31.7 m170 67.81 85.39 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.222 1.409 . . . . 0.0 112.207 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.2 t -145.39 78.59 1.55 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.602 0.715 . . . . 0.0 109.536 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.6 t -149.67 78.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.4 49.81 70.59 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 116.409 1.324 . . . . 0.0 116.409 -163.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.19 130.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 77.81 126.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.955 1.302 . . . . 0.0 112.655 175.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 65.72 69.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.768 1.227 . . . . 0.0 112.534 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 46.6 ttm -154.79 -96.26 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -151.5 101.31 2.8 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -93.23 105.48 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -146.75 99.53 3.21 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.2 m 66.82 108.45 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.189 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -72.04 -60.77 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.69 147.7 32.69 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.696 0.798 . . . . 0.0 110.676 169.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.98 -79.49 0.05 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.272 45.6 m-70 74.98 151.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.322 1.049 . . . . 0.0 112.391 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.45 7.34 5.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 165.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -105.91 -51.72 2.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.354 1.062 . . . . 0.0 111.049 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' MET . . . . . 0.414 ' SD ' HG22 ' A' ' 76' ' ' ILE . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -76.79 144.3 39.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.376 9.4 pt20 66.22 141.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -123.88 109.68 13.91 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 155.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.118 1.367 . . . . 0.0 112.183 -176.809 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.34 134.26 46.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.73 -40.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.41 0.684 . . . . 0.0 112.144 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm -50.52 -44.36 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 119.805 1.184 . . . . 0.0 113.908 165.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 -146.11 -179.74 6.93 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.08 -19.02 48.9 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 120.183 2.833 . . . . 0.0 120.183 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.255 37.5 mt-10 77.25 136.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.76 1.624 . . . . 0.0 111.075 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.88 116.15 40.9 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 117.556 -1.211 . . . . 0.0 111.143 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.61 -148.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.565 2.06 0 C-N-CA 123.081 2.521 . . . . 0.0 113.222 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.85 -27.92 53.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -76.12 -60.09 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.018 0.927 . . . . 0.0 111.237 158.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.49 -56.52 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -157.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -57.56 -31.28 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.984 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.4 -4.13 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.03 -44.62 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 -97.28 0.17 Allowed Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -130.86 163.78 26.66 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.527 1.155 . . . . 0.0 111.67 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.1 147.26 99.08 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.377 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -58.88 0.11 Allowed 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.128 2.552 . . . . 0.0 115.753 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.07 -69.3 0.62 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.814 1.188 . . . . 0.0 111.064 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.302 9.7 pt-20 46.13 42.55 9.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.23 82.52 0.22 Allowed Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.168 -0.796 . . . . 0.0 111.845 -162.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.86 94.4 5.82 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.489 0.662 . . . . 0.0 112.515 -164.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -173.37 94.29 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -127.91 91.17 3.22 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . 0.325 62.1 m 60.67 -102.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.662 1.185 . . . . 0.0 112.36 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.5 t -113.35 -67.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 160.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.0 84.66 0.17 Allowed Glycine 0 N--CA 1.479 1.559 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.3 145.81 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.495 0.718 . . . . 0.0 110.584 -174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 76.05 123.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.696 1.198 . . . . 0.0 113.349 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -77.0 133.98 38.97 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.689 0.757 . . . . 0.0 112.237 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -140.9 80.66 1.76 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -143.11 135.51 27.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -78.02 111.84 14.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t -75.76 138.06 40.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -77.67 107.57 10.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.432 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.8 mt -136.96 141.26 42.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.846 0.832 . . . . 0.0 109.977 -172.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.36 80.27 1.51 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -130.74 102.29 6.03 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -170.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.51 65.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 118.605 2.817 . . . . 0.0 118.605 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.63 -52.09 29.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -73.26 147.17 44.85 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -142.96 153.12 42.72 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.755 0.788 . . . . 0.0 110.972 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -95.08 133.85 38.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 N--CA 1.488 1.469 0 C-N-CA 123.146 0.578 . . . . 0.0 109.57 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -98.67 99.23 10.33 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.024 1.284 . . . . 0.0 108.456 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.444 HG23 ' SG ' ' A' ' 78' ' ' CYS . 16.9 mm -114.56 -38.26 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.001 -169.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.7 -43.94 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 124.702 1.201 . . . . 0.0 114.004 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HB3' ' HZ3' ' A' ' 15' ' ' LYS . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -122.57 -80.12 0.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 -128.37 3.2 Favored Glycine 0 CA--C 1.541 1.715 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -161.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.94 148.72 23.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.611 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.46 103.56 11.41 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 165.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.78 -173.39 1.19 Allowed 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.72 2.28 . . . . 0.0 114.451 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp -55.83 -26.68 47.83 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -77.72 -50.9 11.47 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.988 0.915 . . . . 0.0 113.206 159.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.2 -59.39 2.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.07 0.948 . . . . 0.0 112.85 -161.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -52.56 -27.96 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -1.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 168.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -41.1 -52.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 151.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.17 -120.89 2.12 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -145.85 98.36 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.323 7.7 m-20 55.52 152.0 0.06 OUTLIER Pre-proline 0 CA--C 1.576 1.943 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -63.34 -48.56 5.86 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.039 2.493 . . . . 0.0 115.693 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.68 -76.16 0.32 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.397 0.999 . . . . 0.0 110.196 168.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.263 0.9 OUTLIER 51.47 49.08 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.81 68.31 1.75 Allowed Glycine 0 CA--C 1.545 1.961 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.251 9.2 pt20 -90.15 67.48 6.92 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 tmp_? -156.39 108.44 2.53 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -140.67 140.93 35.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.8 m -59.39 -51.4 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.98 -72.18 0.4 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.807 0.73 . . . . 0.0 111.212 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.01 77.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.49 95.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.64 -64.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.627 1.171 . . . . 0.0 109.303 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 3.4 mp0 74.1 103.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.265 1.426 . . . . 0.0 112.405 169.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.3 ttp -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.09 113.29 7.23 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.89 106.65 5.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.83 80.48 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 m -157.61 128.83 6.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.3 t -142.07 106.83 4.87 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.1 150.96 33.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.906 0.86 . . . . 0.0 110.584 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.39 -62.68 0.46 Allowed Glycine 0 N--CA 1.485 1.913 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.907 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.388 87.0 m-70 91.19 -58.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.291 . . 77.28 -29.57 0.17 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -84.08 -51.45 7.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.7 1.136 . . . . 0.0 112.592 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -72.52 135.68 45.7 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -130.98 111.13 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -120.7 131.01 54.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 122.245 1.021 . . . . 0.0 112.689 -176.373 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.725 0.298 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.78 130.76 35.6 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.512 0.672 . . . . 0.0 111.021 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.15 -43.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.937 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm -47.34 -44.57 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -97.67 -95.61 0.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.06 -110.89 1.8 Allowed Glycine 0 N--CA 1.478 1.497 0 CA-C-N 118.232 0.469 . . . . 0.0 113.831 -165.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 149.65 24.29 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.949 0.881 . . . . 0.0 111.427 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.02 114.88 57.1 Favored Pre-proline 0 CA--C 1.569 1.684 0 CA-C-O 117.34 -1.314 . . . . 0.0 108.579 167.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.75 -168.56 0.41 Allowed 'Trans proline' 0 CA--C 1.567 2.172 0 C-N-CA 122.834 2.356 . . . . 0.0 114.439 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HZ2' ' HH ' ' A' ' 163' ' ' TYR . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -58.38 -24.1 58.93 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -78.37 -57.34 3.83 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.803 0.841 . . . . 0.0 111.978 160.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -87.1 -59.27 2.3 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.342 0.657 . . . . 0.0 112.754 -160.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -56.16 -32.5 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -13.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 171.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.08 -44.92 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.12 -83.44 0.06 OUTLIER Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -80.09 135.61 36.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -85.14 150.95 56.2 Favored Pre-proline 0 CA--C 1.571 1.788 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.536 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.11 -46.61 9.86 Favored 'Trans proline' 0 CA--C 1.56 1.783 0 C-N-CA 123.4 2.733 . . . . 0.0 117.381 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.43 -76.75 0.25 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.029 0.831 . . . . 0.0 109.16 173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 54.71 71.21 0.55 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 -79.36 1.92 Allowed Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.043 0.777 . . . . 0.0 115.043 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 65.24 74.1 0.39 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.907 1.283 . . . . 0.0 112.767 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.294 11.5 ptt-85 -163.23 -79.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.588 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.38 17.7 p80 63.02 137.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.2 m -79.07 -75.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.475 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 71.9 m -101.12 -70.05 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.726 0.694 . . . . 0.0 110.054 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.67 84.16 0.17 Allowed Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.98 115.95 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.92 103.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.652 1.181 . . . . 0.0 113.139 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.32 113.46 5.19 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.8 tpt -138.21 103.38 4.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -89.2 106.29 18.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.815 0.446 . . . . 0.0 110.395 -170.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 67.63 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.967 1.307 . . . . 0.0 113.84 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -141.65 114.64 8.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m -134.78 98.38 4.02 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -111.71 74.99 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.339 0.59 . . . . 0.0 110.029 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.06 143.94 31.26 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.91 0.862 . . . . 0.0 109.451 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -172.05 95.95 0.11 Allowed Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.52 138.38 8.5 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.943 0.878 . . . . 0.0 111.331 -166.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.63 -16.78 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 165.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.47 -46.7 8.91 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.955 1.252 . . . . 0.0 113.337 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.622 ' HH ' ' HZ2' ' A' ' 66' ' ' LYS . 3.3 p90 -73.38 141.52 47.0 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? 67.42 101.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.26 1.024 . . . . 0.0 112.691 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -81.23 125.15 29.96 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.282 0.563 . . . . 0.0 110.788 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -173.724 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -106.14 111.6 24.29 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.939 0.79 . . . . 0.0 109.195 -174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.16 -45.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.134 0.973 . . . . 0.0 109.983 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm -47.41 -44.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 169.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 -96.04 -111.79 0.14 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.59 173.34 47.52 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 118.987 0.812 . . . . 0.0 114.503 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -58.6 154.5 14.18 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.92 127.19 90.32 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.771 -166.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.38 -155.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.234 2.623 . . . . 0.0 113.703 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' O ' ' SD ' ' A' ' 60' ' ' MET . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.77 -24.98 38.75 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.52 -54.81 5.54 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.737 0.815 . . . . 0.0 112.327 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -91.79 -62.27 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.307 0.643 . . . . 0.0 112.255 -159.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.6 mm -54.83 -28.66 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 169.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.26 -12.0 2.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.8 p -45.66 -43.82 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 161.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.55 -94.42 0.11 Allowed Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -120.14 169.37 10.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.053 0.93 . . . . 0.0 111.846 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.69 152.17 59.52 Favored Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 123.718 0.807 . . . . 0.0 111.736 168.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.53 -58.6 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.725 0 C-N-CA 123.385 2.723 . . . . 0.0 116.321 -172.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -80.93 -69.15 0.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.411 0.685 . . . . 0.0 110.716 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 49.34 53.81 12.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.94 78.47 0.25 Allowed Glycine 0 CA--C 1.546 2.019 0 CA-C-O 119.084 -0.842 . . . . 0.0 113.47 -165.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.8 92.2 8.18 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 117.683 0.741 . . . . 0.0 110.834 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -164.1 92.55 0.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -95.54 -63.61 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.992 -156.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 t 71.57 114.03 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.823 1.249 . . . . 0.0 112.694 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.346 21.8 t 76.02 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.762 1.225 . . . . 0.0 112.414 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.36 -179.08 51.8 Favored Glycine 0 CA--C 1.547 2.071 0 CA-C-O 121.704 0.613 . . . . 0.0 114.321 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.53 121.2 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.39 143.75 27.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.848 0.832 . . . . 0.0 111.626 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -71.29 145.09 49.74 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -167.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 45.0 ttp -81.66 124.61 29.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 166.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -100.97 126.86 47.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.915 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.79 144.31 27.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.956 0.884 . . . . 0.0 111.676 -170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.52 108.2 20.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -100.06 73.33 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.231 0.539 . . . . 0.0 110.662 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 137.54 43.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.79 -66.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.643 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.06 83.11 0.44 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -107.32 113.5 26.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.76 -17.16 63.41 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.03 -45.39 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -71.88 158.31 36.29 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -90.93 126.94 36.21 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.389 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 143.18 27.01 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.285 0.634 . . . . 0.0 111.55 176.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 122.131 0.967 . . . . 0.0 109.791 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.952 0.406 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -77.16 134.96 38.52 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.244 0.618 . . . . 0.0 111.976 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.78 -47.19 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.708 0.803 . . . . 0.0 111.63 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -47.69 -43.01 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 168.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -115.48 131.73 56.84 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.62 -135.89 18.03 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 114.736 -1.12 . . . . 0.0 115.356 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.62 146.6 26.95 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.745 0.818 . . . . 0.0 110.758 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -81.87 114.5 50.89 Favored Pre-proline 0 CA--C 1.57 1.741 0 CA-C-O 117.409 -1.282 . . . . 0.0 109.022 168.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.17 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 123.056 2.504 . . . . 0.0 114.136 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.426 HD13 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.05 -26.53 38.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.23 -53.86 6.27 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 123.951 0.9 . . . . 0.0 113.006 159.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -80.46 -54.56 5.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -162.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 mm -52.73 -38.15 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.0 2.79 0.67 Allowed 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.92 -46.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 160.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.85 56.22 0.05 OUTLIER Glycine 0 CA--C 1.542 1.732 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.844 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt 62.7 136.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.837 1.255 . . . . 0.0 113.321 -170.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 0.4 OUTLIER 56.59 165.6 0.06 OUTLIER Pre-proline 0 CA--C 1.584 2.267 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.74 -60.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.029 2.486 . . . . 0.0 114.237 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.23 116.65 4.39 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 0.0 112.431 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 58.9 11.15 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 116.399 1.319 . . . . 0.0 116.399 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -92.71 125.95 37.56 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.601 0.7 . . . . 0.0 110.454 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -128.42 122.18 30.75 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.717 0.807 . . . . 0.0 109.391 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -96.55 137.52 35.5 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 18.0 t -74.04 167.69 21.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.24 120.2 14.7 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.347 0.659 . . . . 0.0 112.194 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.12 59.8 2.24 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 115.823 -0.626 . . . . 0.0 114.578 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.5 t -143.04 123.19 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.14 150.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 49.0 mt-30 64.34 49.16 2.59 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -175.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 26.7 ttt -176.83 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -134.19 140.22 46.36 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -59.12 -55.34 36.26 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 m80 75.51 131.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.598 1.159 . . . . 0.0 113.315 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 87.6 p -87.35 119.72 27.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.971 0.508 . . . . 0.0 109.805 167.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.1 m -76.16 -66.35 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.698 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.95 138.21 42.53 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.843 0.83 . . . . 0.0 108.897 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.92 85.78 0.06 OUTLIER Glycine 0 N--CA 1.476 1.309 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -93.49 150.27 20.57 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.254 0.622 . . . . 0.0 110.559 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.47 -11.26 16.48 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -87.08 -48.22 8.26 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.021 1.282 . . . . 0.0 113.144 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -72.4 173.22 9.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.09 122.89 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.912 0.485 . . . . 0.0 109.922 169.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -78.4 132.04 37.19 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 111.688 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.704 0.764 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.7 113.66 19.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.84 -45.1 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.406 -164.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm -52.09 -40.18 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 121.138 1.79 . . . . 0.0 113.914 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 20.9 ttm105 -143.86 -171.03 3.46 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' H ' ' HG2' ' A' ' 22' ' ' ARG . . . 87.26 -24.54 9.36 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 120.596 2.999 . . . . 0.0 120.596 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.261 37.1 mt-10 78.52 139.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.584 1.554 . . . . 0.0 111.333 -174.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -76.49 118.28 70.41 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.443 -1.265 . . . . 0.0 111.164 -171.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.39 -154.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.567 2.171 0 C-N-CA 123.141 2.561 . . . . 0.0 113.568 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.415 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -50.73 -33.65 23.8 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.2 ttp-105 -82.71 -52.59 6.64 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.478 1.111 . . . . 0.0 113.187 165.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -88.2 -58.16 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.761 0.709 . . . . 0.0 112.594 -158.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.6 mm -57.01 -32.05 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.56 -6.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.24 -47.46 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 159.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.81 -113.52 0.31 Allowed Glycine 0 CA--C 1.539 1.565 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.31 163.85 21.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.544 1.164 . . . . 0.0 113.344 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.42 160.14 82.34 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 114.423 -1.262 . . . . 0.0 113.196 166.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.38 -53.13 1.57 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.622 2.881 . . . . 0.0 116.098 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.7 mt -88.92 -39.52 13.71 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 117.57 -1.205 . . . . 0.0 113.898 165.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.91 115.22 14.27 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.709 1.595 . . . . 0.0 110.215 -172.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.26 -45.8 1.11 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 119.104 -0.831 . . . . 0.0 114.167 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -65.14 -69.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.218 1.009 . . . . 0.0 113.588 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 65.6 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.915 1.286 . . . . 0.0 111.62 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -113.69 -99.86 0.43 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.7 t -164.14 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.1 p -143.05 104.72 4.34 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.74 -172.23 54.29 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 121.841 0.689 . . . . 0.0 114.709 -173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t 68.32 101.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 124.827 1.251 . . . . 0.0 110.091 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.4 120.22 9.92 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.628 0.728 . . . . 0.0 109.642 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -135.28 136.83 41.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.511 1.125 . . . . 0.0 109.532 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 99.7 mmm 78.54 113.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.919 1.287 . . . . 0.0 111.745 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -110.15 116.52 31.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -90.72 94.06 9.52 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -164.96 122.75 1.62 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 m -64.83 -55.57 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 t 61.06 88.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.935 1.294 . . . . 0.0 113.287 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 mt -93.5 -101.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.139 -169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.35 105.22 0.64 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -136.7 115.14 11.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.73 -6.38 40.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.51 -48.91 7.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.694 1.134 . . . . 0.0 112.953 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -71.95 173.28 8.57 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -68.76 107.07 2.88 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.366 0.667 . . . . 0.0 110.714 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.78 103.68 10.91 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.019 -169.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -154.36 139.26 17.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 mt -77.75 -41.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.517 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -54.25 -37.39 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 121.066 1.757 . . . . 0.0 113.926 167.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD13 ' HZ1' ' A' ' 15' ' ' LYS . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HZ1' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -115.98 133.46 56.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.06 -119.47 6.04 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.512 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.92 152.35 36.23 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.665 0.786 . . . . 0.0 110.487 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -77.07 126.75 85.01 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.076 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -81.75 -150.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 123.293 2.662 . . . . 0.0 112.806 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HZ2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.621 ' HG1' ' HG2' ' A' ' 61' ' ' GLU . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.621 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.568 HG13 ' HZ2' ' A' ' 33' ' ' LYS . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.8 -29.05 62.35 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -77.05 -52.99 8.36 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.76 0.824 . . . . 0.0 112.857 158.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -85.47 -60.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -159.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -56.12 -31.38 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 170.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.35 -11.14 13.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.41 -42.78 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.12 -70.0 0.1 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.517 -164.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -81.57 139.93 34.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.209 1.004 . . . . 0.0 113.393 -174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.09 151.49 71.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.579 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.0 -38.25 23.17 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 123.145 2.564 . . . . 0.0 116.997 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.49 -78.92 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.184 0.902 . . . . 0.0 108.796 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 65.04 -0.63 1.01 Allowed 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 118.803 2.89 . . . . 0.0 118.803 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 68.45 1.53 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 119.989 1.268 . . . . 0.0 112.168 -161.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -91.1 113.57 25.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.113 0.565 . . . . 0.0 110.74 -169.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -90.2 115.08 27.16 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.2 m80 76.69 118.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.752 1.221 . . . . 0.0 111.66 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.3 -51.87 12.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 79.8 m -114.42 105.4 13.07 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.4 -93.76 0.13 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.23 98.54 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 168.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.35 111.78 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -91.2 147.79 22.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.533 0.733 . . . . 0.0 110.934 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -87.85 106.96 18.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.862 -161.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.15 161.46 14.26 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.497 0.719 . . . . 0.0 112.614 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . 0.253 7.8 t-80 73.62 95.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.085 1.354 . . . . 0.0 110.281 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t -133.38 -49.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.589 -168.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.6 p -155.76 138.0 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.246 1.385 . . . . 0.0 110.511 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.92 -84.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 118.794 -0.622 . . . . 0.0 109.645 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.58 -86.64 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 65.33 100.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.71 1.204 . . . . 0.0 112.434 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.55 38.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.36 -48.11 7.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.695 1.134 . . . . 0.0 112.996 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -75.86 156.54 34.27 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.16 115.41 18.36 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -116.36 133.9 55.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.514 -176.704 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.289 . . . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.27 122.63 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 111.385 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mm -90.67 -36.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.535 -174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm -51.73 -44.15 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 120.009 1.277 . . . . 0.0 113.771 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -125.83 135.57 52.13 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.8 21.85 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.121 168.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -102.78 148.03 26.12 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.047 0.939 . . . . 0.0 110.036 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.21 123.48 84.71 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.931 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.27 -171.9 1.29 Allowed 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 123.191 2.594 . . . . 0.0 113.386 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.417 ' HG1' ' HG3' ' A' ' 61' ' ' GLU . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.576 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' HG3' ' HG1' ' A' ' 35' ' ' THR . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 -27.41 61.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -83.39 -55.68 4.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.839 0.856 . . . . 0.0 112.449 162.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -80.92 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.603 0.761 . . . . 0.0 113.041 -160.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.9 mm -64.69 -31.25 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.68 -9.75 6.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 118.949 2.944 . . . . 0.0 118.949 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.66 -45.39 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.43 -115.69 0.6 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.74 163.98 14.86 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.63 151.28 39.92 Favored Pre-proline 0 CA--C 1.57 1.736 0 C-N-CA 124.201 1.0 . . . . 0.0 111.975 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.03 -44.02 22.0 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.467 2.778 . . . . 0.0 117.041 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.1 mt -86.0 -48.93 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.091 0.86 . . . . 0.0 112.702 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.07 104.37 9.66 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 119.631 1.105 . . . . 0.0 110.913 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.41 77.67 0.85 Allowed Glycine 0 CA--C 1.542 1.768 0 CA-C-O 119.554 -0.581 . . . . 0.0 113.382 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -79.39 -53.35 6.99 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 77.64 134.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.591 1.157 . . . . 0.0 112.871 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.262 83.7 m-70 78.58 107.38 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.792 1.237 . . . . 0.0 111.949 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.0 m -75.57 -60.27 2.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.829 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.92 110.2 13.91 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.28 112.48 4.04 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 115.858 1.103 . . . . 0.0 115.858 -160.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.48 80.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -169.45 165.64 10.45 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.916 0.865 . . . . 0.0 110.643 -165.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 141.22 58.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.711 -0.618 . . . . 0.0 111.904 163.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 87.5 mtp -62.51 -68.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -166.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.4 mtm-85 -138.42 85.99 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.151 0.887 . . . . 0.0 108.609 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 54.81 89.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.783 1.233 . . . . 0.0 114.317 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -108.19 73.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.63 0.728 . . . . 0.0 109.866 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 p -165.67 98.74 0.68 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.6 m -149.01 138.09 21.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.152 0.581 . . . . 0.0 110.471 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.1 mt -126.05 161.75 26.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.081 0.943 . . . . 0.0 111.296 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -120.55 -65.62 0.26 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 123.885 0.755 . . . . 0.0 111.994 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.391 92.9 m-70 90.03 -54.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.274 . . 73.51 -17.86 0.41 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -170.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.81 -52.02 5.08 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.795 1.179 . . . . 0.0 111.918 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -74.03 140.72 45.61 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.14 151.47 19.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.33 160.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -135.81 126.77 27.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -174.594 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.469 0.652 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.7 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.006 1.322 . . . . 0.0 112.047 -169.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.4 mt -84.64 -37.37 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.16 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.02 -43.35 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 124.686 1.194 . . . . 0.0 114.015 166.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -67.71 -50.95 54.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.9 -120.79 2.03 Favored Glycine 0 CA--C 1.544 1.9 0 C-N-CA 123.889 0.756 . . . . 0.0 112.693 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.42 146.38 40.68 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.982 0.913 . . . . 0.0 112.425 -170.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.44 121.37 66.55 Favored Pre-proline 0 CA--C 1.576 1.952 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.339 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.36 -150.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 123.29 2.66 . . . . 0.0 113.7 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.35 -28.48 59.21 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -77.99 -52.78 8.27 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 159.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.22 -57.16 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.054 0.941 . . . . 0.0 113.191 -160.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.34 -40.28 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 C-N-CA 124.993 1.317 . . . . 0.0 113.967 170.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.35 7.4 0.45 Allowed 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 119.35 3.093 . . . . 0.0 119.35 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.36 -42.52 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 159.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.48 -94.92 0.1 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -128.87 124.76 36.08 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.319 0.9 OUTLIER 57.21 155.71 0.08 OUTLIER Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -175.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.63 -56.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 123.368 2.712 . . . . 0.0 114.58 -171.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.5 mt -59.63 -35.52 74.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 163.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -69.0 100.76 1.26 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.619 1.168 . . . . 0.0 110.403 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.04 87.23 0.13 Allowed Glycine 0 CA--C 1.544 1.901 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.463 -170.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.34 103.41 15.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -142.12 155.99 45.36 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.312 1.053 . . . . 0.0 109.317 -168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -70.97 122.78 20.62 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.099 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.48 -57.07 4.17 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -170.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -84.76 92.8 8.31 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.069 0.849 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.71 -149.65 40.23 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.476 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.97 122.22 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.56 113.05 5.0 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -95.71 73.83 3.15 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.008 0.908 . . . . 0.0 110.222 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 28.3 ttt -161.5 94.74 0.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.85 96.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.583 1.153 . . . . 0.0 110.741 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.39 -77.75 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.188 0.595 . . . . 0.0 110.549 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 63.38 86.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.678 1.191 . . . . 0.0 113.51 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 m -76.07 -56.55 4.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.718 168.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 t -70.81 -62.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.103 0.865 . . . . 0.0 112.874 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.34 3.9 tt 77.79 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.649 1.179 . . . . 0.0 111.552 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.67 -77.76 0.24 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 74.32 97.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.02 61.07 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -86.46 -46.42 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -74.18 132.44 42.2 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 62.76 96.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.247 1.019 . . . . 0.0 112.543 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -81.13 125.96 30.89 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.398 0.618 . . . . 0.0 110.916 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.293 1.044 . . . . 0.0 108.769 -174.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.82 107.31 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.643 1.177 . . . . 0.0 110.309 -167.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -76.79 -43.59 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.107 0.563 . . . . 0.0 111.651 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.69 -44.75 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -133.64 -69.41 0.54 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -179.74 17.04 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 117.351 1.7 . . . . 0.0 117.351 -166.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.42 122.65 28.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.987 -0.713 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.39 113.52 11.88 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 117.394 -1.289 . . . . 0.0 109.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.08 -143.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.094 2.529 . . . . 0.0 112.939 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.56 ' HG1' ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.56 ' HG ' ' HG1' ' A' ' 40' ' ' THR . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -30.91 51.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -81.45 -55.82 4.44 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.618 0.767 . . . . 0.0 112.302 165.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -87.55 -59.37 2.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 119.043 0.838 . . . . 0.0 112.79 -160.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.73 -27.33 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.921 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.46 -16.94 4.26 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 118.883 2.92 . . . . 0.0 118.883 168.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -43.34 -47.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 161.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.06 -95.54 0.22 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 0.5 OUTLIER -146.58 174.21 11.63 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.597 0.713 . . . . 0.0 111.632 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -58.17 143.67 78.38 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.837 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.06 -58.78 0.67 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.104 2.536 . . . . 0.0 115.999 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -77.98 -69.42 0.55 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.025 0.829 . . . . 0.0 110.807 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 53.12 42.2 32.18 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 81.18 0.09 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.697 -161.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -73.59 96.74 2.5 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.82 -162.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -168.22 113.01 0.64 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -87.13 97.32 10.68 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.443 ' SG ' HG23 ' A' ' 124' ' ' VAL . 27.1 p -84.13 103.53 13.42 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.261 20.4 p 49.24 61.73 2.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.31 77.98 0.67 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.674 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.443 HG23 ' SG ' ' A' ' 121' ' ' CYS . 2.7 t -136.87 141.65 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.1 100.13 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.287 1.435 . . . . 0.0 111.533 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.08 -46.16 57.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.3 ptp -142.31 85.48 1.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.952 0.796 . . . . 0.0 109.101 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.8 109.37 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -125.34 149.66 47.89 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.825 0.821 . . . . 0.0 109.858 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -70.46 144.16 51.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.361 0.664 . . . . 0.0 112.274 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -69.61 113.33 6.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.247 0.619 . . . . 0.0 112.3 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -101.9 89.71 3.74 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.44 0.638 . . . . 0.0 109.307 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -96.73 142.63 28.52 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.764 0.826 . . . . 0.0 111.799 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.78 92.22 0.08 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -135.88 155.31 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.202 1.001 . . . . 0.0 109.33 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.05 -16.48 10.47 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.08 -49.34 11.88 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.625 1.102 . . . . 0.0 113.48 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -72.13 143.99 48.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -143.09 146.18 33.56 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.75 139.45 30.66 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 165.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.112 0.958 . . . . 0.0 109.29 -175.109 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 CA--C 1.564 1.987 0 N-CA-C 114.579 0.954 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.568 2.21 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.564 2.007 0 N-CA-C 114.511 0.927 . . . . 0.0 114.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 77' ' ' VAL . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 HG12 ' A' ' 95' ' ' VAL . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 36' ' ' PHE . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.558 HG12 HG11 ' A' ' 72' ' ' VAL . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 95' ' ' VAL . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.569 2.258 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 77' ' ' VAL . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 150' ' ' PHE . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.419 HD13 ' HB3' ' A' ' 89' ' ' LEU . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' A' ' 95' ' ' VAL . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.568 2.22 0 N-CA-C 114.437 0.899 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 95' ' ' VAL 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 72' ' ' VAL . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.563 1.93 0 N-CA-C 114.151 0.789 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 77' ' ' VAL . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 90' ' ' CYS . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 36' ' ' PHE . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 76' ' ' ILE . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 114.134 0.782 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 95' ' ' VAL 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG12 HG11 ' A' ' 72' ' ' VAL . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 95' ' ' VAL . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.565 2.046 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 72' ' ' VAL . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 72' ' ' VAL . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 95' ' ' VAL . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.918 0 CA-C-O 121.857 0.69 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CE2' HG11 ' A' ' 77' ' ' VAL . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.499 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 36' ' ' PHE . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.569 2.263 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 95' ' ' VAL 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.434 HG12 HG11 ' A' ' 72' ' ' VAL . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 119.426 -0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 . . . . . 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 CA--C 1.565 2.06 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 95' ' ' VAL 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG12 HG11 ' A' ' 72' ' ' VAL . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' CYS . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.564 1.977 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.41 ' HA ' HG22 ' A' ' 13' ' ' ILE . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 150' ' ' PHE . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 95' ' ' VAL . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.567 2.172 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 77' ' ' VAL . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 36' ' ' PHE . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.3 p90 . . . . . 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 CA--C 1.569 2.268 0 N-CA-C 113.703 0.617 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 77' ' ' VAL . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG11 HG12 ' A' ' 95' ' ' VAL 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 HG11 ' A' ' 72' ' ' VAL . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 70' ' ' LEU . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 95' ' ' VAL . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.568 2.194 0 N-CA-C 114.136 0.783 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' CD1' ' A' ' 150' ' ' PHE . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' THR . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 . . . . . 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.567 2.171 0 N-CA-C 113.568 0.565 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 95' ' ' VAL 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 150' ' ' PHE . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 70' ' ' LEU . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.467 ' CE1' HG11 ' A' ' 95' ' ' VAL . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.567 2.143 0 CA-C-O 120.862 0.276 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 95' ' ' VAL 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.416 HG22 ' HZ1' ' A' ' 15' ' ' LYS . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 72' ' ' VAL . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 70' ' ' LEU . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HE2' ' HE1' ' A' ' 73' ' ' TRP . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 CA--C 1.563 1.972 0 CA-C-O 121.473 0.53 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 150' ' ' PHE . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 72' ' ' VAL . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 70' ' ' LEU 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 . . . . . 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 CA--C 1.569 2.259 0 N-CA-C 113.7 0.615 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 95' ' ' VAL 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 HG11 ' A' ' 72' ' ' VAL . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.562 1.889 0 N-CA-C 112.939 0.323 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 150' ' ' PHE . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 72' ' ' VAL . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.552 HG12 HD22 ' A' ' 70' ' ' LEU . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -141.19 101.95 4.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -86.36 -39.94 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.183 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.51 -43.57 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 119.915 1.234 . . . . 0.0 113.786 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -143.68 143.84 31.6 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.98 -165.05 30.28 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.526 -1.216 . . . . 0.0 115.509 169.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.73 139.73 30.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.128 -1.036 . . . . 0.0 109.803 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.22 114.7 37.97 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.831 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 -169.46 0.73 Allowed 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.884 2.389 . . . . 0.0 114.579 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -57.08 -27.25 61.58 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -77.89 -55.74 5.07 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.08 0.952 . . . . 0.0 112.249 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -85.08 -58.36 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -160.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.18 -30.37 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.042 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.37 -2.36 1.47 Allowed 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.12 -46.9 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 161.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.96 67.12 0.03 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.012 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 63.54 109.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.748 1.219 . . . . 0.0 113.439 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.293 1.1 m-20 60.79 155.46 0.11 Allowed Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.69 -66.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 123.087 2.525 . . . . 0.0 114.138 -173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp -67.45 -33.81 75.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.49 -57.39 10.07 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.76 83.07 0.32 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 165.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -94.0 72.58 4.07 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.833 0.825 . . . . 0.0 109.968 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -170.66 140.51 1.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.677 0.791 . . . . 0.0 109.252 -165.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -95.99 87.03 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.6 m -135.16 75.82 1.59 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.87 0.843 . . . . 0.0 108.95 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.59 -68.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.34 63.64 0.21 Allowed Glycine 0 CA--C 1.541 1.687 0 CA-C-N 118.594 0.634 . . . . 0.0 112.916 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.6 t -144.11 105.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.64 128.26 9.36 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.148 0.499 . . . . 0.0 109.977 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.256 2.5 mp0 69.63 77.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.776 1.23 . . . . 0.0 111.606 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.2 tpt -157.83 108.52 2.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.04 97.88 9.6 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -150.97 131.11 13.5 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.12 114.91 23.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 167.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 t -74.36 -65.74 0.81 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.462 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.5 m 68.32 101.75 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.676 1.19 . . . . 0.0 112.384 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.65 135.94 36.12 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.526 0.679 . . . . 0.0 111.556 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.44 85.21 0.05 OUTLIER Glycine 0 N--CA 1.476 1.323 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -87.17 157.15 19.42 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.805 0.812 . . . . 0.0 111.012 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.33 -21.26 11.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 164.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.35 -53.13 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 119.425 1.011 . . . . 0.0 113.25 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -73.99 137.94 43.81 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -151.49 145.68 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 110.455 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -90.54 143.08 27.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.447 0.641 . . . . 0.0 110.785 167.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.279 1.038 . . . . 0.0 110.171 -177.819 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.419 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.78 133.03 49.31 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.291 0.636 . . . . 0.0 111.496 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -81.63 -40.36 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.409 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -50.56 -42.79 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 120.205 1.366 . . . . 0.0 113.761 165.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -104.2 84.84 2.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.48 -137.33 9.27 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 111.94 -2.391 . . . . 0.0 113.32 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.6 139.46 52.27 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.993 0.917 . . . . 0.0 111.407 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.54 130.53 94.75 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.532 -1.223 . . . . 0.0 113.924 -166.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.42 -144.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 123.488 2.792 . . . . 0.0 113.891 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.81 -24.24 49.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -82.36 -55.71 4.34 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.99 0.916 . . . . 0.0 112.174 160.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -82.89 -62.54 1.57 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.499 0.72 . . . . 0.0 112.593 -162.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -58.49 -31.12 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.5 -13.14 37.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.75 -47.78 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 120.411 1.46 . . . . 0.0 114.356 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.4 30.13 0.02 OUTLIER Glycine 0 CA--C 1.548 2.138 0 CA-C-O 118.282 -1.288 . . . . 0.0 115.724 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -147.68 119.42 8.06 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.138 1.469 . . . . 0.0 108.301 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -83.2 152.09 64.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.9 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.5 -61.52 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.189 2.593 . . . . 0.0 114.926 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -71.15 -64.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.19 0.904 . . . . 0.0 112.003 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 52.68 66.76 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.056 1.342 . . . . 0.0 114.602 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.46 -82.37 1.52 Allowed Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.991 -0.338 . . . . 0.0 112.625 -169.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 62.75 80.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.752 1.221 . . . . 0.0 113.098 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.01 99.45 3.46 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -96.11 144.22 26.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.562 0.745 . . . . 0.0 111.232 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.3 175.86 7.96 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.65 -58.66 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.15 50.01 1.7 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-N 119.219 0.918 . . . . 0.0 115.191 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -148.96 114.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.72 85.07 1.1 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -158.81 104.79 1.77 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.7 tpt -146.57 -69.76 0.25 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.344 0.657 . . . . 0.0 109.709 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.56 93.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.637 1.175 . . . . 0.0 110.527 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -77.26 119.29 20.71 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.267 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -80.15 142.58 34.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -89.01 119.67 29.74 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.204 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m -90.14 103.06 15.77 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.166 0.508 . . . . 0.0 110.88 -173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.82 147.03 49.83 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.964 0.905 . . . . 0.0 108.825 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.73 67.51 0.18 Allowed Glycine 0 N--CA 1.48 1.581 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.151 167.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -149.17 147.59 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 -18.26 12.57 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -85.62 -47.18 10.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.079 1.309 . . . . 0.0 113.089 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -74.53 151.9 39.42 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.48 146.52 44.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.648 163.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -102.96 122.4 44.52 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.97 0.89 . . . . 0.0 110.547 -171.199 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -116.94 105.23 12.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 mm -76.14 -40.47 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 123.322 0.649 . . . . 0.0 112.215 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm -48.2 -46.0 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 125.353 1.461 . . . . 0.0 114.26 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 145.61 44.85 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.77 -148.93 22.03 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.698 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.814 0.846 . . . . 0.0 110.078 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.45 114.29 36.93 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.142 170.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.16 -166.09 0.36 Allowed 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.921 2.414 . . . . 0.0 114.511 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 77' ' ' VAL . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 HG12 ' A' ' 95' ' ' VAL . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 36' ' ' PHE . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.558 HG12 HG11 ' A' ' 72' ' ' VAL . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.71 -29.57 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -77.62 -56.04 4.85 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 118.759 0.708 . . . . 0.0 112.259 158.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -83.62 -63.18 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.127 0.876 . . . . 0.0 112.252 -158.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -59.82 -22.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.57 -8.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -47.61 -50.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 157.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.83 -91.78 0.08 OUTLIER Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -130.11 167.74 17.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.901 1.334 . . . . 0.0 111.5 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.33 159.04 43.3 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -61.12 -48.54 9.88 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.392 2.728 . . . . 0.0 116.56 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 mt -92.47 -46.31 7.71 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.886 164.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 106.24 3.29 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 119.554 1.07 . . . . 0.0 110.734 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.54 -88.04 0.51 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.476 -0.625 . . . . 0.0 111.685 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.334 75.3 mt-30 66.69 -91.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.411 1.084 . . . . 0.0 111.837 -169.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -78.72 130.75 36.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.429 0.692 . . . . 0.0 110.408 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -83.19 115.67 22.03 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.322 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.37 -69.68 0.69 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.97 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.33 94.83 5.44 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.762 0.71 . . . . 0.0 109.578 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.49 -86.63 0.12 Allowed Glycine 0 N--CA 1.478 1.482 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.2 t 72.71 97.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 125.118 1.367 . . . . 0.0 108.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 110.68 3.48 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.238 -165.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -136.75 112.5 9.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.96 153.92 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.547 0.739 . . . . 0.0 111.543 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -85.99 93.48 8.97 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -133.47 127.93 34.35 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -77.9 123.23 26.51 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.056 0.543 . . . . 0.0 110.946 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.1 t -89.19 101.18 13.84 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.25 0.548 . . . . 0.0 109.743 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.4 t -135.05 -74.51 0.46 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.9 tp 74.37 132.81 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.713 1.205 . . . . 0.0 113.998 164.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.42 95.03 0.11 Allowed Glycine 0 N--CA 1.476 1.355 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -120.04 110.74 17.03 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -13.66 61.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 -45.64 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.409 1.004 . . . . 0.0 113.327 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 95' ' ' VAL . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -71.42 170.68 12.73 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -78.73 104.38 9.31 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -105.79 134.86 48.23 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.657 0.783 . . . . 0.0 109.468 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.072 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.34 . . . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.21 116.17 18.76 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.7 mm -93.31 -48.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 118.543 -0.742 . . . . 0.0 110.869 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.46 -41.09 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.803 1.183 . . . . 0.0 113.662 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -117.1 136.74 52.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.42 -114.59 4.16 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.81 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.43 160.43 41.59 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.881 0.848 . . . . 0.0 110.861 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.52 126.04 81.62 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.724 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.53 -160.78 0.13 Allowed 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.118 2.545 . . . . 0.0 113.249 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 77' ' ' VAL . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 150' ' ' PHE . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.65 -28.91 61.62 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -82.53 -55.01 4.73 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.483 0.713 . . . . 0.0 112.23 161.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -84.61 -62.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.876 0.762 . . . . 0.0 111.875 -159.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -60.36 -28.52 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.889 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -12.68 3.5 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 118.778 2.881 . . . . 0.0 118.778 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.77 -48.54 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.58 66.48 0.15 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.788 -0.451 . . . . 0.0 113.741 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.267 3.2 mmmp? 70.01 163.32 0.24 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 167.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 151.11 86.02 Favored Pre-proline 0 CA--C 1.571 1.782 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.8 -47.73 2.49 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.383 2.722 . . . . 0.0 115.635 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.24 -44.66 87.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.85 98.01 4.07 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.143 0.883 . . . . 0.0 109.752 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.32 76.73 1.13 Allowed Glycine 0 CA--C 1.543 1.835 0 CA-C-O 119.406 -0.663 . . . . 0.0 113.895 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -126.83 111.78 14.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 166.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.64 100.36 12.89 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -115.2 143.65 44.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.429 0.692 . . . . 0.0 111.898 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.03 179.23 7.46 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 76.1 m -68.37 115.16 7.48 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.419 0.687 . . . . 0.0 112.455 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.47 54.72 6.55 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.0 t -145.08 103.28 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.84 116.4 1.66 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 69.21 91.83 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.607 1.163 . . . . 0.0 111.508 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.2 ptm -147.09 122.51 10.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.29 110.02 12.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.83 -62.81 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.469 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.1 135.38 50.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.965 0.802 . . . . 0.0 109.79 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -91.4 113.86 26.24 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.215 0.606 . . . . 0.0 110.751 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.2 t -89.69 159.09 17.28 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.404 0.682 . . . . 0.0 111.504 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.454 0.4 OUTLIER 84.75 143.83 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 125.573 1.549 . . . . 0.0 113.511 177.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.49 96.76 0.13 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -132.69 116.71 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.58 -6.15 59.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -90.48 -47.01 7.97 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.847 1.203 . . . . 0.0 112.523 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.419 HD13 ' HB3' ' A' ' 89' ' ' LEU . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' A' ' 95' ' ' VAL . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -71.14 143.79 50.45 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? 68.28 96.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.514 1.125 . . . . 0.0 111.364 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -81.59 132.95 35.32 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.495 0.665 . . . . 0.0 111.794 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -170.614 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.64 119.43 21.88 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 163.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.6 mt -81.23 -39.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 118.396 -0.812 . . . . 0.0 112.201 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm -48.99 -45.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 120.277 1.398 . . . . 0.0 113.729 164.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -134.38 141.26 46.8 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.02 -138.66 20.31 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 115.047 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.37 147.31 24.82 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.824 0.85 . . . . 0.0 111.957 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -92.86 109.97 42.62 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.018 163.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.45 -155.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.175 2.584 . . . . 0.0 114.437 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 95' ' ' VAL 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 72' ' ' VAL . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER -56.55 -29.06 61.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -79.98 -53.41 6.76 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 123.815 0.846 . . . . 0.0 112.666 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -83.22 -61.51 1.83 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.575 0.75 . . . . 0.0 112.776 -159.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.68 -32.56 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.18 -3.5 1.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 118.951 2.945 . . . . 0.0 118.951 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.29 -47.94 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 159.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.61 59.75 0.28 Allowed Glycine 0 CA--C 1.539 1.547 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.663 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 32.2 mmmt 63.7 174.82 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.77 152.19 87.16 Favored Pre-proline 0 CA--C 1.573 1.841 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.61 -49.11 6.06 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.303 2.668 . . . . 0.0 117.052 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.22 -69.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.704 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.342 9.8 pt-20 56.56 -170.69 0.09 Allowed 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.77 105.99 2.38 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 155.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -76.26 94.44 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.074 0.55 . . . . 0.0 111.936 -162.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -173.24 95.75 0.11 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -158.76 93.74 1.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.2 t -142.08 65.85 1.36 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 160.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.1 t -169.21 -67.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.87 0.868 . . . . 0.0 109.631 -171.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.72 -92.97 0.83 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.362 -0.688 . . . . 0.0 112.725 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.88 100.02 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.27 70.76 0.93 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.427 0.632 . . . . 0.0 109.76 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -146.49 126.99 14.1 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -163.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 70.73 97.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.801 1.241 . . . . 0.0 111.229 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.83 93.76 9.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.45 132.39 13.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -159.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -83.56 98.48 9.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.2 t -81.35 114.66 20.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.08 0.552 . . . . 0.0 110.043 -175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.6 p -101.18 155.14 18.19 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.125 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.11 145.02 56.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.6 84.76 0.06 OUTLIER Glycine 0 N--CA 1.476 1.32 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -142.59 147.79 36.44 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.52 -20.67 11.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 164.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.49 -49.5 21.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -74.79 136.08 41.66 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -150.16 103.68 3.2 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.59 124.91 51.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.772 -176.399 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.57 109.32 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mm -83.81 -40.2 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.173 0.589 . . . . 0.0 112.275 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -50.95 -47.13 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.688 1.195 . . . . 0.0 113.415 165.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -96.49 -93.16 0.21 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 -109.2 3.0 Favored Glycine 0 N--CA 1.479 1.525 0 CA-C-N 117.861 0.3 . . . . 0.0 113.696 -164.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.46 138.24 33.41 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.868 0.842 . . . . 0.0 111.278 -167.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -85.04 110.51 28.94 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.331 -1.318 . . . . 0.0 107.674 166.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -176.23 2.26 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.739 2.293 . . . . 0.0 114.151 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 77' ' ' VAL . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 90' ' ' CYS . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 36' ' ' PHE . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 76' ' ' ILE . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.84 -29.21 54.56 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -80.88 -57.38 3.57 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.669 0.788 . . . . 0.0 112.252 160.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -82.01 -61.0 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.817 0.735 . . . . 0.0 112.899 -159.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -54.18 -35.43 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.68 10.62 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.46 -42.8 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.92 -83.74 0.05 OUTLIER Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.518 -0.601 . . . . 0.0 111.62 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -78.66 129.46 34.76 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 0.0 112.183 -173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.95 139.35 26.42 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.728 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.55 -47.37 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 123.472 2.781 . . . . 0.0 115.524 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -66.03 -41.79 90.47 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.85 -51.98 66.9 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.73 -96.53 0.26 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.008 -0.884 . . . . 0.0 112.539 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.364 6.0 pt20 45.41 79.34 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.253 54.6 ttt85 68.96 91.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.923 -166.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -82.7 134.15 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.492 0.717 . . . . 0.0 111.301 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.6 p -124.09 -53.76 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.833 0.853 . . . . 0.0 112.763 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 27.3 p -95.11 125.73 39.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 119.2 0.909 . . . . 0.0 110.512 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.61 -74.89 0.56 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.994 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.437 3.5 m 72.02 124.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 125.408 1.483 . . . . 0.0 114.669 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.65 173.56 6.41 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.03 0.919 . . . . 0.0 111.392 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -64.39 -47.1 80.51 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 13.1 ttt 61.06 66.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.89 1.276 . . . . 0.0 113.845 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -138.3 85.04 2.07 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -145.98 87.44 1.76 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -151.54 39.64 0.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.4 m -154.26 95.55 1.84 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -155.54 104.08 2.35 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.08 146.98 27.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.88 0.848 . . . . 0.0 111.298 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.05 86.47 0.06 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -163.97 131.19 3.31 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.696 0.76 . . . . 0.0 110.917 -163.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.27 -12.88 3.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.1 -52.05 5.65 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.216 1.371 . . . . 0.0 112.487 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -72.12 170.63 13.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -75.88 101.62 5.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -91.45 130.18 37.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.456 0.646 . . . . 0.0 110.377 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.71 110.69 19.49 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.7 mm -87.74 -44.11 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.509 -169.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -52.61 -40.95 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 120.684 1.584 . . . . 0.0 113.694 167.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.54 152.12 51.02 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.92 -158.34 52.08 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 113.374 -1.739 . . . . 0.0 115.97 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.0 146.24 25.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.641 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.0 116.7 49.19 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 117.391 -1.29 . . . . 0.0 110.257 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.54 -158.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.929 2.42 . . . . 0.0 114.134 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 95' ' ' VAL 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG12 HG11 ' A' ' 72' ' ' VAL . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -23.21 34.76 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -82.37 -59.55 2.5 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.467 0.707 . . . . 0.0 111.989 160.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -79.02 -60.46 2.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.973 0.509 . . . . 0.0 112.188 -160.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.34 -38.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.8 -8.24 4.6 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.897 2.925 . . . . 0.0 118.897 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.2 -41.16 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.42 -81.04 0.06 OUTLIER Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -83.92 118.22 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.629 0.728 . . . . 0.0 111.21 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.52 151.41 38.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.378 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.99 -50.59 1.02 Allowed 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.475 2.783 . . . . 0.0 115.709 -170.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.74 -42.13 15.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 165.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.69 104.84 7.41 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.645 1.111 . . . . 0.0 110.547 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.45 80.39 0.78 Allowed Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.585 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.96 -66.0 0.95 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.128 0.571 . . . . 0.0 110.422 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -75.03 -66.8 0.71 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.524 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.5 m80 72.83 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.822 1.249 . . . . 0.0 112.16 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 42.8 t -143.24 133.91 25.13 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.293 0.637 . . . . 0.0 110.335 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.4 t 68.68 92.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.079 1.352 . . . . 0.0 112.63 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.76 11.52 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.384 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.294 11.0 m 36.16 91.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 166.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 107.5 3.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.04 110.42 20.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -112.14 75.21 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.797 0.808 . . . . 0.0 110.031 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -157.82 115.19 2.98 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -119.08 128.6 54.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.392 0.615 . . . . 0.0 110.493 -168.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -148.24 93.67 2.2 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 170.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.6 m -128.14 92.6 3.48 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 168.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.8 m -133.78 -70.07 0.53 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.194 -167.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mp 73.33 127.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.75 1.22 . . . . 0.0 110.837 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.52 87.99 0.07 OUTLIER Glycine 0 N--CA 1.476 1.306 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -137.31 153.19 50.33 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.023 0.916 . . . . 0.0 109.15 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.36 -10.8 10.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -90.37 -45.14 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.751 1.16 . . . . 0.0 113.259 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 95' ' ' VAL . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -72.9 145.28 46.96 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.331 5.3 pt20 64.25 161.14 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -104.2 123.01 46.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 158.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 122.223 1.011 . . . . 0.0 108.329 179.649 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.34 0.59 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.5 118.18 23.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.37 -40.91 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -47.9 -45.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 125.09 1.356 . . . . 0.0 114.467 164.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -122.31 139.23 54.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.97 -132.93 11.59 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.027 -0.988 . . . . 0.0 115.034 166.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.07 149.64 28.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.397 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.26 112.88 52.47 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.063 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.66 -165.95 0.35 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.863 2.375 . . . . 0.0 114.407 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 72' ' ' VAL . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 72' ' ' VAL . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -25.81 40.06 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -79.52 -56.09 4.57 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 123.787 0.835 . . . . 0.0 112.349 161.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -88.46 -56.13 3.44 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -160.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.99 -31.89 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -5.12 2.04 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 171.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.6 -48.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 160.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.83 -88.8 0.44 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 170.92 15.94 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.046 0.927 . . . . 0.0 112.182 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.22 143.68 77.29 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 123.524 0.73 . . . . 0.0 111.225 171.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.89 -59.99 0.13 Allowed 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 122.867 2.378 . . . . 0.0 115.756 -163.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mp -83.63 -68.85 0.68 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.937 0.79 . . . . 0.0 110.975 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.321 13.2 pt-20 46.48 40.41 8.08 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.13 82.71 0.32 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.715 -159.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -72.81 112.65 9.03 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.449 0.624 . . . . 0.0 111.779 -169.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.59 108.02 6.51 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -106.94 142.23 36.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.382 0.673 . . . . 0.0 112.206 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.6 p -84.07 -67.6 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.948 164.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.2 p -88.6 -64.42 1.15 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.88 0.763 . . . . 0.0 112.323 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.87 92.46 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.2 t -104.61 95.14 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.76 127.14 3.54 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -171.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 76.7 mm-40 74.3 100.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.723 1.209 . . . . 0.0 111.038 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.54 111.72 23.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -84.54 108.54 17.36 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 -156.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.05 92.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.02 1.328 . . . . 0.0 113.103 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -127.88 83.53 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p -161.76 96.71 1.04 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.6 m -126.71 101.07 6.47 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.94 147.78 25.61 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.801 0.81 . . . . 0.0 112.548 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.2 81.83 0.05 OUTLIER Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -168.65 131.02 1.34 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.759 0.79 . . . . 0.0 110.246 -164.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -131.38 -16.25 3.11 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 164.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.53 -46.17 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 120.065 1.302 . . . . 0.0 113.172 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 95' ' ' VAL . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -69.51 140.08 53.9 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 64.74 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.35 1.06 . . . . 0.0 113.039 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.03 125.07 33.15 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.238 0.542 . . . . 0.0 110.004 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -174.049 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -92.97 159.26 15.4 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 110.598 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 mm -75.1 -43.06 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.793 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm -51.59 -42.3 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 120.187 1.358 . . . . 0.0 113.296 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -90.13 -65.0 1.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.83 -160.47 14.14 Favored Glycine 0 CA--C 1.546 1.979 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.54 149.79 22.02 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.498 0.719 . . . . 0.0 110.751 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.82 120.14 80.31 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.291 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.67 -179.92 5.61 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 122.911 2.407 . . . . 0.0 113.647 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CE2' HG11 ' A' ' 77' ' ' VAL . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 36' ' ' PHE . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -57.66 -21.25 38.9 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -83.41 -56.5 3.72 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 118.89 0.768 . . . . 0.0 111.863 156.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -80.27 -60.16 2.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -160.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.9 mm -54.55 -41.47 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -3.31 5.99 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.5 p -59.97 -40.35 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 168.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.38 -80.33 0.05 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -75.8 119.01 19.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.494 0.718 . . . . 0.0 111.326 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.17 154.8 36.96 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 172.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.11 -35.91 31.51 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.901 2.401 . . . . 0.0 116.013 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.75 -70.73 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.012 0.824 . . . . 0.0 110.273 164.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.298 0.6 OUTLIER 64.92 -166.34 0.23 Allowed 'General case' 0 CA--C 1.572 1.823 0 C-N-CA 124.583 1.153 . . . . 0.0 113.175 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.23 99.73 2.27 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 111.032 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -81.5 111.9 18.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.188 0.595 . . . . 0.0 109.95 -168.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.263 98.6 mtt180 66.28 89.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.589 1.156 . . . . 0.0 111.056 -166.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -90.32 127.73 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.778 0.831 . . . . 0.0 110.961 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.26 -59.67 2.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.1 m -79.59 -69.09 0.61 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.846 0.748 . . . . 0.0 112.173 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 175.23 89.63 0.08 OUTLIER Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.32 87.83 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.91 107.32 2.31 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -100.48 112.73 25.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -164.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 67.8 mtt -94.93 107.92 19.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -154.67 131.78 10.98 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.6 -56.0 7.52 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 74.32 134.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.835 1.254 . . . . 0.0 112.691 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.6 p -79.29 98.82 6.82 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.195 0.522 . . . . 0.0 110.182 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.8 m -89.23 135.84 33.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.714 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.432 0.4 OUTLIER 62.91 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -175.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.72 83.78 0.05 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.01 134.57 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 110.694 -161.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.76 -12.33 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -92.12 -48.0 6.95 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.413 1.46 . . . . 0.0 113.025 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -73.46 118.39 16.36 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 57.33 85.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.317 1.047 . . . . 0.0 113.028 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -103.79 105.63 15.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.483 1.197 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 -171.159 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.055 0.455 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 140.17 40.27 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.76 167.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.269 23.7 mt -78.4 -44.51 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.665 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.35 -39.69 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.963 1.711 . . . . 0.0 114.134 167.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 138.92 44.08 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.86 -168.2 17.97 Favored Glycine 0 CA--C 1.543 1.833 0 CA-C-O 122.419 1.01 . . . . 0.0 115.23 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.77 141.89 28.24 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.425 -0.888 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -84.12 115.12 58.55 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.608 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.85 -164.05 0.19 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 123.062 2.508 . . . . 0.0 115.11 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 95' ' ' VAL 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.434 HG12 HG11 ' A' ' 72' ' ' VAL . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.98 -24.18 37.0 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -83.65 -56.13 3.89 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.881 0.872 . . . . 0.0 112.192 160.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -82.36 -59.18 2.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -161.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.57 -34.95 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.919 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.71 2.48 2.48 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 p -49.86 -45.49 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 162.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.82 0.09 OUTLIER Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.0 -0.889 . . . . 0.0 113.453 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 62.84 132.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.066 1.346 . . . . 0.0 114.58 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 62.16 163.12 0.11 Allowed Pre-proline 0 CA--C 1.577 2.005 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 166.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -52.1 0.99 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.022 2.481 . . . . 0.0 115.556 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.14 -86.16 0.2 Allowed 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 36.02 68.03 0.26 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.51 59.9 9.93 Favored Glycine 0 CA--C 1.549 2.201 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.23 117.72 29.2 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.126 0.963 . . . . 0.0 111.686 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -94.6 -51.91 4.53 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.49 0.716 . . . . 0.0 112.286 165.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.253 31.7 m170 67.81 85.39 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.222 1.409 . . . . 0.0 112.207 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.2 t -145.39 78.59 1.55 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.602 0.715 . . . . 0.0 109.536 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.6 t -149.67 78.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.4 49.81 70.59 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 116.409 1.324 . . . . 0.0 116.409 -163.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.19 130.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 77.81 126.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.955 1.302 . . . . 0.0 112.655 175.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 65.72 69.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.768 1.227 . . . . 0.0 112.534 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 46.6 ttm -154.79 -96.26 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -151.5 101.31 2.8 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -93.23 105.48 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -146.75 99.53 3.21 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.2 m 66.82 108.45 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.189 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -72.04 -60.77 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.69 147.7 32.69 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.696 0.798 . . . . 0.0 110.676 169.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.98 -79.49 0.05 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.272 45.6 m-70 74.98 151.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.322 1.049 . . . . 0.0 112.391 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.45 7.34 5.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 165.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -105.91 -51.72 2.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.354 1.062 . . . . 0.0 111.049 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -76.79 144.3 39.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.376 9.4 pt20 66.22 141.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -123.88 109.68 13.91 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 155.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.118 1.367 . . . . 0.0 112.183 -176.809 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.34 134.26 46.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.73 -40.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.41 0.684 . . . . 0.0 112.144 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm -50.52 -44.36 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 119.805 1.184 . . . . 0.0 113.908 165.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 -146.11 -179.74 6.93 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.08 -19.02 48.9 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 120.183 2.833 . . . . 0.0 120.183 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.255 37.5 mt-10 77.25 136.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.76 1.624 . . . . 0.0 111.075 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.88 116.15 40.9 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 117.556 -1.211 . . . . 0.0 111.143 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.61 -148.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.565 2.06 0 C-N-CA 123.081 2.521 . . . . 0.0 113.222 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 95' ' ' VAL 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG12 HG11 ' A' ' 72' ' ' VAL . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.85 -27.92 53.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -76.12 -60.09 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.018 0.927 . . . . 0.0 111.237 158.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.49 -56.52 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -157.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -57.56 -31.28 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.984 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.4 -4.13 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.03 -44.62 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 -97.28 0.17 Allowed Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -130.86 163.78 26.66 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.527 1.155 . . . . 0.0 111.67 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.1 147.26 99.08 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.377 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -58.88 0.11 Allowed 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.128 2.552 . . . . 0.0 115.753 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.07 -69.3 0.62 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.814 1.188 . . . . 0.0 111.064 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.302 9.7 pt-20 46.13 42.55 9.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.23 82.52 0.22 Allowed Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.168 -0.796 . . . . 0.0 111.845 -162.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.86 94.4 5.82 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.489 0.662 . . . . 0.0 112.515 -164.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -173.37 94.29 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -127.91 91.17 3.22 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . 0.325 62.1 m 60.67 -102.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.662 1.185 . . . . 0.0 112.36 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.5 t -113.35 -67.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 160.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.0 84.66 0.17 Allowed Glycine 0 N--CA 1.479 1.559 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.3 145.81 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.495 0.718 . . . . 0.0 110.584 -174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 76.05 123.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.696 1.198 . . . . 0.0 113.349 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -77.0 133.98 38.97 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.689 0.757 . . . . 0.0 112.237 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -140.9 80.66 1.76 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -143.11 135.51 27.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -78.02 111.84 14.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t -75.76 138.06 40.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -77.67 107.57 10.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.432 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.8 mt -136.96 141.26 42.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.846 0.832 . . . . 0.0 109.977 -172.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.36 80.27 1.51 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -130.74 102.29 6.03 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -170.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.51 65.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 118.605 2.817 . . . . 0.0 118.605 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.63 -52.09 29.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -73.26 147.17 44.85 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -142.96 153.12 42.72 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.755 0.788 . . . . 0.0 110.972 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -95.08 133.85 38.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 N--CA 1.488 1.469 0 C-N-CA 123.146 0.578 . . . . 0.0 109.57 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -98.67 99.23 10.33 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.024 1.284 . . . . 0.0 108.456 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 78' ' ' CYS . 16.9 mm -114.56 -38.26 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.001 -169.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.7 -43.94 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 124.702 1.201 . . . . 0.0 114.004 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' CYS . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -122.57 -80.12 0.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 -128.37 3.2 Favored Glycine 0 CA--C 1.541 1.715 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -161.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.94 148.72 23.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.611 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.46 103.56 11.41 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 165.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.78 -173.39 1.19 Allowed 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.72 2.28 . . . . 0.0 114.451 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.41 ' HA ' HG22 ' A' ' 13' ' ' ILE . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 150' ' ' PHE . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp -55.83 -26.68 47.83 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -77.72 -50.9 11.47 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.988 0.915 . . . . 0.0 113.206 159.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.2 -59.39 2.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.07 0.948 . . . . 0.0 112.85 -161.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -52.56 -27.96 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -1.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 168.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -41.1 -52.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 151.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.17 -120.89 2.12 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -145.85 98.36 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.323 7.7 m-20 55.52 152.0 0.06 OUTLIER Pre-proline 0 CA--C 1.576 1.943 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -63.34 -48.56 5.86 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.039 2.493 . . . . 0.0 115.693 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.68 -76.16 0.32 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.397 0.999 . . . . 0.0 110.196 168.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.263 0.9 OUTLIER 51.47 49.08 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.81 68.31 1.75 Allowed Glycine 0 CA--C 1.545 1.961 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.251 9.2 pt20 -90.15 67.48 6.92 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 tmp_? -156.39 108.44 2.53 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -140.67 140.93 35.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.8 m -59.39 -51.4 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.98 -72.18 0.4 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.807 0.73 . . . . 0.0 111.212 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.01 77.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.49 95.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.64 -64.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.627 1.171 . . . . 0.0 109.303 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 3.4 mp0 74.1 103.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.265 1.426 . . . . 0.0 112.405 169.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.3 ttp -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.09 113.29 7.23 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.89 106.65 5.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.83 80.48 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 m -157.61 128.83 6.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.3 t -142.07 106.83 4.87 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.1 150.96 33.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.906 0.86 . . . . 0.0 110.584 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.39 -62.68 0.46 Allowed Glycine 0 N--CA 1.485 1.913 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.907 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.388 87.0 m-70 91.19 -58.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.291 . . 77.28 -29.57 0.17 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -84.08 -51.45 7.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.7 1.136 . . . . 0.0 112.592 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 95' ' ' VAL . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -72.52 135.68 45.7 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -130.98 111.13 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -120.7 131.01 54.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 122.245 1.021 . . . . 0.0 112.689 -176.373 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.725 0.298 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.78 130.76 35.6 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.512 0.672 . . . . 0.0 111.021 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.15 -43.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.937 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm -47.34 -44.57 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -97.67 -95.61 0.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.06 -110.89 1.8 Allowed Glycine 0 N--CA 1.478 1.497 0 CA-C-N 118.232 0.469 . . . . 0.0 113.831 -165.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 149.65 24.29 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.949 0.881 . . . . 0.0 111.427 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.02 114.88 57.1 Favored Pre-proline 0 CA--C 1.569 1.684 0 CA-C-O 117.34 -1.314 . . . . 0.0 108.579 167.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.75 -168.56 0.41 Allowed 'Trans proline' 0 CA--C 1.567 2.172 0 C-N-CA 122.834 2.356 . . . . 0.0 114.439 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 77' ' ' VAL . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 36' ' ' PHE . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -58.38 -24.1 58.93 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -78.37 -57.34 3.83 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.803 0.841 . . . . 0.0 111.978 160.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -87.1 -59.27 2.3 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.342 0.657 . . . . 0.0 112.754 -160.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -56.16 -32.5 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -13.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 171.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.08 -44.92 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.12 -83.44 0.06 OUTLIER Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -80.09 135.61 36.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -85.14 150.95 56.2 Favored Pre-proline 0 CA--C 1.571 1.788 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.536 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.11 -46.61 9.86 Favored 'Trans proline' 0 CA--C 1.56 1.783 0 C-N-CA 123.4 2.733 . . . . 0.0 117.381 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.43 -76.75 0.25 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.029 0.831 . . . . 0.0 109.16 173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 54.71 71.21 0.55 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 -79.36 1.92 Allowed Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.043 0.777 . . . . 0.0 115.043 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 65.24 74.1 0.39 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.907 1.283 . . . . 0.0 112.767 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.294 11.5 ptt-85 -163.23 -79.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.588 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.38 17.7 p80 63.02 137.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.2 m -79.07 -75.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.475 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 71.9 m -101.12 -70.05 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.726 0.694 . . . . 0.0 110.054 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.67 84.16 0.17 Allowed Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.98 115.95 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.92 103.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.652 1.181 . . . . 0.0 113.139 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.32 113.46 5.19 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.8 tpt -138.21 103.38 4.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -89.2 106.29 18.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.815 0.446 . . . . 0.0 110.395 -170.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 67.63 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.967 1.307 . . . . 0.0 113.84 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -141.65 114.64 8.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m -134.78 98.38 4.02 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -111.71 74.99 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.339 0.59 . . . . 0.0 110.029 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.06 143.94 31.26 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.91 0.862 . . . . 0.0 109.451 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -172.05 95.95 0.11 Allowed Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.52 138.38 8.5 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.943 0.878 . . . . 0.0 111.331 -166.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.63 -16.78 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 165.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.47 -46.7 8.91 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.955 1.252 . . . . 0.0 113.337 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -73.38 141.52 47.0 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? 67.42 101.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.26 1.024 . . . . 0.0 112.691 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -81.23 125.15 29.96 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.282 0.563 . . . . 0.0 110.788 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -173.724 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -106.14 111.6 24.29 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.939 0.79 . . . . 0.0 109.195 -174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.16 -45.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.134 0.973 . . . . 0.0 109.983 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm -47.41 -44.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 169.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 -96.04 -111.79 0.14 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.59 173.34 47.52 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 118.987 0.812 . . . . 0.0 114.503 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -58.6 154.5 14.18 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.92 127.19 90.32 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.771 -166.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.38 -155.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.234 2.623 . . . . 0.0 113.703 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 77' ' ' VAL . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG11 HG12 ' A' ' 95' ' ' VAL 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 HG11 ' A' ' 72' ' ' VAL . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 70' ' ' LEU . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.77 -24.98 38.75 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.52 -54.81 5.54 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.737 0.815 . . . . 0.0 112.327 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -91.79 -62.27 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.307 0.643 . . . . 0.0 112.255 -159.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.6 mm -54.83 -28.66 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 169.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.26 -12.0 2.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.8 p -45.66 -43.82 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 161.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.55 -94.42 0.11 Allowed Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -120.14 169.37 10.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.053 0.93 . . . . 0.0 111.846 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.69 152.17 59.52 Favored Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 123.718 0.807 . . . . 0.0 111.736 168.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.53 -58.6 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.725 0 C-N-CA 123.385 2.723 . . . . 0.0 116.321 -172.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -80.93 -69.15 0.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.411 0.685 . . . . 0.0 110.716 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 49.34 53.81 12.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.94 78.47 0.25 Allowed Glycine 0 CA--C 1.546 2.019 0 CA-C-O 119.084 -0.842 . . . . 0.0 113.47 -165.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.8 92.2 8.18 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 117.683 0.741 . . . . 0.0 110.834 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -164.1 92.55 0.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -95.54 -63.61 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.992 -156.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 t 71.57 114.03 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.823 1.249 . . . . 0.0 112.694 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.346 21.8 t 76.02 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.762 1.225 . . . . 0.0 112.414 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.36 -179.08 51.8 Favored Glycine 0 CA--C 1.547 2.071 0 CA-C-O 121.704 0.613 . . . . 0.0 114.321 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.53 121.2 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.39 143.75 27.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.848 0.832 . . . . 0.0 111.626 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -71.29 145.09 49.74 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -167.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 45.0 ttp -81.66 124.61 29.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 166.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -100.97 126.86 47.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.915 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.79 144.31 27.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.956 0.884 . . . . 0.0 111.676 -170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.52 108.2 20.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -100.06 73.33 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.231 0.539 . . . . 0.0 110.662 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 137.54 43.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.79 -66.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.643 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.06 83.11 0.44 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -107.32 113.5 26.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.76 -17.16 63.41 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.03 -45.39 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 95' ' ' VAL . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -71.88 158.31 36.29 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -90.93 126.94 36.21 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.389 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 143.18 27.01 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.285 0.634 . . . . 0.0 111.55 176.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 122.131 0.967 . . . . 0.0 109.791 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.952 0.406 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -77.16 134.96 38.52 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.244 0.618 . . . . 0.0 111.976 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.78 -47.19 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.708 0.803 . . . . 0.0 111.63 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -47.69 -43.01 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 168.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -115.48 131.73 56.84 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.62 -135.89 18.03 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 114.736 -1.12 . . . . 0.0 115.356 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.62 146.6 26.95 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.745 0.818 . . . . 0.0 110.758 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -81.87 114.5 50.89 Favored Pre-proline 0 CA--C 1.57 1.741 0 CA-C-O 117.409 -1.282 . . . . 0.0 109.022 168.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.17 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 123.056 2.504 . . . . 0.0 114.136 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' CD1' ' A' ' 150' ' ' PHE . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.05 -26.53 38.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.23 -53.86 6.27 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 123.951 0.9 . . . . 0.0 113.006 159.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -80.46 -54.56 5.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -162.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 mm -52.73 -38.15 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.0 2.79 0.67 Allowed 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.92 -46.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 160.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.85 56.22 0.05 OUTLIER Glycine 0 CA--C 1.542 1.732 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.844 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt 62.7 136.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.837 1.255 . . . . 0.0 113.321 -170.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 0.4 OUTLIER 56.59 165.6 0.06 OUTLIER Pre-proline 0 CA--C 1.584 2.267 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.74 -60.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.029 2.486 . . . . 0.0 114.237 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.23 116.65 4.39 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 0.0 112.431 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 58.9 11.15 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 116.399 1.319 . . . . 0.0 116.399 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -92.71 125.95 37.56 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.601 0.7 . . . . 0.0 110.454 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -128.42 122.18 30.75 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.717 0.807 . . . . 0.0 109.391 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -96.55 137.52 35.5 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 18.0 t -74.04 167.69 21.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.24 120.2 14.7 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.347 0.659 . . . . 0.0 112.194 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.12 59.8 2.24 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 115.823 -0.626 . . . . 0.0 114.578 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.5 t -143.04 123.19 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.14 150.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 49.0 mt-30 64.34 49.16 2.59 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 26.7 ttt -176.83 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -134.19 140.22 46.36 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -59.12 -55.34 36.26 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 m80 75.51 131.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.598 1.159 . . . . 0.0 113.315 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 87.6 p -87.35 119.72 27.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.971 0.508 . . . . 0.0 109.805 167.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.1 m -76.16 -66.35 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.698 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.95 138.21 42.53 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.843 0.83 . . . . 0.0 108.897 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.92 85.78 0.06 OUTLIER Glycine 0 N--CA 1.476 1.309 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -93.49 150.27 20.57 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.254 0.622 . . . . 0.0 110.559 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.47 -11.26 16.48 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -87.08 -48.22 8.26 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.021 1.282 . . . . 0.0 113.144 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' THR . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -72.4 173.22 9.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.09 122.89 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.912 0.485 . . . . 0.0 109.922 169.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.4 132.04 37.19 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 111.688 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.883 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.704 0.764 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.7 113.66 19.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.84 -45.1 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.406 -164.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm -52.09 -40.18 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 121.138 1.79 . . . . 0.0 113.914 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -143.86 -171.03 3.46 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.26 -24.54 9.36 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 120.596 2.999 . . . . 0.0 120.596 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.261 37.1 mt-10 78.52 139.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.584 1.554 . . . . 0.0 111.333 -174.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -76.49 118.28 70.41 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.443 -1.265 . . . . 0.0 111.164 -171.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.39 -154.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.567 2.171 0 C-N-CA 123.141 2.561 . . . . 0.0 113.568 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 95' ' ' VAL 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 150' ' ' PHE . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 70' ' ' LEU . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -50.73 -33.65 23.8 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.2 ttp-105 -82.71 -52.59 6.64 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.478 1.111 . . . . 0.0 113.187 165.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -88.2 -58.16 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.761 0.709 . . . . 0.0 112.594 -158.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.6 mm -57.01 -32.05 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.56 -6.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.24 -47.46 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 159.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.81 -113.52 0.31 Allowed Glycine 0 CA--C 1.539 1.565 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.31 163.85 21.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.544 1.164 . . . . 0.0 113.344 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.42 160.14 82.34 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 114.423 -1.262 . . . . 0.0 113.196 166.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.38 -53.13 1.57 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.622 2.881 . . . . 0.0 116.098 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.7 mt -88.92 -39.52 13.71 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 117.57 -1.205 . . . . 0.0 113.898 165.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.91 115.22 14.27 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.709 1.595 . . . . 0.0 110.215 -172.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.26 -45.8 1.11 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 119.104 -0.831 . . . . 0.0 114.167 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -65.14 -69.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.218 1.009 . . . . 0.0 113.588 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 65.6 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.915 1.286 . . . . 0.0 111.62 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -113.69 -99.86 0.43 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.7 t -164.14 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.1 p -143.05 104.72 4.34 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.74 -172.23 54.29 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 121.841 0.689 . . . . 0.0 114.709 -173.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t 68.32 101.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 124.827 1.251 . . . . 0.0 110.091 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.4 120.22 9.92 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.628 0.728 . . . . 0.0 109.642 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -135.28 136.83 41.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.511 1.125 . . . . 0.0 109.532 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 99.7 mmm 78.54 113.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.919 1.287 . . . . 0.0 111.745 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -110.15 116.52 31.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -90.72 94.06 9.52 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -164.96 122.75 1.62 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 m -64.83 -55.57 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 t 61.06 88.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.935 1.294 . . . . 0.0 113.287 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 mt -93.5 -101.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.139 -169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.35 105.22 0.64 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -136.7 115.14 11.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.73 -6.38 40.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.51 -48.91 7.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.694 1.134 . . . . 0.0 112.953 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.467 ' CE1' HG11 ' A' ' 95' ' ' VAL . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -71.95 173.28 8.57 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -68.76 107.07 2.88 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.366 0.667 . . . . 0.0 110.714 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.78 103.68 10.91 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.019 -169.893 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -154.36 139.26 17.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 mt -77.75 -41.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.517 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -54.25 -37.39 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 121.066 1.757 . . . . 0.0 113.926 167.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -115.98 133.46 56.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.06 -119.47 6.04 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.512 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.92 152.35 36.23 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.665 0.786 . . . . 0.0 110.487 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -77.07 126.75 85.01 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.076 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -81.75 -150.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 123.293 2.662 . . . . 0.0 112.806 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 95' ' ' VAL 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.416 HG22 ' HZ1' ' A' ' 15' ' ' LYS . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 72' ' ' VAL . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 70' ' ' LEU . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.8 -29.05 62.35 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -77.05 -52.99 8.36 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.76 0.824 . . . . 0.0 112.857 158.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -85.47 -60.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -159.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -56.12 -31.38 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 170.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.35 -11.14 13.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.41 -42.78 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.12 -70.0 0.1 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.517 -164.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -81.57 139.93 34.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.209 1.004 . . . . 0.0 113.393 -174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.09 151.49 71.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.579 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.0 -38.25 23.17 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 123.145 2.564 . . . . 0.0 116.997 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.49 -78.92 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.184 0.902 . . . . 0.0 108.796 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 65.04 -0.63 1.01 Allowed 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 118.803 2.89 . . . . 0.0 118.803 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 68.45 1.53 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 119.989 1.268 . . . . 0.0 112.168 -161.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -91.1 113.57 25.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.113 0.565 . . . . 0.0 110.74 -169.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -90.2 115.08 27.16 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.2 m80 76.69 118.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.752 1.221 . . . . 0.0 111.66 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.3 -51.87 12.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 79.8 m -114.42 105.4 13.07 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.4 -93.76 0.13 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.23 98.54 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 168.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.35 111.78 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -91.2 147.79 22.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.533 0.733 . . . . 0.0 110.934 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -87.85 106.96 18.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.862 -161.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.15 161.46 14.26 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.497 0.719 . . . . 0.0 112.614 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . 0.253 7.8 t-80 73.62 95.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.085 1.354 . . . . 0.0 110.281 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t -133.38 -49.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.589 -168.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.6 p -155.76 138.0 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.246 1.385 . . . . 0.0 110.511 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.92 -84.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 118.794 -0.622 . . . . 0.0 109.645 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.58 -86.64 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 65.33 100.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.71 1.204 . . . . 0.0 112.434 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.55 38.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.36 -48.11 7.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.695 1.134 . . . . 0.0 112.996 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HE2' ' HE1' ' A' ' 73' ' ' TRP . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -75.86 156.54 34.27 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.16 115.41 18.36 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -116.36 133.9 55.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.514 -176.704 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.289 . . . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.27 122.63 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 111.385 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mm -90.67 -36.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.535 -174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm -51.73 -44.15 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 120.009 1.277 . . . . 0.0 113.771 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -125.83 135.57 52.13 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.8 21.85 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.121 168.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -102.78 148.03 26.12 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.047 0.939 . . . . 0.0 110.036 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.21 123.48 84.71 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.931 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.27 -171.9 1.29 Allowed 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 123.191 2.594 . . . . 0.0 113.386 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 150' ' ' PHE . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 72' ' ' VAL . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 70' ' ' LEU 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 -27.41 61.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -83.39 -55.68 4.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.839 0.856 . . . . 0.0 112.449 162.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -80.92 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.603 0.761 . . . . 0.0 113.041 -160.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.9 mm -64.69 -31.25 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.68 -9.75 6.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 118.949 2.944 . . . . 0.0 118.949 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.66 -45.39 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.43 -115.69 0.6 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.74 163.98 14.86 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.63 151.28 39.92 Favored Pre-proline 0 CA--C 1.57 1.736 0 C-N-CA 124.201 1.0 . . . . 0.0 111.975 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.03 -44.02 22.0 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.467 2.778 . . . . 0.0 117.041 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.1 mt -86.0 -48.93 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.091 0.86 . . . . 0.0 112.702 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.07 104.37 9.66 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 119.631 1.105 . . . . 0.0 110.913 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.41 77.67 0.85 Allowed Glycine 0 CA--C 1.542 1.768 0 CA-C-O 119.554 -0.581 . . . . 0.0 113.382 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -79.39 -53.35 6.99 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 77.64 134.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.591 1.157 . . . . 0.0 112.871 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.262 83.7 m-70 78.58 107.38 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.792 1.237 . . . . 0.0 111.949 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.0 m -75.57 -60.27 2.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.829 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.92 110.2 13.91 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.28 112.48 4.04 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 115.858 1.103 . . . . 0.0 115.858 -160.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.48 80.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -169.45 165.64 10.45 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.916 0.865 . . . . 0.0 110.643 -165.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 141.22 58.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.711 -0.618 . . . . 0.0 111.904 163.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 87.5 mtp -62.51 -68.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -166.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.4 mtm-85 -138.42 85.99 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.151 0.887 . . . . 0.0 108.609 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 54.81 89.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.783 1.233 . . . . 0.0 114.317 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -108.19 73.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.63 0.728 . . . . 0.0 109.866 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 p -165.67 98.74 0.68 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.6 m -149.01 138.09 21.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.152 0.581 . . . . 0.0 110.471 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.1 mt -126.05 161.75 26.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.081 0.943 . . . . 0.0 111.296 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -120.55 -65.62 0.26 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 123.885 0.755 . . . . 0.0 111.994 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.391 92.9 m-70 90.03 -54.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.274 . . 73.51 -17.86 0.41 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -170.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.81 -52.02 5.08 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.795 1.179 . . . . 0.0 111.918 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -74.03 140.72 45.61 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.14 151.47 19.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.33 160.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -135.81 126.77 27.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -174.594 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.469 0.652 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.7 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.006 1.322 . . . . 0.0 112.047 -169.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.4 mt -84.64 -37.37 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.16 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.02 -43.35 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 124.686 1.194 . . . . 0.0 114.015 166.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -67.71 -50.95 54.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.9 -120.79 2.03 Favored Glycine 0 CA--C 1.544 1.9 0 C-N-CA 123.889 0.756 . . . . 0.0 112.693 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.42 146.38 40.68 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.982 0.913 . . . . 0.0 112.425 -170.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.44 121.37 66.55 Favored Pre-proline 0 CA--C 1.576 1.952 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.339 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.36 -150.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 123.29 2.66 . . . . 0.0 113.7 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 95' ' ' VAL 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 HG11 ' A' ' 72' ' ' VAL . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.35 -28.48 59.21 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -77.99 -52.78 8.27 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 159.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.22 -57.16 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.054 0.941 . . . . 0.0 113.191 -160.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.34 -40.28 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 C-N-CA 124.993 1.317 . . . . 0.0 113.967 170.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.35 7.4 0.45 Allowed 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 119.35 3.093 . . . . 0.0 119.35 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.36 -42.52 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 159.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.48 -94.92 0.1 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -128.87 124.76 36.08 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.319 0.9 OUTLIER 57.21 155.71 0.08 OUTLIER Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -175.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.63 -56.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 123.368 2.712 . . . . 0.0 114.58 -171.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.5 mt -59.63 -35.52 74.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 163.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -69.0 100.76 1.26 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.619 1.168 . . . . 0.0 110.403 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.04 87.23 0.13 Allowed Glycine 0 CA--C 1.544 1.901 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.463 -170.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.34 103.41 15.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -142.12 155.99 45.36 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.312 1.053 . . . . 0.0 109.317 -168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -70.97 122.78 20.62 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.099 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.48 -57.07 4.17 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -170.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -84.76 92.8 8.31 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.069 0.849 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.71 -149.65 40.23 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.476 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.97 122.22 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.56 113.05 5.0 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -95.71 73.83 3.15 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.008 0.908 . . . . 0.0 110.222 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 28.3 ttt -161.5 94.74 0.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.85 96.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.583 1.153 . . . . 0.0 110.741 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.39 -77.75 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.188 0.595 . . . . 0.0 110.549 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 63.38 86.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.678 1.191 . . . . 0.0 113.51 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 m -76.07 -56.55 4.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.718 168.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 t -70.81 -62.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.103 0.865 . . . . 0.0 112.874 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.34 3.9 tt 77.79 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.649 1.179 . . . . 0.0 111.552 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.67 -77.76 0.24 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 74.32 97.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.02 61.07 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -86.46 -46.42 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -74.18 132.44 42.2 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 62.76 96.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.247 1.019 . . . . 0.0 112.543 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -81.13 125.96 30.89 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.398 0.618 . . . . 0.0 110.916 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.293 1.044 . . . . 0.0 108.769 -174.366 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.82 107.31 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.643 1.177 . . . . 0.0 110.309 -167.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -76.79 -43.59 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.107 0.563 . . . . 0.0 111.651 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.69 -44.75 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -133.64 -69.41 0.54 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -179.74 17.04 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 117.351 1.7 . . . . 0.0 117.351 -166.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.42 122.65 28.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.987 -0.713 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.39 113.52 11.88 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 117.394 -1.289 . . . . 0.0 109.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.08 -143.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.094 2.529 . . . . 0.0 112.939 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 150' ' ' PHE . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 72' ' ' VAL . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.552 HG12 HD22 ' A' ' 70' ' ' LEU . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -30.91 51.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -81.45 -55.82 4.44 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.618 0.767 . . . . 0.0 112.302 165.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -87.55 -59.37 2.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 119.043 0.838 . . . . 0.0 112.79 -160.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.73 -27.33 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.921 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.46 -16.94 4.26 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 118.883 2.92 . . . . 0.0 118.883 168.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -43.34 -47.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 161.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.06 -95.54 0.22 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 0.5 OUTLIER -146.58 174.21 11.63 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.597 0.713 . . . . 0.0 111.632 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -58.17 143.67 78.38 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.837 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.06 -58.78 0.67 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.104 2.536 . . . . 0.0 115.999 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -77.98 -69.42 0.55 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.025 0.829 . . . . 0.0 110.807 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 53.12 42.2 32.18 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 81.18 0.09 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.697 -161.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -73.59 96.74 2.5 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.82 -162.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -168.22 113.01 0.64 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -87.13 97.32 10.68 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 124' ' ' VAL . 27.1 p -84.13 103.53 13.42 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.261 20.4 p 49.24 61.73 2.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.31 77.98 0.67 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.674 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 121' ' ' CYS . 2.7 t -136.87 141.65 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.1 100.13 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.287 1.435 . . . . 0.0 111.533 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.08 -46.16 57.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.3 ptp -142.31 85.48 1.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.952 0.796 . . . . 0.0 109.101 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.8 109.37 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -125.34 149.66 47.89 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.825 0.821 . . . . 0.0 109.858 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -70.46 144.16 51.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.361 0.664 . . . . 0.0 112.274 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -69.61 113.33 6.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.247 0.619 . . . . 0.0 112.3 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -101.9 89.71 3.74 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.44 0.638 . . . . 0.0 109.307 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 133' ' ' LEU . 2.6 pt? -96.73 142.63 28.52 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.764 0.826 . . . . 0.0 111.799 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.78 92.22 0.08 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -135.88 155.31 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.202 1.001 . . . . 0.0 109.33 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.05 -16.48 10.47 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.08 -49.34 11.88 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.625 1.102 . . . . 0.0 113.48 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -72.13 143.99 48.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -143.09 146.18 33.56 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.75 139.45 30.66 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 165.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.112 0.958 . . . . 0.0 109.29 -175.109 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 CA--C 1.564 1.987 0 N-CA-C 114.579 0.954 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.568 2.21 0 N-CA-C 113.891 0.689 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.564 2.007 0 N-CA-C 114.511 0.927 . . . . 0.0 114.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 77' ' ' VAL . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 HG12 ' A' ' 95' ' ' VAL . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 36' ' ' PHE . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.558 HG12 HG11 ' A' ' 72' ' ' VAL . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 95' ' ' VAL . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.569 2.258 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 77' ' ' VAL . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 149' ' ' ILE . 1.6 tm0? -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 150' ' ' PHE . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.433 HG23 HE21 ' A' ' 87' ' ' GLN . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' A' ' 95' ' ' VAL . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.568 2.22 0 N-CA-C 114.437 0.899 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 95' ' ' VAL 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 72' ' ' VAL . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HE ' HE22 ' A' ' 14' ' ' GLN . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.426 HE22 ' HE ' ' A' ' 9' ' ' ARG . 30.0 tp60 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.563 1.93 0 N-CA-C 114.151 0.789 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 77' ' ' VAL . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 90' ' ' CYS . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 36' ' ' PHE . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 76' ' ' ILE . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 114.134 0.782 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 95' ' ' VAL 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG12 HG11 ' A' ' 72' ' ' VAL . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 95' ' ' VAL . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.565 2.046 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 72' ' ' VAL . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 72' ' ' VAL . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 95' ' ' VAL . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.918 0 CA-C-O 121.857 0.69 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CE2' HG11 ' A' ' 77' ' ' VAL . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.499 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 36' ' ' PHE . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.569 2.263 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 95' ' ' VAL 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 149' ' ' ILE . 1.5 tm0? -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.434 HG12 HG11 ' A' ' 72' ' ' VAL . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 119.426 -0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 87' ' ' GLN . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 . . . . . 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 CA--C 1.565 2.06 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 95' ' ' VAL 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 149' ' ' ILE . 1.4 tm0? -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG12 HG11 ' A' ' 72' ' ' VAL . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 87' ' ' GLN . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' CYS . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.564 1.977 0 N-CA-C 114.451 0.904 . . . . 0.0 114.451 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.41 ' HA ' HG22 ' A' ' 13' ' ' ILE . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 150' ' ' PHE . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 95' ' ' VAL . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.567 2.172 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 77' ' ' VAL . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 36' ' ' PHE . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.3 p90 . . . . . 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 CA--C 1.569 2.268 0 N-CA-C 113.703 0.617 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 77' ' ' VAL . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG11 HG12 ' A' ' 95' ' ' VAL 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 HG11 ' A' ' 72' ' ' VAL . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 70' ' ' LEU . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 95' ' ' VAL . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.568 2.194 0 N-CA-C 114.136 0.783 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' CD1' ' A' ' 150' ' ' PHE . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' THR . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 . . . . . 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.567 2.171 0 N-CA-C 113.568 0.565 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 95' ' ' VAL 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 150' ' ' PHE . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 70' ' ' LEU . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.467 ' CE1' HG11 ' A' ' 95' ' ' VAL . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.567 2.143 0 CA-C-O 120.862 0.276 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 95' ' ' VAL 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.416 HG22 ' HZ1' ' A' ' 15' ' ' LYS . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 72' ' ' VAL . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 70' ' ' LEU . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HE2' ' HE1' ' A' ' 73' ' ' TRP . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 CA--C 1.563 1.972 0 CA-C-O 121.473 0.53 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 150' ' ' PHE . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 72' ' ' VAL . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 70' ' ' LEU 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 . . . . . 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 CA--C 1.569 2.259 0 N-CA-C 113.7 0.615 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 95' ' ' VAL 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 HG11 ' A' ' 72' ' ' VAL . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 . . . . . 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.562 1.889 0 N-CA-C 112.939 0.323 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 150' ' ' PHE . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 72' ' ' VAL . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.552 HG12 HD22 ' A' ' 70' ' ' LEU . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -141.19 101.95 4.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -86.36 -39.94 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.183 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.51 -43.57 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 119.915 1.234 . . . . 0.0 113.786 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.95 74.54 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -77.1 -31.11 55.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.05 -45.8 83.86 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.876 1.671 . . . . 0.0 114.286 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -55.36 -43.76 75.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.31 -4.77 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 167.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.15 -2.43 44.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.9 -39.32 2.78 Favored Glycine 0 CA--C 1.551 2.325 0 CA-C-N 120.326 1.421 . . . . 0.0 115.345 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.73 166.8 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 C-N-CA 125.377 1.471 . . . . 0.0 111.769 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -144.25 115.23 7.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -100.85 156.94 17.08 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -149.94 124.98 9.98 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.31 135.43 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.675 0.75 . . . . 0.0 110.416 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.21 -66.03 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.606 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.9 112.95 20.3 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.63 119.69 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.394 0.678 . . . . 0.0 111.07 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.44 -124.85 0.27 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 -165.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -143.68 143.84 31.6 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.28 1.038 . . . . 0.0 110.205 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.98 -165.05 30.28 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 114.526 -1.216 . . . . 0.0 115.509 169.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.73 139.73 30.39 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.128 -1.036 . . . . 0.0 109.803 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.22 114.7 37.97 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.831 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 -169.46 0.73 Allowed 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.884 2.389 . . . . 0.0 114.579 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.4 -54.55 45.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 56.29 52.68 9.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -123.23 -177.32 3.66 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.334 1.054 . . . . 0.0 110.152 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -67.11 100.83 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.889 0.852 . . . . 0.0 112.464 -166.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.54 38.53 1.75 Allowed Glycine 0 CA--C 1.548 2.142 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.343 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 m -108.59 128.21 54.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 120.539 2.17 . . . . 0.0 106.099 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -86.73 96.52 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.005 0.522 . . . . 0.0 110.166 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.37 114.39 26.8 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.332 0.586 . . . . 0.0 110.21 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -104.95 123.46 47.81 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' O ' ' SD ' ' A' ' 60' ' ' MET . 35.1 p90 -158.88 167.78 28.52 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.757 0.789 . . . . 0.0 110.558 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -92.95 165.02 13.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 112.073 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -146.81 142.76 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.824 0.849 . . . . 0.0 109.955 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.64 97.39 2.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.9 p -91.13 118.37 30.38 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.879 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.65 155.06 51.16 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.168 0.985 . . . . 0.0 110.193 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -70.21 138.53 51.81 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.549 0.74 . . . . 0.0 111.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -74.99 -64.49 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -167.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.06 -4.23 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.36 -54.44 32.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.896 1.68 . . . . 0.0 113.51 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.17 -39.56 2.68 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.492 0.717 . . . . 0.0 111.883 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.38 10.59 79.65 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.687 1.835 . . . . 0.0 117.687 -158.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -81.05 139.85 35.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.226 1.513 . . . . 0.0 112.28 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -87.04 113.52 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.28 -35.2 31.39 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.315 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -146.16 146.55 30.88 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.711 0.804 . . . . 0.0 109.486 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -157.37 112.53 2.77 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 p -103.45 -49.87 3.59 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -18.32 37.52 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 165.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.93 91.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -10.18 42.02 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 165.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 29.79 52.64 Favored Glycine 0 CA--C 1.549 2.17 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.79 102.72 52.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 118.455 1.128 . . . . 0.0 108.517 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.14 145.71 17.46 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.969 2.446 . . . . 0.0 113.948 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -82.86 173.13 12.11 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.333 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -138.87 124.04 19.09 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.953 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp -113.47 130.22 56.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.83 127.37 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.2 mm -73.1 109.18 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.64 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.63 43.24 91.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.979 2.752 . . . . 0.0 119.979 162.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -152.41 -63.38 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.108 0.954 . . . . 0.0 109.453 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.46 -50.21 6.44 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.698 0.799 . . . . 0.0 112.305 170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.54 141.55 42.97 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.365 1.078 . . . . 0.0 113.521 -163.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.71 -31.51 26.02 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.78 103.88 14.5 Favored Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 119.523 1.056 . . . . 0.0 109.794 -171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.31 -16.14 19.69 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.702 2.935 . . . . 0.0 118.421 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.274 11.7 p -67.9 -36.5 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 117.553 -1.213 . . . . 0.0 114.127 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -52.94 -38.05 61.59 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 165.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -43.32 70.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -69.47 -36.04 76.18 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.757 1.223 . . . . 0.0 113.788 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.6 mt -51.33 -57.87 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 124.537 1.135 . . . . 0.0 111.94 163.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.14 -8.93 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.38 -31.06 68.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -76.12 -8.96 58.19 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 168.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 mmm -106.45 136.74 45.67 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.56 1.144 . . . . 0.0 111.367 -165.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -112.24 173.33 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.243 1.017 . . . . 0.0 111.41 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.8 107.83 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.195 0.998 . . . . 0.0 112.079 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.33 9.98 57.47 Favored Glycine 0 CA--C 1.555 2.558 0 N-CA-C 118.666 2.226 . . . . 0.0 118.666 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -97.11 139.85 32.5 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 120.107 1.954 . . . . 0.0 109.845 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.32 119.53 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.36 132.96 36.27 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.214 0.606 . . . . 0.0 111.779 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.28 133.52 53.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.435 0.694 . . . . 0.0 111.368 177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -173.23 154.13 2.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.37 149.11 26.92 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.7 m -123.87 141.52 51.96 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.592 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.26 145.14 55.48 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.336 0.588 . . . . 0.0 111.798 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -31.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -50.51 -28.26 8.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -95.15 -43.99 7.84 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.144 1.378 . . . . 0.0 111.178 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.94 21.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.04 -43.87 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.452 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.92 12.42 30.39 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.1 -47.35 99.01 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.235 -2.317 . . . . 0.0 115.792 162.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.28 -10.65 28.25 Favored 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 125.297 2.927 . . . . 0.0 117.945 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.65 -43.71 11.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.246 0.93 . . . . 0.0 111.812 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.91 -26.82 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.94 -31.42 17.69 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 160.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 20.53 0.62 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 166.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -145.59 -38.53 0.25 Allowed 'General case' 0 CA--C 1.562 1.411 0 O-C-N 120.499 -1.376 . . . . 0.0 113.53 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -57.08 -27.25 61.58 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 164.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -77.89 -55.74 5.07 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.08 0.952 . . . . 0.0 112.249 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -85.08 -58.36 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -160.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -58.18 -30.37 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.042 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.37 -2.36 1.47 Allowed 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.12 -46.9 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 161.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.96 67.12 0.03 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.012 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 63.54 109.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.748 1.219 . . . . 0.0 113.439 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.293 1.1 m-20 60.79 155.46 0.11 Allowed Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.69 -66.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 123.087 2.525 . . . . 0.0 114.138 -173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp -67.45 -33.81 75.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.49 -57.39 10.07 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.76 83.07 0.32 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 165.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -94.0 72.58 4.07 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.833 0.825 . . . . 0.0 109.968 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -170.66 140.51 1.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.677 0.791 . . . . 0.0 109.252 -165.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -95.99 87.03 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.6 m -135.16 75.82 1.59 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.87 0.843 . . . . 0.0 108.95 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -161.59 -68.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.34 63.64 0.21 Allowed Glycine 0 CA--C 1.541 1.687 0 CA-C-N 118.594 0.634 . . . . 0.0 112.916 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.6 t -144.11 105.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.64 128.26 9.36 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.148 0.499 . . . . 0.0 109.977 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.256 2.5 mp0 69.63 77.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.776 1.23 . . . . 0.0 111.606 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.2 tpt -157.83 108.52 2.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.04 97.88 9.6 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -150.97 131.11 13.5 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -86.12 114.91 23.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 167.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 t -74.36 -65.74 0.81 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.462 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.5 m 68.32 101.75 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.676 1.19 . . . . 0.0 112.384 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.65 135.94 36.12 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.526 0.679 . . . . 0.0 111.556 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.44 85.21 0.05 OUTLIER Glycine 0 N--CA 1.476 1.323 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -87.17 157.15 19.42 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.805 0.812 . . . . 0.0 111.012 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.33 -21.26 11.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 164.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.35 -53.13 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 119.425 1.011 . . . . 0.0 113.25 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.32 -20.1 41.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.83 -12.62 60.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.87 -32.31 31.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 158.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.33 -39.33 78.25 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -56.41 -34.36 66.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -85.85 -34.44 21.03 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 93.29 3.21 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 120.265 1.393 . . . . 0.0 108.338 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.06 139.48 24.18 Favored 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.011 2.474 . . . . 0.0 113.678 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.73 140.66 32.6 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.702 -167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.59 114.09 3.63 Favored 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 123.227 2.618 . . . . 0.0 112.128 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.31 156.88 16.51 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -163.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.78 116.46 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 124.536 1.134 . . . . 0.0 108.168 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -106.12 101.51 10.99 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.19 97.54 11.26 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.9 mmt -93.11 144.87 24.85 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.002 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.94 103.71 6.94 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 44.3 tpp -72.53 133.68 44.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -62.34 1.6 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.841 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -135.89 155.67 49.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.314 1.054 . . . . 0.0 109.072 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -154.45 127.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.21 144.8 49.14 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.244 1.021 . . . . 0.0 110.65 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.7 m -94.42 163.97 21.4 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.427 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.79 108.62 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.567 2.845 . . . . 0.0 113.406 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.58 -56.88 0.6 Allowed Glycine 0 CA--C 1.538 1.529 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.289 -165.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.1 t -84.84 -36.26 21.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -73.99 137.94 43.81 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.888 1.222 . . . . 0.0 112.054 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -151.49 145.68 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 110.455 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -90.54 143.08 27.09 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.447 0.641 . . . . 0.0 110.785 167.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 122.279 1.038 . . . . 0.0 110.171 -177.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.419 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.78 133.03 49.31 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.291 0.636 . . . . 0.0 111.496 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 mm -81.63 -40.36 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.409 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -50.56 -42.79 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 120.205 1.366 . . . . 0.0 113.761 165.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.8 76.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -76.74 -29.27 56.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 168.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mt -71.38 -42.0 68.97 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.866 1.667 . . . . 0.0 114.426 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.16 -42.34 69.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.17 -2.28 40.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 167.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.62 -5.56 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.16 -42.74 1.82 Allowed Glycine 0 CA--C 1.551 2.305 0 CA-C-N 119.981 1.264 . . . . 0.0 114.42 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.48 171.63 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 C-N-CA 124.975 1.31 . . . . 0.0 111.635 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -142.56 120.18 11.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -89.13 136.19 33.15 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.737 0.815 . . . . 0.0 111.409 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.83 129.89 15.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.789 0.436 . . . . 0.0 109.976 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.04 146.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 124.205 1.002 . . . . 0.0 112.65 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.29 -65.18 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 102.79 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 119.317 0.962 . . . . 0.0 109.394 -176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -48.52 124.89 8.83 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.11 175.84 31.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 122.766 1.203 . . . . 0.0 115.837 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -104.2 84.84 2.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 123.413 1.578 . . . . 0.0 113.14 -158.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.48 -137.33 9.27 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 111.94 -2.391 . . . . 0.0 113.32 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.6 139.46 52.27 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.993 0.917 . . . . 0.0 111.407 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.54 130.53 94.75 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.532 -1.223 . . . . 0.0 113.924 -166.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.42 -144.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 123.488 2.792 . . . . 0.0 113.891 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.86 -67.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 112.793 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.25 72.4 m-85 56.32 55.78 6.34 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -167.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -128.54 -174.57 3.27 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 124.645 1.178 . . . . 0.0 110.114 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -58.88 102.18 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.92 38.68 3.09 Favored Glycine 0 CA--C 1.544 1.858 0 CA-C-O 117.921 -1.488 . . . . 0.0 115.331 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -105.1 125.1 50.6 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.81 94.6 9.59 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.18 116.72 29.29 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.397 0.618 . . . . 0.0 110.122 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.1 m -105.24 123.94 48.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.46 167.18 29.33 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.693 0.758 . . . . 0.0 111.076 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.18 163.92 13.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 112.341 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -145.51 142.8 29.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.863 0.865 . . . . 0.0 109.597 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -145.92 97.26 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 p -88.2 119.81 28.96 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.77 154.79 51.12 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 121.899 0.857 . . . . 0.0 110.104 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -72.0 134.76 46.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.553 -0.717 . . . . 0.0 111.42 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.8 p -68.57 -70.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.27 17.85 3.18 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.45 -58.74 2.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.331 1.053 . . . . 0.0 111.345 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -109.51 -38.58 5.41 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.966 0.906 . . . . 0.0 111.583 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 10.06 85.75 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.774 1.87 . . . . 0.0 117.774 -159.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -90.35 144.8 25.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.054 1.427 . . . . 0.0 111.41 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.93 112.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.93 -33.46 34.06 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.457 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.37 144.56 27.59 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 123.72 0.808 . . . . 0.0 109.379 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -155.65 116.71 3.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.3 0.64 . . . . 0.0 109.705 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.6 p -107.46 -50.23 3.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -20.67 61.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 166.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.04 88.19 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 164.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -80.72 -26.6 37.3 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 167.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.08 44.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -119.37 102.05 48.53 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.975 1.387 . . . . 0.0 108.88 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.39 146.12 17.21 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.907 2.404 . . . . 0.0 114.308 -174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -83.22 176.66 9.0 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.454 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -144.16 119.17 10.02 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.973 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.24 138.94 47.06 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.514 1.15 . . . . 0.0 107.984 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.38 129.67 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -78.31 109.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.204 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.6 56.28 24.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 161.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -162.19 -71.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 -38.49 8.8 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.453 1.101 . . . . 0.0 113.765 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.72 141.59 39.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 122.357 1.075 . . . . 0.0 112.794 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -80.86 -34.81 33.44 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.63 104.17 19.8 Favored Pre-proline 0 CA--C 1.567 1.601 0 C-N-CA 124.381 1.072 . . . . 0.0 109.859 -170.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.38 -13.48 18.61 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 123.734 2.956 . . . . 0.0 118.341 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 9.6 p -67.97 -38.68 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.853 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -50.88 -40.4 56.41 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 164.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.46 -38.98 71.25 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.1 m -70.07 -39.34 75.68 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.389 1.076 . . . . 0.0 113.313 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 90' ' ' CYS . 67.8 mt -49.85 -59.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 124.903 1.281 . . . . 0.0 112.133 165.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.23 -11.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.1 t -62.53 -25.1 67.86 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.1 p -93.6 23.36 4.71 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 164.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mtp -129.31 153.4 47.87 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.531 1.132 . . . . 0.0 110.942 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 176.62 8.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.916 0.886 . . . . 0.0 111.203 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.76 110.05 1.07 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.238 -1.539 . . . . 0.0 113.446 -170.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.97 12.28 59.22 Favored Glycine 0 CA--C 1.556 2.594 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.39 137.61 32.19 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 119.344 1.572 . . . . 0.0 110.152 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.81 115.27 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.58 132.25 34.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.287 0.635 . . . . 0.0 110.536 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.09 128.34 51.22 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.13 0.572 . . . . 0.0 109.923 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -170.98 155.1 4.38 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.22 1.009 . . . . 0.0 113.631 -166.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.99 154.21 22.27 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.879 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 76' ' ' ILE . 34.5 m -127.59 140.57 52.02 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.799 166.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.51 149.21 47.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.25 1.1 pt -56.09 -28.6 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.81 -28.46 6.38 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -96.98 -43.23 7.54 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.098 1.359 . . . . 0.0 111.288 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.99 24.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.255 0.8 OUTLIER -65.05 -43.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 124.588 1.155 . . . . 0.0 113.101 173.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 15.05 22.16 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.13 -48.56 91.66 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 114.824 -2.512 . . . . 0.0 114.679 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -68.0 -6.54 17.35 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 CA-C-N 125.996 3.177 . . . . 0.0 117.96 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.57 -44.03 12.23 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 119.074 0.852 . . . . 0.0 111.639 167.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.45 -37.61 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.7 1.2 . . . . 0.0 113.556 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.89 -29.98 44.04 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 163.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.23 16.76 0.91 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 165.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.5 m -139.91 -38.6 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.783 1.233 . . . . 0.0 112.811 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.81 -24.24 49.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -82.36 -55.71 4.34 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.99 0.916 . . . . 0.0 112.174 160.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -82.89 -62.54 1.57 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.499 0.72 . . . . 0.0 112.593 -162.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -58.49 -31.12 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.5 -13.14 37.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.75 -47.78 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 120.411 1.46 . . . . 0.0 114.356 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.4 30.13 0.02 OUTLIER Glycine 0 CA--C 1.548 2.138 0 CA-C-O 118.282 -1.288 . . . . 0.0 115.724 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -147.68 119.42 8.06 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.138 1.469 . . . . 0.0 108.301 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -83.2 152.09 64.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.9 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.5 -61.52 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 C-N-CA 123.189 2.593 . . . . 0.0 114.926 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -71.15 -64.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.19 0.904 . . . . 0.0 112.003 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 52.68 66.76 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.056 1.342 . . . . 0.0 114.602 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.46 -82.37 1.52 Allowed Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.991 -0.338 . . . . 0.0 112.625 -169.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 62.75 80.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.752 1.221 . . . . 0.0 113.098 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.01 99.45 3.46 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -96.11 144.22 26.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.562 0.745 . . . . 0.0 111.232 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.3 175.86 7.96 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.65 -58.66 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.15 50.01 1.7 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-N 119.219 0.918 . . . . 0.0 115.191 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -148.96 114.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.72 85.07 1.1 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -158.81 104.79 1.77 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 16.7 tpt -146.57 -69.76 0.25 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.344 0.657 . . . . 0.0 109.709 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.56 93.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.637 1.175 . . . . 0.0 110.527 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -77.26 119.29 20.71 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.267 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -80.15 142.58 34.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -89.01 119.67 29.74 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.204 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.1 m -90.14 103.06 15.77 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.166 0.508 . . . . 0.0 110.88 -173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.82 147.03 49.83 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.964 0.905 . . . . 0.0 108.825 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.73 67.51 0.18 Allowed Glycine 0 N--CA 1.48 1.581 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.151 167.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -149.17 147.59 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 -18.26 12.57 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -85.62 -47.18 10.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.079 1.309 . . . . 0.0 113.089 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -76.54 -18.12 58.87 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -78.67 -15.17 58.81 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 163.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.35 -26.51 63.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.89 -35.97 77.51 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 168.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -55.8 -37.5 68.71 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -83.58 -34.79 25.09 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 167.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.71 93.18 3.29 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 120.292 1.405 . . . . 0.0 109.08 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.26 141.95 23.66 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.052 2.501 . . . . 0.0 113.387 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.8 144.69 36.74 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.558 -165.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.81 120.3 5.44 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.068 2.512 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.69 152.32 23.3 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -163.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.16 116.65 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 124.747 1.219 . . . . 0.0 107.843 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -103.85 102.42 12.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -87.43 96.8 10.51 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.5 mmt -91.69 142.99 27.0 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.644 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 101.64 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.1 tpp -71.36 127.74 33.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.95 0.881 . . . . 0.0 111.766 173.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.0 -55.75 2.41 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.239 171.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -138.93 163.09 33.23 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.832 1.301 . . . . 0.0 110.285 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 p -162.54 131.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.24 128.96 51.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.8 m -85.95 167.12 25.65 Favored Pre-proline 0 CA--C 1.573 1.829 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.55 107.43 1.23 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.726 2.951 . . . . 0.0 113.506 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.27 -60.22 0.55 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.583 -162.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -92.7 -23.52 18.91 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -74.53 151.9 39.42 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 120.488 1.495 . . . . 0.0 114.528 -170.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -137.48 146.52 44.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.648 163.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -102.96 122.4 44.52 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.97 0.89 . . . . 0.0 110.547 -171.199 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -116.94 105.23 12.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 mm -76.14 -40.47 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 123.322 0.649 . . . . 0.0 112.215 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.2 mm -48.2 -46.0 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 125.353 1.461 . . . . 0.0 114.26 164.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.37 -32.05 71.87 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 26.4 ptt180 -77.37 -30.27 53.7 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 170.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.69 -41.46 68.6 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.613 1.552 . . . . 0.0 115.036 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -53.24 -44.4 68.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.56 -4.86 42.28 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 166.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.32 27.51 1.91 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.344 1.429 . . . . 0.0 114.244 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.89 0.13 54.17 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 pt -127.7 155.38 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 125.27 1.428 . . . . 0.0 108.692 -165.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -104.75 161.7 13.93 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.603 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.78 126.0 9.98 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 110.4 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -147.68 119.11 7.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.73 135.17 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.551 0.74 . . . . 0.0 110.879 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.6 -64.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.78 112.42 18.35 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.21 122.36 16.92 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.283 0.633 . . . . 0.0 111.105 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.7 -131.32 0.43 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 -165.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 145.61 44.85 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.863 0.84 . . . . 0.0 111.201 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.77 -148.93 22.03 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.698 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.814 0.846 . . . . 0.0 110.078 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.45 114.29 36.93 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 117.43 -1.271 . . . . 0.0 109.142 170.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.16 -166.09 0.36 Allowed 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.921 2.414 . . . . 0.0 114.511 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.78 -57.99 10.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 57.18 51.22 10.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -123.42 -172.45 2.52 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.377 1.071 . . . . 0.0 109.906 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.18 98.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.29 2.68 Favored Glycine 0 CA--C 1.545 1.912 0 CA-C-O 117.748 -1.584 . . . . 0.0 115.595 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -102.86 125.44 49.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -91.0 94.3 9.57 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.265 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.13 110.32 21.07 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.0 m -102.37 120.13 39.98 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 77' ' ' VAL . 45.4 p90 -157.23 169.74 24.08 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.06 0.933 . . . . 0.0 110.488 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -95.72 159.23 15.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 111.751 167.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -141.02 141.27 34.36 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.277 0.631 . . . . 0.0 109.486 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -142.48 102.69 4.12 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -94.14 120.75 34.84 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.575 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 154.89 48.55 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.173 0.987 . . . . 0.0 110.005 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -70.65 132.93 46.16 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.218 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.1 t -69.68 -62.69 1.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -133.98 -17.83 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.52 -53.82 52.92 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.26 -37.53 4.98 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.595 0.758 . . . . 0.0 111.592 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.76 3.27 79.21 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 117.959 1.944 . . . . 0.0 117.959 -160.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -87.69 146.39 25.71 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 119.262 1.531 . . . . 0.0 111.973 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.89 114.03 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.32 -34.37 36.78 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.255 -1.338 . . . . 0.0 114.48 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 141.73 26.32 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.818 0.847 . . . . 0.0 109.167 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -151.56 119.29 6.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.477 0.711 . . . . 0.0 109.133 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 m -105.69 -50.51 3.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.76 0.824 . . . . 0.0 113.166 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -22.54 66.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.66 85.12 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -79.32 -30.19 42.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 168.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.43 26.56 32.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -120.54 99.58 47.63 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-N 118.669 1.235 . . . . 0.0 108.658 -174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.94 146.54 18.42 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.949 2.432 . . . . 0.0 114.155 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.02 174.29 9.86 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.572 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.72 125.83 19.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.713 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -115.11 135.73 53.89 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.17 130.05 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.9 mm -78.8 99.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.32 60.8 7.68 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 164.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -158.79 -68.11 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -86.02 -47.19 9.8 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.052 0.941 . . . . 0.0 112.53 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -75.3 134.94 40.94 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.12 0.962 . . . . 0.0 112.89 -164.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.86 -33.61 39.98 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 114.06 54.67 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.595 1.089 . . . . 0.0 110.369 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.13 -20.31 10.06 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 123.163 2.575 . . . . 0.0 117.599 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 HG12 ' A' ' 95' ' ' VAL . 4.7 p -66.65 -40.73 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.024 1.284 . . . . 0.0 114.125 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -54.38 -36.65 64.12 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 165.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.44 -23.93 58.99 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -85.91 -49.98 7.45 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.717 1.607 . . . . 0.0 112.487 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 pt -59.1 -34.53 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 36' ' ' PHE . 32.2 m -74.38 -29.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.64 -25.55 39.73 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 p -74.01 -16.52 61.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 23.0 mtm -113.42 145.35 41.28 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.279 1.031 . . . . 0.0 111.68 -167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -108.81 -177.08 3.21 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.58 1.152 . . . . 0.0 111.288 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.07 112.53 2.13 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.35 10.04 66.31 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.02 130.61 44.84 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.555 2.177 . . . . 0.0 109.502 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.34 120.41 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.61 129.85 22.26 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.065 0.546 . . . . 0.0 110.808 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 132.49 56.63 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.572 0.749 . . . . 0.0 110.839 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -172.42 150.48 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.64 159.56 19.8 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 58.3 m -133.11 145.55 50.81 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.668 168.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.06 145.64 55.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.17 0.51 . . . . 0.0 112.09 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.77 -30.35 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -52.91 -27.67 19.82 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -94.15 -43.98 8.22 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 125.339 1.456 . . . . 0.0 111.335 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.558 HG12 HG11 ' A' ' 72' ' ' VAL . 29.6 m -90.33 22.86 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.97 -43.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 C-N-CA 124.698 1.199 . . . . 0.0 113.579 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.99 15.14 23.2 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 172.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.34 -49.27 94.83 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 115.061 -2.4 . . . . 0.0 115.695 159.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.56 -16.04 49.84 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 125.64 3.05 . . . . 0.0 117.611 170.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.58 -41.41 17.91 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 123.513 0.725 . . . . 0.0 112.159 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -81.78 -32.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -31.19 55.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 160.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -81.31 23.2 0.62 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.1 p -144.73 -34.94 0.35 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.88 1.272 . . . . 0.0 113.98 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.71 -29.57 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 166.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -77.62 -56.04 4.85 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 118.759 0.708 . . . . 0.0 112.259 158.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -83.62 -63.18 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.127 0.876 . . . . 0.0 112.252 -158.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -59.82 -22.99 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.57 -8.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -47.61 -50.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 157.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.83 -91.78 0.08 OUTLIER Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -130.11 167.74 17.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.901 1.334 . . . . 0.0 111.5 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.33 159.04 43.3 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -61.12 -48.54 9.88 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.392 2.728 . . . . 0.0 116.56 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 mt -92.47 -46.31 7.71 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.886 164.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 106.24 3.29 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 119.554 1.07 . . . . 0.0 110.734 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.54 -88.04 0.51 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.476 -0.625 . . . . 0.0 111.685 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.334 75.3 mt-30 66.69 -91.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.411 1.084 . . . . 0.0 111.837 -169.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -78.72 130.75 36.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.429 0.692 . . . . 0.0 110.408 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -83.19 115.67 22.03 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.322 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.37 -69.68 0.69 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.97 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.33 94.83 5.44 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.762 0.71 . . . . 0.0 109.578 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.49 -86.63 0.12 Allowed Glycine 0 N--CA 1.478 1.482 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.2 t 72.71 97.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 125.118 1.367 . . . . 0.0 108.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 110.68 3.48 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.238 -165.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -136.75 112.5 9.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.96 153.92 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.547 0.739 . . . . 0.0 111.543 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -85.99 93.48 8.97 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -133.47 127.93 34.35 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -77.9 123.23 26.51 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.056 0.543 . . . . 0.0 110.946 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.1 t -89.19 101.18 13.84 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.25 0.548 . . . . 0.0 109.743 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.4 t -135.05 -74.51 0.46 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.9 tp 74.37 132.81 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.713 1.205 . . . . 0.0 113.998 164.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.42 95.03 0.11 Allowed Glycine 0 N--CA 1.476 1.355 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -120.04 110.74 17.03 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -13.66 61.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 -45.64 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 119.409 1.004 . . . . 0.0 113.327 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.41 -20.64 58.79 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 164.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.47 -17.4 60.14 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 164.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.98 60.77 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 161.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.1 -37.79 78.6 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -56.0 -38.74 70.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -83.3 -33.71 25.89 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.81 93.06 3.05 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 120.51 1.505 . . . . 0.0 109.113 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.2 143.35 12.62 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.096 2.531 . . . . 0.0 113.314 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 152.18 27.66 Favored Pre-proline 0 CA--C 1.574 1.9 0 C-N-CA 123.781 0.833 . . . . 0.0 110.592 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.47 124.13 10.09 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.986 2.457 . . . . 0.0 113.249 -173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.6 mt -102.96 160.57 14.5 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 123.251 0.62 . . . . 0.0 112.536 -169.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -93.38 119.19 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.429 1.092 . . . . 0.0 108.357 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.44 ' CE1' HG11 ' A' ' 95' ' ' VAL . 48.8 m-85 -107.8 101.8 11.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -87.46 97.57 10.9 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.8 mmt -92.48 135.46 34.04 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.418 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -123.43 101.97 7.64 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.6 ttm -74.49 142.24 44.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.794 0.807 . . . . 0.0 113.045 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 -60.48 1.49 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.957 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -137.07 153.42 50.59 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.124 0.964 . . . . 0.0 108.812 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.256 1.4 p -152.12 123.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.16 131.32 56.41 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 0.0 108.775 -168.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.3 m -88.02 164.71 32.62 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.35 107.31 1.37 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.511 2.807 . . . . 0.0 113.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.34 -59.58 0.56 Allowed Glycine 0 CA--C 1.541 1.703 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.79 -162.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.3 t -91.1 -26.91 18.89 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -71.42 170.68 12.73 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 120.124 1.329 . . . . 0.0 114.562 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -78.73 104.38 9.31 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -105.79 134.86 48.23 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.657 0.783 . . . . 0.0 109.468 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.072 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.34 . . . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.21 116.17 18.76 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.7 mm -93.31 -48.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 118.543 -0.742 . . . . 0.0 110.869 -168.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.46 -41.09 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.803 1.183 . . . . 0.0 113.662 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.57 90.45 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -74.96 -32.92 61.83 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.06 -30.19 39.31 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -58.45 -41.77 85.87 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 121.17 1.805 . . . . 0.0 114.827 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.31 3.56 12.75 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 163.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.29 -8.32 56.83 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.72 -45.01 1.37 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 119.921 1.237 . . . . 0.0 114.101 -165.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -70.13 164.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.123 1.369 . . . . 0.0 112.397 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -145.89 125.72 13.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.63 153.48 18.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -155.64 122.97 5.49 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.178 159.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 137.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.659 0.783 . . . . 0.0 110.85 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.86 -66.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.42 109.34 15.64 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.91 119.92 10.97 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.337 0.655 . . . . 0.0 111.228 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.81 -137.84 1.09 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -162.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -117.1 136.74 52.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.49 0.662 . . . . 0.0 110.726 -169.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.42 -114.59 4.16 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.81 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.43 160.43 41.59 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.881 0.848 . . . . 0.0 110.861 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.52 126.04 81.62 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.724 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.53 -160.78 0.13 Allowed 'Trans proline' 0 CA--C 1.569 2.258 0 C-N-CA 123.118 2.545 . . . . 0.0 113.249 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.65 -56.5 11.81 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 57.85 62.87 1.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -129.88 -177.33 4.24 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.493 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -64.17 102.76 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.75 0.786 . . . . 0.0 112.278 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.2 35.48 2.91 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 117.735 -1.591 . . . . 0.0 115.672 -171.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -105.95 128.2 53.65 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -91.33 94.52 9.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.095 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.01 109.26 20.72 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.445 0.641 . . . . 0.0 110.028 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.9 m -100.65 121.98 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.8 p90 -156.55 166.9 32.08 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.287 1.041 . . . . 0.0 110.26 -172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.57 161.5 14.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.542 -0.724 . . . . 0.0 111.984 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -145.85 142.96 29.31 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.487 0.715 . . . . 0.0 109.461 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -143.97 96.91 2.97 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 p -91.42 119.46 31.43 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.61 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.04 153.79 50.53 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.856 0.836 . . . . 0.0 109.971 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -68.93 133.35 48.09 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.332 0.653 . . . . 0.0 111.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.9 p -67.31 -57.32 6.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.05 -21.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.01 -55.92 27.02 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -113.53 -35.81 5.13 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.006 0.922 . . . . 0.0 111.942 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.17 9.12 80.36 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 -159.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -89.07 146.89 24.54 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.945 1.373 . . . . 0.0 111.379 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.46 115.73 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.0 -33.57 33.56 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.58 142.74 25.03 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.429 0.692 . . . . 0.0 109.248 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.37 118.78 6.01 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -103.76 -53.35 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.88 -40.82 85.57 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 164.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -80.92 -23.18 39.09 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.34 24.09 59.69 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -165.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.4 100.42 47.35 Favored Pre-proline 0 CA--C 1.565 1.541 0 CA-C-N 118.981 1.391 . . . . 0.0 108.998 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.09 149.34 19.83 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.023 2.482 . . . . 0.0 114.354 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.56 174.62 9.86 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.355 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -139.33 124.31 18.77 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.188 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.34 132.3 55.06 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.08 127.25 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.81 113.6 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.61 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.63 48.77 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 119.303 2.481 . . . . 0.0 119.303 161.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -161.22 -67.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -97.69 -46.7 5.89 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.393 1.077 . . . . 0.0 113.001 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.19 142.56 45.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.26 1.029 . . . . 0.0 113.7 -163.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -85.85 -25.2 26.39 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -106.04 99.26 21.98 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.363 1.438 . . . . 0.0 109.386 -175.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.39 -7.8 16.04 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 123.631 2.887 . . . . 0.0 118.275 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.281 12.3 p -65.13 -39.03 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.706 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.607 ' O ' HG22 ' A' ' 77' ' ' VAL . 20.3 m0 -51.21 -38.81 54.47 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.35 -40.45 70.67 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 m -67.88 -47.92 67.51 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.032 1.333 . . . . 0.0 113.321 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.32 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.8 m -80.52 -10.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -50.76 -38.52 48.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 120.892 1.678 . . . . 0.0 115.501 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.4 p -77.39 -9.36 58.81 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 173.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.8 mmm -102.31 130.16 48.95 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.536 1.134 . . . . 0.0 110.404 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -102.9 178.41 4.57 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.535 0.734 . . . . 0.0 112.045 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.01 108.78 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.451 0.701 . . . . 0.0 111.437 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.76 58.44 Favored Glycine 0 CA--C 1.553 2.443 0 N-CA-C 118.546 2.179 . . . . 0.0 118.546 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -98.15 137.58 36.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 120.229 2.015 . . . . 0.0 109.85 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.06 119.11 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.46 131.6 34.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.327 0.584 . . . . 0.0 111.561 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 149' ' ' ILE . 1.6 tm0? -123.4 124.36 42.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.195 0.998 . . . . 0.0 109.172 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -173.38 159.91 3.83 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.2 pp -92.52 156.12 17.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.9 m -120.48 138.25 53.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.877 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.65 142.62 58.33 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.66 -29.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -29.19 23.45 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 165.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -95.93 -42.77 8.13 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.291 1.436 . . . . 0.0 111.266 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 150' ' ' PHE . 33.1 m -89.33 26.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -40.09 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 124.869 1.268 . . . . 0.0 113.367 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 7.79 44.84 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 168.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -59.41 -45.5 98.95 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 114.919 -2.467 . . . . 0.0 116.169 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -64.3 -12.64 33.86 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 CA-C-N 125.833 3.119 . . . . 0.0 117.142 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.1 -45.51 9.09 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 124.818 1.247 . . . . 0.0 111.583 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.5 t -78.89 -31.67 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.48 -30.56 20.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 162.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -79.2 13.17 1.96 Allowed 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.9 p -139.89 -36.75 0.49 Allowed 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.572 1.149 . . . . 0.0 113.951 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.65 -28.91 61.62 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 166.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -82.53 -55.01 4.73 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.483 0.713 . . . . 0.0 112.23 161.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -84.61 -62.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.876 0.762 . . . . 0.0 111.875 -159.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -60.36 -28.52 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.889 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -12.68 3.5 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 118.778 2.881 . . . . 0.0 118.778 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.77 -48.54 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.58 66.48 0.15 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.788 -0.451 . . . . 0.0 113.741 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.267 3.2 mmmp? 70.01 163.32 0.24 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 167.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 151.11 86.02 Favored Pre-proline 0 CA--C 1.571 1.782 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.8 -47.73 2.49 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.383 2.722 . . . . 0.0 115.635 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.24 -44.66 87.48 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -75.85 98.01 4.07 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.143 0.883 . . . . 0.0 109.752 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.32 76.73 1.13 Allowed Glycine 0 CA--C 1.543 1.835 0 CA-C-O 119.406 -0.663 . . . . 0.0 113.895 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -126.83 111.78 14.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 166.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.64 100.36 12.89 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -115.2 143.65 44.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.429 0.692 . . . . 0.0 111.898 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.03 179.23 7.46 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 76.1 m -68.37 115.16 7.48 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.419 0.687 . . . . 0.0 112.455 -175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.47 54.72 6.55 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.0 t -145.08 103.28 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.84 116.4 1.66 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 69.21 91.83 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.607 1.163 . . . . 0.0 111.508 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.2 ptm -147.09 122.51 10.35 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.29 110.02 12.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.83 -62.81 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.469 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.1 135.38 50.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.965 0.802 . . . . 0.0 109.79 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.1 m -91.4 113.86 26.24 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.215 0.606 . . . . 0.0 110.751 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.2 t -89.69 159.09 17.28 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.404 0.682 . . . . 0.0 111.504 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.454 0.4 OUTLIER 84.75 143.83 0.06 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 125.573 1.549 . . . . 0.0 113.511 177.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.49 96.76 0.13 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -132.69 116.71 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.58 -6.15 59.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -90.48 -47.01 7.97 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.847 1.203 . . . . 0.0 112.523 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -80.19 -8.23 59.33 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.5 13.11 32.97 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 120.221 1.373 . . . . 0.0 114.156 157.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.98 72.01 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -70.15 -35.32 73.94 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -50.92 -39.05 53.62 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -89.18 -33.25 17.09 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.57 89.18 4.79 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 119.823 1.192 . . . . 0.0 109.274 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.09 125.35 4.64 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 123.034 2.489 . . . . 0.0 112.986 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.91 148.99 12.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 C-N-CA 123.809 0.844 . . . . 0.0 109.566 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.19 124.32 11.6 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.27 2.646 . . . . 0.0 113.702 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.73 158.44 17.54 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.202 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.433 HG23 HE21 ' A' ' 87' ' ' GLN . 15.7 mm -92.39 113.43 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' A' ' 95' ' ' VAL . 63.9 m-85 -103.4 101.74 11.66 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -90.36 97.24 11.07 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -88.29 148.27 24.39 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.782 0.801 . . . . 0.0 112.031 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.58 103.46 5.68 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.0 ttm -77.09 137.59 39.02 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 122.608 1.194 . . . . 0.0 112.782 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 -57.12 2.15 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 112.499 -2.137 . . . . 0.0 110.195 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 123.135 1.445 . . . . 0.0 109.784 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -161.88 125.7 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.12 130.4 50.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.095 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.7 m -88.05 167.95 18.21 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.76 108.74 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.434 2.756 . . . . 0.0 113.815 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.06 -58.8 0.6 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.804 -163.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.16 -24.09 18.36 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -71.14 143.79 50.45 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.502 1.501 . . . . 0.0 114.428 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? 68.28 96.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.514 1.125 . . . . 0.0 111.364 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -81.59 132.95 35.32 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.495 0.665 . . . . 0.0 111.794 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -170.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -78.64 119.43 21.88 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 163.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.6 mt -81.23 -39.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 118.396 -0.812 . . . . 0.0 112.201 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mm -48.99 -45.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 120.277 1.398 . . . . 0.0 113.729 164.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.83 88.27 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 7.4 ptm180 -68.56 -27.71 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.33 -40.61 93.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtp-105 -53.95 -53.76 48.37 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.459 1.481 . . . . 0.0 113.942 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.1 0.3 9.94 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.53 -4.88 53.39 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.92 -53.75 0.63 Allowed Glycine 0 CA--C 1.545 1.93 0 CA-C-N 120.364 1.438 . . . . 0.0 112.789 -163.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 pt -65.97 168.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.166 1.386 . . . . 0.0 112.365 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -144.54 113.45 6.81 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -89.7 145.54 25.14 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 112.811 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.9 ttm-85 -144.66 124.08 13.12 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.848 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.23 137.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.774 0.829 . . . . 0.0 110.993 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.08 -66.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 171.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.73 113.74 21.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.4 122.45 16.76 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.304 0.642 . . . . 0.0 111.099 168.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.2 -141.26 1.73 Allowed Glycine 0 CA--C 1.54 1.615 0 N-CA-C 117.284 1.674 . . . . 0.0 117.284 -164.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -134.38 141.26 46.8 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.129 0.966 . . . . 0.0 109.876 -166.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.02 -138.66 20.31 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 114.934 -1.03 . . . . 0.0 115.047 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.37 147.31 24.82 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.824 0.85 . . . . 0.0 111.957 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -92.86 109.97 42.62 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.018 163.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.45 -155.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.22 0 C-N-CA 123.175 2.584 . . . . 0.0 114.437 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.34 -59.99 4.53 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 55.58 48.96 17.55 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -160.31 96.65 1.2 Allowed 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.539 -0.725 . . . . 0.0 109.728 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.256 14.7 m-20 49.68 61.32 3.22 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.75 87.22 0.33 Allowed Glycine 0 N--CA 1.473 1.146 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -159.38 130.6 6.09 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -88.0 99.19 11.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.922 . . . . 0.0 109.303 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.32 109.78 21.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.66 0.743 . . . . 0.0 109.805 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.1 m -99.64 122.83 43.24 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' SD ' ' A' ' 60' ' ' MET . 44.4 p90 -159.45 165.68 32.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.037 0.922 . . . . 0.0 110.524 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -91.59 160.97 15.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -0.75 . . . . 0.0 112.217 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -143.72 142.32 30.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.666 0.787 . . . . 0.0 109.61 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -145.41 95.23 2.63 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -89.65 119.15 29.81 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.755 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.14 156.19 49.43 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.136 0.97 . . . . 0.0 110.228 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -69.99 134.97 48.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.299 0.639 . . . . 0.0 111.829 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -65.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -137.24 -10.17 1.71 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.04 -54.97 38.57 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.391 1.451 . . . . 0.0 114.744 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.99 -34.51 2.97 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.88 0.872 . . . . 0.0 112.513 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.9 6.6 89.04 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 117.855 1.902 . . . . 0.0 117.855 -161.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 t -85.92 144.08 27.85 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.122 1.461 . . . . 0.0 111.94 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.54 112.52 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -34.26 46.62 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.518 173.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -147.68 141.31 25.55 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.525 0.73 . . . . 0.0 109.107 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.58 124.35 9.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.656 0.782 . . . . 0.0 109.112 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -113.04 -48.66 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.052 0.941 . . . . 0.0 113.34 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -24.51 67.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 167.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.21 87.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 164.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -72.04 -37.04 69.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.98 9.65 Favored Glycine 0 CA--C 1.544 1.849 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -166.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 111.21 3.82 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-N 118.422 1.111 . . . . 0.0 109.317 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -82.06 156.4 17.54 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.351 2.701 . . . . 0.0 115.111 -169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.45 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -84.06 175.82 9.25 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.532 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -142.33 118.01 10.42 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.949 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -107.35 132.99 52.54 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.84 128.44 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -77.24 115.76 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.35 54.36 27.28 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 119.617 2.607 . . . . 0.0 119.617 162.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -161.74 -68.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -92.97 -48.51 6.48 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.007 0.923 . . . . 0.0 112.761 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -76.0 139.18 41.36 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.405 1.098 . . . . 0.0 113.15 -162.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -87.49 -23.08 24.54 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.94 101.48 14.23 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-N 120.319 1.418 . . . . 0.0 109.182 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.17 -13.26 19.12 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 C-N-CA 123.547 2.831 . . . . 0.0 118.157 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 95' ' ' VAL 0.25 10.4 p -67.85 -36.09 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.117 173.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -53.18 -39.28 63.52 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.53 -40.48 76.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.2 m -71.87 -36.67 70.17 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.826 1.25 . . . . 0.0 113.778 172.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.9 mt -50.72 -55.6 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 124.674 1.19 . . . . 0.0 112.304 163.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.35 -11.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 24.6 p -59.98 -23.73 63.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.2 p -99.77 31.44 3.24 Favored 'General case' 0 CA--C 1.58 2.106 0 C-N-CA 124.363 1.065 . . . . 0.0 113.592 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 80.5 mtp -134.51 142.66 47.09 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.791 1.237 . . . . 0.0 109.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -117.0 -178.48 3.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.693 1.197 . . . . 0.0 111.554 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -62.72 108.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.893 0.877 . . . . 0.0 111.536 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.05 10.44 58.6 Favored Glycine 0 CA--C 1.552 2.382 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -94.49 133.14 38.41 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.953 2.377 . . . . 0.0 109.738 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.12 118.58 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.54 38.65 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 130.27 53.28 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.271 0.628 . . . . 0.0 110.628 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.93 154.54 2.88 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.54 149.27 26.02 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.85 138.94 54.41 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.436 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.58 144.24 54.71 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.488 0.715 . . . . 0.0 112.72 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.57 -30.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -28.3 6.76 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 164.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -96.96 -42.92 7.68 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.899 1.28 . . . . 0.0 111.243 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 72' ' ' VAL . 26.4 m -89.3 22.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.35 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 124.85 1.26 . . . . 0.0 113.721 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.68 14.89 23.41 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.93 -46.07 96.71 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 114.989 -2.434 . . . . 0.0 115.553 160.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -66.3 -5.05 11.7 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.769 3.096 . . . . 0.0 118.042 168.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.21 -43.3 7.78 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.257 1.023 . . . . 0.0 111.744 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.04 -29.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.78 1.232 . . . . 0.0 114.181 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.4 14.84 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 160.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.72 9.11 2.48 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 167.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -137.54 -37.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.118 1.327 . . . . 0.0 113.442 173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.255 0.5 OUTLIER -56.55 -29.06 61.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 167.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -79.98 -53.41 6.76 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 123.815 0.846 . . . . 0.0 112.666 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -83.22 -61.51 1.83 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.575 0.75 . . . . 0.0 112.776 -159.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.68 -32.56 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.18 -3.5 1.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 118.951 2.945 . . . . 0.0 118.951 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.29 -47.94 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 159.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.61 59.75 0.28 Allowed Glycine 0 CA--C 1.539 1.547 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.663 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 32.2 mmmt 63.7 174.82 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.77 152.19 87.16 Favored Pre-proline 0 CA--C 1.573 1.841 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.61 -49.11 6.06 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.303 2.668 . . . . 0.0 117.052 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.22 -69.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.704 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.342 9.8 pt-20 56.56 -170.69 0.09 Allowed 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.77 105.99 2.38 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 155.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -76.26 94.44 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.074 0.55 . . . . 0.0 111.936 -162.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -173.24 95.75 0.11 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -158.76 93.74 1.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.2 t -142.08 65.85 1.36 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 160.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.1 t -169.21 -67.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.87 0.868 . . . . 0.0 109.631 -171.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.72 -92.97 0.83 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.362 -0.688 . . . . 0.0 112.725 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.88 100.02 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.27 70.76 0.93 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.427 0.632 . . . . 0.0 109.76 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -146.49 126.99 14.1 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -163.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 70.73 97.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.801 1.241 . . . . 0.0 111.229 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.83 93.76 9.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.45 132.39 13.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -159.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -83.56 98.48 9.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.2 t -81.35 114.66 20.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.08 0.552 . . . . 0.0 110.043 -175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.6 p -101.18 155.14 18.19 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.125 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.11 145.02 56.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.6 84.76 0.06 OUTLIER Glycine 0 N--CA 1.476 1.32 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -142.59 147.79 36.44 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.52 -20.67 11.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 164.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.49 -49.5 21.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.85 -21.4 40.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 168.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.28 -6.7 52.61 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.64 -30.83 63.74 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 156.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -70.28 -38.41 75.04 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -55.93 -37.04 68.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -83.42 -35.49 24.97 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.88 92.25 3.36 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.362 1.437 . . . . 0.0 109.358 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.13 139.14 11.69 Favored 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 123.054 2.502 . . . . 0.0 113.106 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 155.09 34.23 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.632 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.73 127.76 15.08 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.901 2.4 . . . . 0.0 113.095 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.65 158.26 16.49 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.0 115.91 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.228 1.011 . . . . 0.0 108.738 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.6 m-85 -105.84 102.07 11.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.53 96.88 10.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.38 142.11 28.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.818 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.45 100.66 5.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.9 ttm -74.84 139.18 43.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.031 0.92 . . . . 0.0 112.526 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 -57.47 2.03 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.326 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -143.61 144.11 31.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.253 2.5 p -149.91 128.56 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.768 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -124.64 143.84 50.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.432 -164.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 99.9 p -89.32 156.26 48.55 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.94 118.54 5.74 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.793 2.995 . . . . 0.0 113.216 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 133.26 -56.31 0.73 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.692 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.9 t -89.85 -31.18 17.46 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -74.79 136.08 41.66 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.577 1.535 . . . . 0.0 113.569 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -150.16 103.68 3.2 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.59 124.91 51.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.772 -176.399 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.57 109.32 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mm -83.81 -40.2 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.173 0.589 . . . . 0.0 112.275 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -50.95 -47.13 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.688 1.195 . . . . 0.0 113.415 165.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.24 -45.94 92.46 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -65.79 -27.77 68.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.38 -37.05 80.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HE ' HE22 ' A' ' 14' ' ' GLN . 35.4 mtp180 -55.44 -54.71 40.44 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.334 1.425 . . . . 0.0 113.738 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.43 -2.37 10.9 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.68 -4.57 52.35 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 169.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.87 -38.4 3.16 Favored Glycine 0 CA--C 1.554 2.47 0 CA-C-N 120.433 1.47 . . . . 0.0 115.326 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 pt -76.75 172.12 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 125.811 1.644 . . . . 0.0 111.657 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.426 HE22 ' HE ' ' A' ' 9' ' ' ARG . 30.0 tp60 -141.89 122.76 14.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.13 140.06 31.4 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.714 0.806 . . . . 0.0 111.724 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -146.82 127.2 13.99 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 0.0 109.816 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.2 143.47 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 124.02 0.928 . . . . 0.0 111.679 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -90.19 -65.51 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.84 112.66 17.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.74 125.02 23.99 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.442 0.697 . . . . 0.0 111.351 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.01 -143.64 1.66 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.686 1.834 . . . . 0.0 117.686 -163.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -96.49 -93.16 0.21 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.653 -161.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 -109.2 3.0 Favored Glycine 0 N--CA 1.479 1.525 0 CA-C-N 117.861 0.3 . . . . 0.0 113.696 -164.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.46 138.24 33.41 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.868 0.842 . . . . 0.0 111.278 -167.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -85.04 110.51 28.94 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.331 -1.318 . . . . 0.0 107.674 166.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -176.23 2.26 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.739 2.293 . . . . 0.0 114.151 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.86 -42.6 94.74 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 65.13 80.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.614 1.166 . . . . 0.0 111.179 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -137.5 177.11 8.12 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.547 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.66 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 39.6 3.75 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 118.216 -1.324 . . . . 0.0 115.495 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 m -102.01 127.96 48.65 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -89.0 95.99 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.734 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.96 111.24 22.25 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.918 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.8 m -102.19 124.63 48.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 77' ' ' VAL . 37.0 p90 -160.11 167.46 27.71 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.066 0.936 . . . . 0.0 110.434 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -93.09 162.35 14.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.44 -0.788 . . . . 0.0 112.127 167.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -144.51 141.51 29.58 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.385 0.674 . . . . 0.0 109.817 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -142.92 99.18 3.41 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 120.68 34.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.678 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.9 155.36 49.87 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 122.292 1.044 . . . . 0.0 110.1 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -72.4 133.03 44.7 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.51 0.724 . . . . 0.0 110.836 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.6 p -69.1 -61.84 1.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 -167.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.93 -3.43 1.43 Allowed 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.16 -57.0 9.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.888 1.676 . . . . 0.0 113.505 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.02 -32.04 4.57 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.688 0.795 . . . . 0.0 112.735 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.61 9.87 86.68 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 117.766 1.867 . . . . 0.0 117.766 -164.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 t -85.44 142.22 29.39 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.826 1.313 . . . . 0.0 111.98 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 p -84.84 114.21 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.09 -33.86 38.47 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.362 -1.29 . . . . 0.0 114.426 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.04 144.31 27.83 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.585 0.754 . . . . 0.0 109.639 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -151.55 118.32 5.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.272 0.629 . . . . 0.0 109.343 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -105.89 -51.83 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.816 0.846 . . . . 0.0 113.15 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -22.47 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 170.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.88 83.0 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 164.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -81.25 -25.81 36.32 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 168.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.37 27.41 48.35 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -120.1 99.15 48.85 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 118.729 1.265 . . . . 0.0 108.854 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.56 147.43 22.34 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.961 2.441 . . . . 0.0 114.37 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -83.64 174.85 10.17 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.436 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -143.47 116.4 8.83 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.798 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -106.45 132.74 52.13 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.36 129.87 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.8 101.22 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.36 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 55.12 57.88 16.32 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 118.288 2.075 . . . . 0.0 118.288 161.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -156.11 -67.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -97.07 -41.73 8.21 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -73.58 140.38 46.21 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 119.471 1.032 . . . . 0.0 112.914 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -91.25 -23.09 20.28 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -172.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.65 101.88 17.1 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-N 120.385 1.448 . . . . 0.0 109.275 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.78 -12.13 18.17 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.573 2.849 . . . . 0.0 118.287 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.277 11.9 p -68.09 -36.5 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.928 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -53.23 -38.57 63.07 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 164.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -69.46 -40.65 77.0 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -69.65 -41.11 76.0 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.805 1.242 . . . . 0.0 113.613 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 90' ' ' CYS . 70.1 mt -49.72 -55.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.742 1.217 . . . . 0.0 112.269 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 36' ' ' PHE . 32.0 m -83.35 -11.66 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.02 -32.61 69.88 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 121.275 1.852 . . . . 0.0 115.825 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -76.81 -4.97 46.3 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -109.44 128.01 54.83 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 119.706 1.139 . . . . 0.0 110.675 -167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -101.89 172.15 7.1 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.601 0.76 . . . . 0.0 111.702 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.09 106.93 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.195 0.998 . . . . 0.0 112.184 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.85 53.45 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 118.55 2.18 . . . . 0.0 118.55 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.33 136.7 38.89 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.132 1.966 . . . . 0.0 109.765 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.44 114.09 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.25 132.04 37.33 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.72 0.771 . . . . 0.0 110.909 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.86 123.22 39.47 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.78 155.99 6.11 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.996 0.903 . . . . 0.0 113.321 -167.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 158.71 19.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 76' ' ' ILE . 51.6 m -128.96 143.41 50.87 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.505 166.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.31 147.58 52.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.429 0.691 . . . . 0.0 112.169 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -62.39 -22.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -176.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -51.43 -29.0 14.48 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 162.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -94.8 -43.27 8.31 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.01 1.324 . . . . 0.0 111.348 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.1 25.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -67.79 -42.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 124.87 1.268 . . . . 0.0 113.526 173.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.42 11.77 27.24 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 168.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -60.65 -43.73 93.17 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.96 162.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.49 -24.68 70.5 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 126.394 3.319 . . . . 0.0 116.529 168.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.53 -43.84 46.73 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 119.09 0.859 . . . . 0.0 112.217 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.8 -32.52 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.35 1.06 . . . . 0.0 113.792 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.74 -33.03 46.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 161.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.92 21.89 0.66 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 167.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -144.21 -39.95 0.28 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.713 1.205 . . . . 0.0 113.569 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.84 -29.21 54.56 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -80.88 -57.38 3.57 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.669 0.788 . . . . 0.0 112.252 160.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -82.01 -61.0 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.817 0.735 . . . . 0.0 112.899 -159.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -54.18 -35.43 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.68 10.62 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.46 -42.8 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.92 -83.74 0.05 OUTLIER Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.518 -0.601 . . . . 0.0 111.62 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -78.66 129.46 34.76 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 0.0 112.183 -173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.95 139.35 26.42 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.728 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.55 -47.37 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 123.472 2.781 . . . . 0.0 115.524 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -66.03 -41.79 90.47 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.85 -51.98 66.9 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.73 -96.53 0.26 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.008 -0.884 . . . . 0.0 112.539 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.364 6.0 pt20 45.41 79.34 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -172.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.253 54.6 ttt85 68.96 91.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.923 -166.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -82.7 134.15 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.492 0.717 . . . . 0.0 111.301 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.6 p -124.09 -53.76 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.833 0.853 . . . . 0.0 112.763 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 27.3 p -95.11 125.73 39.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 119.2 0.909 . . . . 0.0 110.512 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.61 -74.89 0.56 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.994 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.437 3.5 m 72.02 124.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 125.408 1.483 . . . . 0.0 114.669 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.65 173.56 6.41 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.03 0.919 . . . . 0.0 111.392 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -64.39 -47.1 80.51 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 13.1 ttt 61.06 66.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.89 1.276 . . . . 0.0 113.845 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -138.3 85.04 2.07 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -145.98 87.44 1.76 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -151.54 39.64 0.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.4 m -154.26 95.55 1.84 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -155.54 104.08 2.35 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.08 146.98 27.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.88 0.848 . . . . 0.0 111.298 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.05 86.47 0.06 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -163.97 131.19 3.31 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.696 0.76 . . . . 0.0 110.917 -163.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.27 -12.88 3.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.1 -52.05 5.65 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.216 1.371 . . . . 0.0 112.487 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -70.06 -27.75 64.88 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 165.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.36 -9.18 59.54 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 168.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.43 -28.14 63.04 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 165.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.31 -38.59 78.32 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -52.26 -38.84 59.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.12 -32.36 18.72 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.26 93.62 3.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 120.241 1.382 . . . . 0.0 109.088 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.01 138.96 34.91 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.255 2.637 . . . . 0.0 113.799 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -153.4 143.42 15.35 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.8 -167.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.94 122.76 5.47 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.899 2.4 . . . . 0.0 112.233 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.1 mt -101.71 158.27 16.23 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.173 0.511 . . . . 0.0 112.244 -167.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.26 141.85 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -132.4 100.35 4.96 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.97 95.9 9.65 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 19.2 mmt -92.88 141.4 28.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.864 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.13 103.11 7.02 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 49.1 tpp -73.79 133.2 43.21 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.732 0.777 . . . . 0.0 111.698 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -57.25 2.29 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.51 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.0 tmpt? -144.37 146.2 32.39 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 122.452 1.12 . . . . 0.0 108.263 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.97 128.14 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.73 128.01 35.96 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.871 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.2 m -84.75 167.79 24.64 Favored Pre-proline 0 CA--C 1.574 1.886 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.04 109.13 1.87 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.508 2.805 . . . . 0.0 113.87 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.09 -57.77 0.62 Allowed Glycine 0 CA--C 1.541 1.71 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.918 -162.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.2 t -91.72 -30.19 16.41 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -72.12 170.63 13.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 120.346 1.43 . . . . 0.0 113.688 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -75.88 101.62 5.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -91.45 130.18 37.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.456 0.646 . . . . 0.0 110.377 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -85.71 110.69 19.49 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.7 mm -87.74 -44.11 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.509 -169.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -52.61 -40.95 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 120.684 1.584 . . . . 0.0 113.694 167.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.01 71.87 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -84.73 -29.01 25.88 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.08 -34.49 56.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.26 1.391 . . . . 0.0 114.189 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -54.66 -43.63 72.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.76 -0.13 25.84 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 168.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -86.7 17.63 3.85 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.71 -41.45 2.99 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 120.037 1.289 . . . . 0.0 115.778 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.29 169.75 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.859 1.664 . . . . 0.0 112.25 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -140.58 134.19 30.17 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -117.36 133.97 55.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.179 0.991 . . . . 0.0 110.416 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -147.96 120.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.444 0.698 . . . . 0.0 109.962 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.26 139.51 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 123.464 0.706 . . . . 0.0 112.029 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -87.3 -66.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.76 111.27 18.25 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.6 119.86 10.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.468 0.707 . . . . 0.0 111.218 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.99 -127.57 0.42 Allowed Glycine 0 CA--C 1.542 1.746 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.54 152.12 51.02 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.89 1.329 . . . . 0.0 111.742 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.92 -158.34 52.08 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 113.374 -1.739 . . . . 0.0 115.97 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.0 146.24 25.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.641 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.0 116.7 49.19 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 117.391 -1.29 . . . . 0.0 110.257 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.54 -158.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.929 2.42 . . . . 0.0 114.134 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.91 -60.15 3.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 57.09 51.61 10.19 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -124.38 -178.15 4.02 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.571 1.148 . . . . 0.0 110.243 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -57.45 102.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.21 3.38 Favored Glycine 0 CA--C 1.546 1.995 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.712 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -105.34 128.85 53.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.052 1.926 . . . . 0.0 105.995 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -88.38 94.97 10.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.25 113.79 26.15 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.423 0.63 . . . . 0.0 109.851 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.4 m -104.78 123.97 48.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.6 p90 -160.78 166.54 28.47 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.959 0.885 . . . . 0.0 111.17 -170.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -93.09 163.59 13.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.392 0.677 . . . . 0.0 112.144 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -146.2 143.13 29.05 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.962 0.905 . . . . 0.0 109.472 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.68 98.63 3.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.4 p -90.25 118.8 30.03 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.881 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.77 154.24 51.68 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.94 0.876 . . . . 0.0 110.13 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.67 135.82 47.02 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.309 0.643 . . . . 0.0 111.304 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 t -68.54 -64.87 0.78 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -168.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -138.03 -8.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.31 -59.12 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 120.719 1.599 . . . . 0.0 113.488 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.22 -36.96 8.74 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.611 0.764 . . . . 0.0 111.237 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.6 74.5 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.006 1.963 . . . . 0.0 118.006 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -94.14 144.14 25.76 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.537 1.169 . . . . 0.0 111.472 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.24 111.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 -33.74 37.25 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 114.183 -1.371 . . . . 0.0 114.436 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -146.75 145.3 29.91 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.649 0.78 . . . . 0.0 109.409 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.79 116.89 3.87 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.521 0.728 . . . . 0.0 109.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 55.7 p -104.3 -51.46 3.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -17.05 38.3 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 166.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.48 89.02 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -86.53 -27.29 24.07 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.2 30.48 8.72 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.854 1.502 . . . . 0.0 116.854 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -117.84 104.04 49.54 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-N 118.343 1.071 . . . . 0.0 108.711 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.66 149.6 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.048 2.499 . . . . 0.0 114.363 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.411 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.1 ppp? -85.17 175.47 8.95 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.254 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -143.45 114.32 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.475 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -103.91 132.96 49.66 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.99 126.7 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -75.4 110.16 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.12 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.65 48.51 55.93 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 119.236 2.454 . . . . 0.0 119.236 164.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -154.65 -62.84 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -128.63 63.4 1.45 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.006 0.922 . . . . 0.0 111.007 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.89 144.75 20.44 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.221 1.01 . . . . 0.0 110.526 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.1 -27.58 16.85 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 99.92 30.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 CA-C-N 120.529 1.513 . . . . 0.0 109.494 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.37 -9.66 16.24 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.633 2.889 . . . . 0.0 118.579 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 95' ' ' VAL 0.257 11.2 p -66.29 -35.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -51.58 -39.35 57.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 164.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -68.77 -39.29 80.31 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -72.92 -36.67 67.29 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.674 1.19 . . . . 0.0 113.703 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.6 mt -48.95 -55.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 124.473 1.109 . . . . 0.0 112.085 162.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.72 -9.0 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.9 t -58.25 -38.58 77.17 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.239 1.836 . . . . 0.0 115.088 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.6 p -76.71 -3.79 39.89 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -104.88 130.38 53.03 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.736 1.153 . . . . 0.0 110.687 -170.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -103.26 171.31 7.45 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.727 0.811 . . . . 0.0 111.71 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.27 107.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.303 1.041 . . . . 0.0 112.389 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.65 53.28 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.504 2.162 . . . . 0.0 118.504 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -97.55 137.48 36.42 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.284 2.042 . . . . 0.0 110.206 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.46 117.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.6 28.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.123 0.569 . . . . 0.0 110.78 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.19 131.27 54.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.491 0.717 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -174.82 157.35 2.43 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.753 0.787 . . . . 0.0 112.79 -166.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.63 156.89 19.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 36.8 m -126.86 143.35 51.29 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.442 163.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.89 147.02 53.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.465 0.65 . . . . 0.0 111.895 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.19 -29.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -53.56 -26.92 23.46 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 165.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -95.04 -43.81 7.96 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 125.273 1.429 . . . . 0.0 110.817 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG12 HG11 ' A' ' 72' ' ' VAL . 28.4 m -90.57 24.58 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.19 -42.7 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.51 1.124 . . . . 0.0 113.823 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.85 14.63 20.88 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 170.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -59.85 -46.2 98.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 114.665 -2.588 . . . . 0.0 115.588 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.35 -12.55 33.56 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 CA-C-N 126.123 3.222 . . . . 0.0 117.657 169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -86.88 -42.42 13.22 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 119.154 0.888 . . . . 0.0 112.144 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.7 t -81.81 -34.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.639 1.175 . . . . 0.0 113.729 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.48 38.98 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 162.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.7 8.44 1.47 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 165.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -138.87 -38.67 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 120.314 1.415 . . . . 0.0 113.21 173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -23.21 34.76 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.72 2.118 . . . . 0.0 116.72 164.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -82.37 -59.55 2.5 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.467 0.707 . . . . 0.0 111.989 160.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -79.02 -60.46 2.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.973 0.509 . . . . 0.0 112.188 -160.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.34 -38.3 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.8 -8.24 4.6 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.897 2.925 . . . . 0.0 118.897 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.2 -41.16 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.42 -81.04 0.06 OUTLIER Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -83.92 118.22 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.629 0.728 . . . . 0.0 111.21 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.52 151.41 38.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.378 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.99 -50.59 1.02 Allowed 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.475 2.783 . . . . 0.0 115.709 -170.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.74 -42.13 15.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 165.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.69 104.84 7.41 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.645 1.111 . . . . 0.0 110.547 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.45 80.39 0.78 Allowed Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.585 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.96 -66.0 0.95 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.128 0.571 . . . . 0.0 110.422 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -75.03 -66.8 0.71 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.524 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.5 m80 72.83 123.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.822 1.249 . . . . 0.0 112.16 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 42.8 t -143.24 133.91 25.13 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.293 0.637 . . . . 0.0 110.335 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.4 t 68.68 92.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.079 1.352 . . . . 0.0 112.63 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.76 11.52 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.384 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.294 11.0 m 36.16 91.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 166.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.43 107.5 3.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.04 110.42 20.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -112.14 75.21 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.797 0.808 . . . . 0.0 110.031 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -157.82 115.19 2.98 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -119.08 128.6 54.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.392 0.615 . . . . 0.0 110.493 -168.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -148.24 93.67 2.2 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 170.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.6 m -128.14 92.6 3.48 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 168.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.8 m -133.78 -70.07 0.53 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.194 -167.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mp 73.33 127.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.75 1.22 . . . . 0.0 110.837 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.52 87.99 0.07 OUTLIER Glycine 0 N--CA 1.476 1.306 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -137.31 153.19 50.33 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.023 0.916 . . . . 0.0 109.15 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.36 -10.8 10.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -90.37 -45.14 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.751 1.16 . . . . 0.0 113.259 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -25.07 58.49 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.676 1.125 . . . . 0.0 114.022 163.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.17 -10.55 59.69 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 167.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.06 -30.31 64.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 156.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.6 -38.71 77.41 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 170.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -55.93 -37.67 69.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.35 -34.04 23.74 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 167.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.84 92.85 3.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 CA-C-N 120.3 1.409 . . . . 0.0 108.943 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.02 138.3 25.4 Favored 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 123.005 2.47 . . . . 0.0 113.219 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.66 141.85 17.32 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.695 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.32 122.2 7.35 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.164 2.576 . . . . 0.0 112.747 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.84 159.14 15.6 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.5 mm -92.66 117.63 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.616 1.166 . . . . 0.0 108.073 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 95' ' ' VAL . 56.5 m-85 -107.73 101.32 10.63 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.19 97.89 11.46 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.17 146.9 23.93 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.687 171.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.03 104.65 7.7 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -72.93 129.45 38.16 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.642 0.735 . . . . 0.0 111.321 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.62 -62.47 1.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.199 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -130.17 161.4 31.2 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 123.511 1.624 . . . . 0.0 110.414 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.71 125.28 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.26 125.5 45.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.8 m -83.95 166.56 33.02 Favored Pre-proline 0 CA--C 1.574 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.94 107.39 1.1 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.761 2.974 . . . . 0.0 113.62 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.55 -60.2 0.55 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.797 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.8 t -91.31 -28.44 17.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -72.9 145.28 46.96 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 120.234 1.379 . . . . 0.0 113.554 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.331 7.3 pt20 64.25 161.14 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -104.2 123.01 46.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 158.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 122.223 1.011 . . . . 0.0 108.329 179.649 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.34 0.59 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.5 118.18 23.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 170.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.37 -40.91 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -47.9 -45.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 125.09 1.356 . . . . 0.0 114.467 164.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.36 72.53 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -77.9 -24.08 48.51 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.25 -38.57 56.13 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.564 1.984 . . . . 0.0 115.204 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -53.07 -43.43 66.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.96 -2.84 38.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.87 34.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.61 1.55 . . . . 0.0 113.533 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.7 6.58 36.9 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 120.002 2.761 . . . . 0.0 120.002 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.3 157.6 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 C-N-CA 125.502 1.521 . . . . 0.0 108.124 -166.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -113.92 151.76 31.79 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.833 0.853 . . . . 0.0 109.953 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 135.87 46.69 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.437 1.095 . . . . 0.0 110.304 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -150.78 119.71 6.66 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -95.77 135.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.679 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.4 -65.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.24 111.93 18.84 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.22 120.29 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.334 0.653 . . . . 0.0 111.031 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.69 -142.27 2.12 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -162.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -122.31 139.23 54.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.89 0.853 . . . . 0.0 110.004 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.97 -132.93 11.59 Favored Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.027 -0.988 . . . . 0.0 115.034 166.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.07 149.64 28.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.397 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.26 112.88 52.47 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.063 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.66 -165.95 0.35 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.863 2.375 . . . . 0.0 114.407 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -61.39 -52.67 63.66 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 57.57 53.29 7.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -124.76 -168.12 1.77 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.308 1.043 . . . . 0.0 109.894 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.31 96.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.08 37.92 2.81 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 117.855 -1.525 . . . . 0.0 115.444 -173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 m -97.25 126.14 42.26 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.7 95.08 8.5 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.92 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.17 111.54 23.27 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.551 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.8 m -103.9 122.25 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' O ' ' SD ' ' A' ' 60' ' ' MET . 46.4 p90 -159.79 168.03 26.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.761 0.791 . . . . 0.0 110.723 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -93.11 161.79 14.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.922 . . . . 0.0 112.529 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -145.14 143.81 30.56 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.492 0.717 . . . . 0.0 109.896 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -148.06 97.98 2.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.2 p -87.77 120.59 29.25 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 152.65 50.13 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 121.814 0.816 . . . . 0.0 109.906 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -69.39 132.5 46.47 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.552 -0.718 . . . . 0.0 111.013 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.6 t -71.6 -62.86 1.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -170.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -131.45 -16.75 3.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -54.69 -48.32 72.57 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.58 -33.48 1.63 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.683 0.793 . . . . 0.0 112.6 170.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.87 5.79 89.03 Favored Glycine 0 CA--C 1.558 2.729 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -161.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -86.62 140.61 29.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.381 1.59 . . . . 0.0 112.204 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.22 113.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 122.056 0.932 . . . . 0.0 108.616 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.65 -34.53 23.04 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.798 -1.546 . . . . 0.0 114.394 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.92 145.95 29.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.82 0.848 . . . . 0.0 109.207 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.29 128.79 8.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -170.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -116.68 -48.98 2.66 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.869 0.868 . . . . 0.0 113.296 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -25.25 67.25 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 166.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.04 87.29 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -71.16 -37.96 72.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 42.44 7.82 Favored Glycine 0 CA--C 1.544 1.844 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -167.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 112.69 3.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-N 118.531 1.166 . . . . 0.0 109.266 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.62 154.52 18.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.147 2.565 . . . . 0.0 114.918 -170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.9 ppp? -84.82 174.91 9.49 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.239 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.83 122.59 15.32 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.403 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 tp -114.8 132.74 56.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.49 126.6 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.05 105.26 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.31 57.21 12.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.76 -68.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -164.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -134.25 78.15 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.714 1.143 . . . . 0.0 108.838 159.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -155.67 140.42 17.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.156 0.979 . . . . 0.0 110.317 168.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -85.99 -31.74 21.89 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 72' ' ' VAL . 1.6 tt -93.93 114.92 64.39 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-N 119.943 1.247 . . . . 0.0 110.124 -171.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.25 -23.57 5.1 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.701 2.934 . . . . 0.0 118.025 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 1.2 p -67.87 -35.41 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.21 1.368 . . . . 0.0 113.796 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 20.4 m0 -55.75 -36.39 67.23 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 167.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.61 -25.34 56.88 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.3 m -83.73 -49.86 8.71 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.63 1.572 . . . . 0.0 112.735 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.1 -35.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 25.9 m -73.76 -26.06 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 11.3 t -59.01 -25.5 63.71 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.2 p -72.76 -11.35 60.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 166.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -114.52 138.01 51.15 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.687 1.195 . . . . 0.0 110.904 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -110.06 -179.63 3.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.283 1.033 . . . . 0.0 111.592 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -63.62 109.42 1.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.919 0.888 . . . . 0.0 111.356 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.51 9.01 59.29 Favored Glycine 0 CA--C 1.553 2.42 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -173.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -95.39 131.25 41.72 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.409 2.105 . . . . 0.0 109.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.45 116.41 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.76 27.55 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.281 0.632 . . . . 0.0 110.791 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.53 131.13 56.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.663 0.785 . . . . 0.0 110.594 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -171.0 151.3 3.25 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -169.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.01 154.9 23.01 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.615 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.9 m -132.35 145.04 50.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.848 168.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.32 146.1 54.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.401 0.619 . . . . 0.0 111.909 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -52.37 -28.67 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -53.21 -28.26 25.95 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 165.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -96.0 -43.75 7.65 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 125.19 1.396 . . . . 0.0 111.425 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 72' ' ' VAL . 27.5 m -88.06 23.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.52 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 125.163 1.385 . . . . 0.0 114.078 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.28 19.7 16.08 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.94 -53.75 63.37 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.972 155.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.18 3.53 3.97 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 CA-C-N 125.337 2.942 . . . . 0.0 117.794 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.56 -43.7 9.5 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 123.858 0.863 . . . . 0.0 111.373 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.63 -32.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.153 1.381 . . . . 0.0 113.827 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.93 -29.38 28.3 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 163.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -76.97 9.77 2.73 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.8 m -135.99 -40.78 0.67 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 120.016 1.28 . . . . 0.0 112.991 170.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -25.81 40.06 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -79.52 -56.09 4.57 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 123.787 0.835 . . . . 0.0 112.349 161.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -88.46 -56.13 3.44 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -160.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.99 -31.89 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.13 -5.12 2.04 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 171.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -49.6 -48.2 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 160.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.83 -88.8 0.44 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 170.92 15.94 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.046 0.927 . . . . 0.0 112.182 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.22 143.68 77.29 Favored Pre-proline 0 N--CA 1.493 1.676 0 C-N-CA 123.524 0.73 . . . . 0.0 111.225 171.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.89 -59.99 0.13 Allowed 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 122.867 2.378 . . . . 0.0 115.756 -163.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mp -83.63 -68.85 0.68 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.937 0.79 . . . . 0.0 110.975 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.321 13.2 pt-20 46.48 40.41 8.08 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.13 82.71 0.32 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.715 -159.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -72.81 112.65 9.03 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.449 0.624 . . . . 0.0 111.779 -169.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.59 108.02 6.51 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -106.94 142.23 36.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.382 0.673 . . . . 0.0 112.206 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.6 p -84.07 -67.6 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.948 164.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.2 p -88.6 -64.42 1.15 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.88 0.763 . . . . 0.0 112.323 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.87 92.46 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.2 t -104.61 95.14 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.76 127.14 3.54 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -171.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.255 76.7 mm-40 74.3 100.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.723 1.209 . . . . 0.0 111.038 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.54 111.72 23.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -84.54 108.54 17.36 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 -156.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.05 92.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.02 1.328 . . . . 0.0 113.103 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -127.88 83.53 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p -161.76 96.71 1.04 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.6 m -126.71 101.07 6.47 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.94 147.78 25.61 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.801 0.81 . . . . 0.0 112.548 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.2 81.83 0.05 OUTLIER Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -168.65 131.02 1.34 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.759 0.79 . . . . 0.0 110.246 -164.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -131.38 -16.25 3.11 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 164.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.53 -46.17 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 120.065 1.302 . . . . 0.0 113.172 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -26.32 64.91 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 119.864 1.211 . . . . 0.0 114.05 161.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -79.11 -20.65 48.13 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 168.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.49 64.38 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 160.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -67.67 -37.44 82.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.31 -35.58 65.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.52 -34.02 18.76 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 166.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.51 92.96 3.12 Favored Pre-proline 0 CA--C 1.563 1.477 0 CA-C-N 120.328 1.422 . . . . 0.0 108.993 -173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.2 145.75 31.14 Favored 'Trans proline' 0 CA--C 1.557 1.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.746 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -139.2 143.6 37.19 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.951 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.29 120.31 5.61 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.047 2.498 . . . . 0.0 111.92 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.9 156.38 19.76 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.424 0.631 . . . . 0.0 111.729 -162.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.08 114.66 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 95' ' ' VAL . 45.4 m-85 -100.63 94.95 6.37 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -86.17 103.38 14.76 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 46.8 mtt -108.9 141.05 41.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.929 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.56 101.55 6.46 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -174.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.4 ttm -76.0 138.95 41.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.09 0.947 . . . . 0.0 112.677 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -55.15 1.91 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.524 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -135.24 157.09 47.79 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.791 1.281 . . . . 0.0 109.678 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 1.9 p -161.48 126.17 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -120.16 154.23 35.07 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.317 1.047 . . . . 0.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.2 m -100.15 163.57 18.06 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -67.56 107.23 1.39 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.491 2.794 . . . . 0.0 113.335 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.42 -59.71 0.53 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 -163.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -87.62 -32.28 19.37 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -69.51 140.08 53.9 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.001 1.273 . . . . 0.0 113.961 -170.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 64.74 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.35 1.06 . . . . 0.0 113.039 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.03 125.07 33.15 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.238 0.542 . . . . 0.0 110.004 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 -174.049 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -92.97 159.26 15.4 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 110.598 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 mm -75.1 -43.06 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.793 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 mm -51.59 -42.3 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 120.187 1.358 . . . . 0.0 113.296 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.69 80.44 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -77.62 -32.12 53.28 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.12 -30.34 34.59 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -55.53 -41.09 72.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 164.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.97 1.81 22.49 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 166.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.46 -6.18 52.54 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.57 -39.07 2.9 Favored Glycine 0 CA--C 1.554 2.503 0 CA-C-N 120.222 1.374 . . . . 0.0 115.138 -166.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -72.23 167.95 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.554 1.542 . . . . 0.0 111.828 166.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -151.46 128.21 10.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 153.79 18.82 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -153.93 123.88 6.82 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.004 159.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -92.9 138.24 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.596 0.758 . . . . 0.0 111.374 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.88 -65.89 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.66 113.66 22.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.62 120.74 12.96 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.482 0.713 . . . . 0.0 111.253 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.37 -167.76 10.47 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 118.518 2.167 . . . . 0.0 118.518 -164.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -90.13 -65.0 1.06 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 112.693 -1.754 . . . . 0.0 113.535 -166.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.83 -160.47 14.14 Favored Glycine 0 CA--C 1.546 1.979 0 N-CA-C 115.779 1.072 . . . . 0.0 115.779 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.54 149.79 22.02 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.498 0.719 . . . . 0.0 110.751 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.82 120.14 80.31 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.291 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.67 -179.92 5.61 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 122.911 2.407 . . . . 0.0 113.647 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -58.34 -41.07 83.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 56.9 59.42 3.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -128.08 -171.52 2.47 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.652 1.181 . . . . 0.0 110.742 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -64.33 101.44 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.72 0.771 . . . . 0.0 112.212 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.93 39.25 1.73 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-O 117.709 -1.606 . . . . 0.0 115.214 -172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -108.52 127.52 54.0 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.624 2.212 . . . . 0.0 105.23 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.71 95.9 9.04 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.429 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.83 115.07 26.89 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.709 0.766 . . . . 0.0 110.924 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -110.0 121.68 45.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CE2' HG11 ' A' ' 77' ' ' VAL . 43.3 p90 -160.82 168.44 24.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.746 0.784 . . . . 0.0 111.027 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -94.11 160.81 14.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.526 -0.734 . . . . 0.0 112.244 166.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.62 144.88 32.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.948 0.899 . . . . 0.0 109.2 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -147.87 97.17 2.77 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.6 p -88.34 120.44 29.7 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.29 155.68 49.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.127 0.965 . . . . 0.0 110.04 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -70.96 135.96 48.2 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.624 0.77 . . . . 0.0 111.119 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -72.01 -63.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -170.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -133.49 -17.46 2.28 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -52.93 -53.62 46.8 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -128.04 -31.26 2.38 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 123.692 0.797 . . . . 0.0 112.993 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.31 87.73 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 -162.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 t -83.85 141.08 31.59 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.964 1.382 . . . . 0.0 111.779 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 p -82.77 110.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.79 -34.35 45.52 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.201 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.15 146.14 28.63 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.845 0.831 . . . . 0.0 109.468 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -156.42 122.3 4.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.874 0.87 . . . . 0.0 108.754 -170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -110.35 -49.81 3.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -17.34 55.78 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 167.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.82 -42.29 88.87 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.52 -21.36 24.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.44 29.22 19.94 Favored Glycine 0 CA--C 1.549 2.203 0 N-CA-C 117.549 1.78 . . . . 0.0 117.549 -173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -117.92 103.21 50.49 Favored Pre-proline 0 CA--C 1.566 1.591 0 CA-C-N 118.581 1.191 . . . . 0.0 108.686 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -79.81 148.43 19.96 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 122.998 2.465 . . . . 0.0 114.517 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -85.61 175.03 9.01 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.213 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -140.63 121.8 14.78 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.04 134.44 54.86 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.94 127.3 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.3 mm -75.57 108.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.09 56.76 19.55 Favored Glycine 0 CA--C 1.546 2.001 0 N-CA-C 119.424 2.529 . . . . 0.0 119.424 166.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -154.3 -58.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.494 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -135.89 44.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 171.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.45 138.11 51.25 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.275 1.035 . . . . 0.0 110.122 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -83.46 -33.45 25.62 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.77 104.26 23.84 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 119.451 1.023 . . . . 0.0 109.835 -170.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.81 -15.16 19.16 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 123.725 2.95 . . . . 0.0 118.302 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.266 12.7 p -67.24 -38.23 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -53.09 -35.23 59.37 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.87 -32.57 63.68 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -80.78 -44.65 18.24 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.291 1.436 . . . . 0.0 113.225 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 HG21 ' SG ' ' A' ' 90' ' ' CYS . 6.3 pt -62.82 -38.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 36' ' ' PHE . 21.7 m -70.61 -23.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 25.7 t -55.49 -33.29 63.57 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.2 p -89.4 17.8 5.87 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.7 mtp -123.24 128.76 50.44 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.312 1.045 . . . . 0.0 109.773 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -100.91 -179.19 3.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.53 0.732 . . . . 0.0 111.5 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.05 108.37 1.04 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.972 0.909 . . . . 0.0 111.26 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.0 59.26 Favored Glycine 0 CA--C 1.553 2.434 0 N-CA-C 118.641 2.217 . . . . 0.0 118.641 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -90.66 136.74 32.87 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.614 2.207 . . . . 0.0 109.56 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.05 115.98 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.075 0.55 . . . . 0.0 110.855 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 129.44 52.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.268 0.627 . . . . 0.0 110.79 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -174.29 157.35 2.74 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.841 0.829 . . . . 0.0 112.922 -167.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.03 153.51 22.08 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 76' ' ' ILE . 58.6 m -122.02 142.55 50.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 166.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.56 146.17 53.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.869 0.468 . . . . 0.0 111.769 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -56.64 -27.67 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 117.943 2.571 . . . . 0.0 117.943 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -50.99 -27.92 8.78 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -96.55 -43.48 7.58 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 125.133 1.373 . . . . 0.0 111.139 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.77 25.35 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.6 OUTLIER -66.1 -43.33 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 124.437 1.095 . . . . 0.0 113.191 175.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.4 15.62 17.21 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 168.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.64 -45.62 93.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 CA-C-O 114.55 -2.643 . . . . 0.0 115.227 162.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.42 -8.01 21.83 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 CA-C-N 126.459 3.342 . . . . 0.0 117.851 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -84.96 -41.88 15.45 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 119.301 0.955 . . . . 0.0 111.654 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.17 -32.16 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 124.683 1.193 . . . . 0.0 113.927 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.6 42.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 160.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 21.2 0.52 Allowed 'General case' 0 CA--C 1.58 2.102 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 166.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.3 m -144.32 -41.52 0.26 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.075 1.35 . . . . 0.0 112.263 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -57.66 -21.25 38.9 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -83.41 -56.5 3.72 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 118.89 0.768 . . . . 0.0 111.863 156.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -80.27 -60.16 2.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -160.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.9 mm -54.55 -41.47 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -3.31 5.99 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.5 p -59.97 -40.35 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 168.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.38 -80.33 0.05 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -75.8 119.01 19.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.494 0.718 . . . . 0.0 111.326 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.17 154.8 36.96 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 172.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.11 -35.91 31.51 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.901 2.401 . . . . 0.0 116.013 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.75 -70.73 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.012 0.824 . . . . 0.0 110.273 164.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.298 0.6 OUTLIER 64.92 -166.34 0.23 Allowed 'General case' 0 CA--C 1.572 1.823 0 C-N-CA 124.583 1.153 . . . . 0.0 113.175 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.23 99.73 2.27 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 111.032 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -81.5 111.9 18.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.188 0.595 . . . . 0.0 109.95 -168.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.263 98.6 mtt180 66.28 89.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.589 1.156 . . . . 0.0 111.056 -166.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -90.32 127.73 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.778 0.831 . . . . 0.0 110.961 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.26 -59.67 2.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.1 m -79.59 -69.09 0.61 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.846 0.748 . . . . 0.0 112.173 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 175.23 89.63 0.08 OUTLIER Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.32 87.83 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.91 107.32 2.31 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -100.48 112.73 25.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -164.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 67.8 mtt -94.93 107.92 19.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -154.67 131.78 10.98 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.6 -56.0 7.52 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 74.32 134.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.835 1.254 . . . . 0.0 112.691 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.6 p -79.29 98.82 6.82 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.195 0.522 . . . . 0.0 110.182 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.8 m -89.23 135.84 33.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.714 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.432 0.4 OUTLIER 62.91 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -175.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.72 83.78 0.05 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.01 134.57 3.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.883 0.849 . . . . 0.0 110.694 -161.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.76 -12.33 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -92.12 -48.0 6.95 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.413 1.46 . . . . 0.0 113.025 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -70.59 -24.13 62.7 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 163.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.03 -13.12 56.49 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 164.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.24 -28.19 67.82 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 162.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.0 -36.95 86.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -54.97 -37.76 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -87.58 -30.89 20.17 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 95.55 2.81 Favored Pre-proline 0 N--CA 1.485 1.299 0 CA-C-N 120.506 1.503 . . . . 0.0 108.714 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.78 138.59 10.61 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.917 2.411 . . . . 0.0 112.52 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.31 147.91 29.99 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.38 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.85 125.64 12.33 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 123.146 2.564 . . . . 0.0 113.36 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -104.77 158.71 16.33 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.87 -163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.3 mm -92.56 118.07 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.94 101.21 10.66 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -89.6 97.73 11.36 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -87.39 144.86 26.55 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.4 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 102.11 6.6 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.1 ttm -74.41 139.74 44.23 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.812 0.815 . . . . 0.0 113.022 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 -53.96 2.06 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.55 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -145.2 154.1 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.773 0.829 . . . . 0.0 110.444 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.64 132.13 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -123.16 153.39 40.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.431 1.093 . . . . 0.0 110.878 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -102.85 165.74 13.15 Favored Pre-proline 0 CA--C 1.572 1.796 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.33 108.64 1.83 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.471 2.781 . . . . 0.0 113.32 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.09 -57.03 0.59 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.094 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.0 t -88.82 -30.86 18.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -73.46 118.39 16.36 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 120.137 1.335 . . . . 0.0 111.862 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 57.33 85.72 0.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.317 1.047 . . . . 0.0 113.028 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -103.79 105.63 15.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.483 1.197 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 -171.159 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.055 0.455 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 140.17 40.27 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.76 167.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.269 23.7 mt -78.4 -44.51 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.665 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.35 -39.69 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.963 1.711 . . . . 0.0 114.134 167.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.51 78.21 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.1 ptt85 -72.19 -33.31 67.54 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.27 -34.67 42.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -55.53 -41.11 72.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.46 0.72 24.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 165.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.47 9.87 14.54 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.85 -45.84 1.79 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 120.257 1.39 . . . . 0.0 114.44 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.94 168.39 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.165 1.386 . . . . 0.0 112.397 170.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -142.76 118.1 10.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.42 134.19 47.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.967 0.907 . . . . 0.0 111.106 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -144.48 120.18 10.49 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.193 0.597 . . . . 0.0 109.445 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.16 140.02 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.728 0.811 . . . . 0.0 111.724 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.93 -66.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.27 112.19 19.15 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.64 122.03 16.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.275 0.63 . . . . 0.0 110.852 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.12 -147.7 2.15 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 116.736 1.454 . . . . 0.0 116.736 -166.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 138.92 44.08 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.56 0.695 . . . . 0.0 109.621 -174.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.86 -168.2 17.97 Favored Glycine 0 CA--C 1.543 1.833 0 CA-C-O 122.419 1.01 . . . . 0.0 115.23 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.77 141.89 28.24 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.425 -0.888 . . . . 0.0 110.61 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -84.12 115.12 58.55 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.608 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.85 -164.05 0.19 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 123.062 2.508 . . . . 0.0 115.11 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -62.93 -61.69 2.23 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 55.52 50.72 14.04 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -161.27 97.02 1.1 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.65 -0.656 . . . . 0.0 109.453 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 47.63 60.83 3.26 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.86 0.35 Allowed Glycine 0 N--CA 1.473 1.112 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -164.13 133.01 3.72 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 167.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 101.08 13.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.74 111.87 24.27 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.553 0.692 . . . . 0.0 110.936 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.0 m -102.4 123.79 46.8 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.9 p90 -159.01 166.2 32.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.722 0.772 . . . . 0.0 110.561 -172.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -90.83 163.29 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 112.485 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -147.17 144.85 29.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.945 0.898 . . . . 0.0 109.85 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -145.94 96.22 2.76 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.4 p -88.83 120.26 30.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.63 154.56 50.62 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.119 0.962 . . . . 0.0 110.072 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.54 134.87 45.45 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.285 0.634 . . . . 0.0 111.08 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 t -69.72 -67.19 0.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.11 -6.09 2.35 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.33 -57.25 5.07 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.235 1.38 . . . . 0.0 113.619 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.95 -38.33 7.03 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.451 0.7 . . . . 0.0 111.215 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.95 85.2 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 -163.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -92.33 144.26 25.57 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.88 1.34 . . . . 0.0 111.676 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.51 114.08 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -34.91 27.01 Favored 'General case' 0 CA--C 1.562 1.404 0 CA-C-N 114.242 -1.345 . . . . 0.0 114.43 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.78 146.79 29.31 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.818 0.847 . . . . 0.0 109.401 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.24 119.6 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.258 0.623 . . . . 0.0 109.786 -169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.4 p -110.34 -51.53 2.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -19.82 64.46 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.33 -43.86 75.33 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 163.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.7 mtp85 -76.1 -33.52 59.5 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.523 1.529 . . . . 0.0 114.119 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.42 55.38 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 116.791 -2.116 . . . . 0.0 118.123 -165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 125.87 27.01 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 120.423 2.112 . . . . 0.0 111.913 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.88 158.57 6.04 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.159 2.573 . . . . 0.0 114.905 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -86.0 175.94 8.31 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.642 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -140.41 122.71 15.92 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.598 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.6 132.66 56.56 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.47 129.61 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.36 114.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.6 54.52 20.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 119.571 2.589 . . . . 0.0 119.571 166.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -159.21 -66.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.43 -28.72 13.13 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -92.14 141.32 28.72 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.22 1.373 . . . . 0.0 112.009 -170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.79 -34.35 34.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.8 105.12 15.17 Favored Pre-proline 0 CA--C 1.569 1.696 0 CA-C-N 120.059 1.299 . . . . 0.0 110.449 -170.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.09 -17.03 19.68 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.775 2.983 . . . . 0.0 118.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 95' ' ' VAL 0.27 9.6 p -67.53 -37.92 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 117.659 -1.162 . . . . 0.0 113.873 175.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -51.89 -38.75 57.35 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.6 -39.72 80.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.7 m -72.87 -39.07 66.77 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.152 1.381 . . . . 0.0 113.595 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -47.02 -53.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 124.744 1.217 . . . . 0.0 112.917 163.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.4 m -87.49 -5.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 48.8 t -58.47 -38.63 77.97 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.5 p -79.54 -3.49 47.08 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 171.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.5 mtp -103.37 131.68 50.25 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 119.671 1.123 . . . . 0.0 110.714 -168.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -108.13 174.79 5.72 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.639 1.176 . . . . 0.0 111.345 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.31 107.74 0.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.915 0.886 . . . . 0.0 112.375 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.24 11.32 56.24 Favored Glycine 0 CA--C 1.554 2.508 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -94.92 134.28 37.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.475 2.137 . . . . 0.0 109.816 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.83 117.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.66 132.75 41.09 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.221 0.609 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 149' ' ' ILE . 1.5 tm0? -127.68 124.1 37.07 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.095 0.958 . . . . 0.0 108.692 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -173.96 165.16 4.27 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -92.48 154.18 18.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 38.3 m -122.37 144.85 48.77 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.804 165.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.69 147.0 51.14 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.141 0.576 . . . . 0.0 112.012 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -55.95 -28.6 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.75 -26.75 15.11 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 164.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -96.71 -43.7 7.43 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 125.162 1.385 . . . . 0.0 110.91 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.434 HG12 HG11 ' A' ' 72' ' ' VAL . 29.5 m -89.01 25.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER -66.24 -44.37 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.369 1.068 . . . . 0.0 113.843 178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.85 16.1 15.04 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 169.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.56 -45.74 97.24 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 114.482 -2.675 . . . . 0.0 115.539 162.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -64.49 -14.91 47.02 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 126.527 3.367 . . . . 0.0 117.561 169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.34 -42.85 22.19 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.192 0.905 . . . . 0.0 111.966 170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.6 -34.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.696 1.198 . . . . 0.0 113.547 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.06 35.57 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -77.84 15.09 0.92 Allowed 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.8 p -141.76 -38.83 0.39 Allowed 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.797 1.239 . . . . 0.0 113.602 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.98 -24.18 37.0 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 165.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -83.65 -56.13 3.89 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.881 0.872 . . . . 0.0 112.192 160.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -82.36 -59.18 2.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -161.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.57 -34.95 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.919 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 170.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.71 2.48 2.48 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 118.815 2.894 . . . . 0.0 118.815 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 p -49.86 -45.49 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 162.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.82 0.09 OUTLIER Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.0 -0.889 . . . . 0.0 113.453 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 62.84 132.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.066 1.346 . . . . 0.0 114.58 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 62.16 163.12 0.11 Allowed Pre-proline 0 CA--C 1.577 2.005 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 166.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -52.1 0.99 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.022 2.481 . . . . 0.0 115.556 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.14 -86.16 0.2 Allowed 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 36.02 68.03 0.26 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.51 59.9 9.93 Favored Glycine 0 CA--C 1.549 2.201 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.23 117.72 29.2 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.126 0.963 . . . . 0.0 111.686 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -94.6 -51.91 4.53 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.49 0.716 . . . . 0.0 112.286 165.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.253 31.7 m170 67.81 85.39 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.222 1.409 . . . . 0.0 112.207 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.2 t -145.39 78.59 1.55 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.602 0.715 . . . . 0.0 109.536 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.6 t -149.67 78.32 1.36 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.4 49.81 70.59 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 116.409 1.324 . . . . 0.0 116.409 -163.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.19 130.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 77.81 126.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.955 1.302 . . . . 0.0 112.655 175.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 65.72 69.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.768 1.227 . . . . 0.0 112.534 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 46.6 ttm -154.79 -96.26 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -151.5 101.31 2.8 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -93.23 105.48 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -146.75 99.53 3.21 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.2 m 66.82 108.45 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.189 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -72.04 -60.77 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.69 147.7 32.69 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.696 0.798 . . . . 0.0 110.676 169.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.98 -79.49 0.05 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.272 45.6 m-70 74.98 151.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.322 1.049 . . . . 0.0 112.391 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.45 7.34 5.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 165.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -105.91 -51.72 2.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.354 1.062 . . . . 0.0 111.049 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -76.1 -20.78 57.36 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 165.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -80.79 -16.77 52.91 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 120.816 1.643 . . . . 0.0 115.273 162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.2 64.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 163.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.99 -36.91 83.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -55.04 -39.2 68.91 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.79 -32.36 21.85 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.78 93.67 3.0 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 120.288 1.404 . . . . 0.0 108.765 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.24 138.86 14.43 Favored 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 122.954 2.436 . . . . 0.0 112.477 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.0 149.15 34.69 Favored Pre-proline 0 CA--C 1.571 1.764 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.002 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.07 124.15 9.83 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 123.083 2.522 . . . . 0.0 113.208 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.8 mt -103.73 156.59 17.69 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.08 -164.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 87' ' ' GLN . 18.8 mm -91.1 117.81 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.82 99.54 9.11 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.09 101.9 13.91 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 40.2 mtt -110.18 145.02 37.96 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.736 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.72 103.36 6.32 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.7 tpp -71.61 133.4 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.691 0.758 . . . . 0.0 111.477 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -59.58 1.9 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.64 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 147.4 47.56 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 122.204 1.002 . . . . 0.0 109.026 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 129.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.52 145.85 49.92 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.585 -165.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -95.2 157.07 37.02 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.46 118.02 5.36 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.914 3.076 . . . . 0.0 113.221 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 134.55 -56.07 0.72 Allowed Glycine 0 CA--C 1.54 1.641 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.826 -158.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -90.19 -33.55 16.16 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -76.79 144.3 39.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.512 1.506 . . . . 0.0 114.015 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . 0.376 9.4 pt20 66.22 141.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -123.88 109.68 13.91 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 155.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.118 1.367 . . . . 0.0 112.183 -176.809 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.34 134.26 46.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.73 -40.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.41 0.684 . . . . 0.0 112.144 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.4 mm -50.52 -44.36 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 119.805 1.184 . . . . 0.0 113.908 165.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.59 -32.52 74.15 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.26 11.3 ptt180 -75.14 -32.35 61.32 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 171.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.92 -39.09 56.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -53.52 -42.35 67.3 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.14 -1.7 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 0.78 30.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.1 -39.87 2.65 Favored Glycine 0 CA--C 1.553 2.417 0 CA-C-N 120.53 1.514 . . . . 0.0 115.129 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 pt -75.38 167.77 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 C-N-CA 125.577 1.551 . . . . 0.0 111.923 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -128.08 143.52 51.07 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.282 0.633 . . . . 0.0 109.718 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -114.53 132.95 56.13 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.096 0.958 . . . . 0.0 109.318 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -142.7 130.42 21.49 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.75 146.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.933 0.893 . . . . 0.0 112.494 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.22 -67.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.333 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.87 103.26 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.48 115.88 1.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.82 -151.3 5.7 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 -146.11 -179.74 6.93 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 121.954 0.883 . . . . 0.0 110.573 -170.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.08 -19.02 48.9 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 120.183 2.833 . . . . 0.0 120.183 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.255 37.5 mt-10 77.25 136.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.76 1.624 . . . . 0.0 111.075 -173.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.88 116.15 40.9 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 117.556 -1.211 . . . . 0.0 111.143 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.61 -148.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.565 2.06 0 C-N-CA 123.081 2.521 . . . . 0.0 113.222 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.25 -65.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 53.45 65.67 1.45 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.51 1.148 . . . . 0.0 114.094 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.53 -172.2 3.57 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.505 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.95 98.4 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 112.188 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.07 41.06 1.01 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 117.359 -1.801 . . . . 0.0 115.178 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -114.81 129.77 56.75 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 120.975 2.387 . . . . 0.0 106.103 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.58 95.19 9.79 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.961 174.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.52 116.07 29.02 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.687 0.795 . . . . 0.0 111.019 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.8 m -109.27 123.6 49.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -159.5 170.3 22.01 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.863 0.839 . . . . 0.0 111.458 -169.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -96.41 162.9 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.909 0.884 . . . . 0.0 112.148 167.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -146.95 142.3 27.4 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.5 0.72 . . . . 0.0 109.784 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.51 97.78 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 p -89.86 118.64 29.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.992 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.66 153.17 51.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -65.71 138.76 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.818 . . . . 0.0 112.576 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 m -67.47 -64.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -140.19 -13.68 1.04 Allowed 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -57.8 -57.23 13.69 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.401 1.455 . . . . 0.0 114.711 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.77 -36.77 4.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.848 0.859 . . . . 0.0 111.523 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.71 10.16 79.66 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -160.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -87.87 142.31 27.9 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.919 1.36 . . . . 0.0 111.358 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.6 109.27 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.7 -33.09 53.3 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.352 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.94 142.46 25.35 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.596 0.758 . . . . 0.0 109.555 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.56 117.82 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.44 0.638 . . . . 0.0 109.313 -174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -106.35 -52.17 2.84 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.032 0.933 . . . . 0.0 112.883 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -22.27 66.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 168.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.4 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 164.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -78.18 -28.54 48.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.14 26.87 51.4 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -165.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.78 93.45 48.39 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-N 118.981 1.39 . . . . 0.0 108.767 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.61 148.06 36.65 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.159 2.573 . . . . 0.0 114.897 -169.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -84.37 175.26 9.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.443 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.77 12.72 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.384 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 tp -113.21 133.81 54.89 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -99.56 128.01 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.52 111.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.4 52.23 38.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 119.084 2.394 . . . . 0.0 119.084 165.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -161.99 -69.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -94.49 -48.46 6.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.136 0.88 . . . . 0.0 113.04 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.6 144.61 39.46 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.433 1.111 . . . . 0.0 113.626 -159.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -81.42 -35.4 30.72 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -94.75 106.13 22.76 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-N 119.641 1.109 . . . . 0.0 110.166 -170.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.96 -17.0 20.0 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.614 2.876 . . . . 0.0 118.357 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.496 HG11 HG12 ' A' ' 95' ' ' VAL 0.262 7.6 p -69.41 -36.55 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -52.75 -40.12 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 164.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.38 -40.17 85.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.5 m -72.36 -38.11 68.64 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.688 1.195 . . . . 0.0 113.582 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.4 mt -49.37 -55.82 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 124.66 1.184 . . . . 0.0 112.201 163.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -85.21 -9.12 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.4 t -59.15 -31.66 69.18 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.252 1.842 . . . . 0.0 115.824 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 p -78.77 -6.7 56.59 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 168.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.1 mtp -109.61 129.94 55.55 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.784 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.18 176.98 4.99 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.957 0.903 . . . . 0.0 112.168 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.01 105.71 0.72 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.005 0.922 . . . . 0.0 112.553 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.41 15.27 44.59 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 118.456 2.142 . . . . 0.0 118.456 -170.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.69 134.91 33.92 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.428 1.614 . . . . 0.0 110.33 177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.29 110.53 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.89 36.06 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.931 0.872 . . . . 0.0 110.899 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 149' ' ' ILE . 1.4 tm0? -123.27 123.74 41.42 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.745 -173.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -170.09 157.37 6.43 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -86.56 159.43 19.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.3 m -132.9 139.55 47.43 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.867 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.33 145.21 54.45 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.703 0.801 . . . . 0.0 112.683 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.294 0.6 OUTLIER -57.68 -25.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -28.62 21.73 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 163.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -95.04 -42.89 8.39 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.127 1.371 . . . . 0.0 111.135 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG12 HG11 ' A' ' 72' ' ' VAL . 22.7 m -89.56 22.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.25 0.9 OUTLIER -65.19 -43.16 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.761 1.224 . . . . 0.0 113.6 174.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.43 13.89 26.34 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -58.45 -49.74 91.85 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.23 160.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.57 -7.3 19.98 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 CA-C-N 125.013 2.826 . . . . 0.0 117.709 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.72 -44.5 10.52 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 119.259 0.936 . . . . 0.0 111.549 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LEU . 60.7 t -75.9 -27.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.18 -31.91 9.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 159.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -80.19 19.31 0.75 Allowed 'General case' 0 CA--C 1.58 2.133 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -143.3 -40.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.545 -1.347 . . . . 0.0 112.747 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.85 -27.92 53.98 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 164.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -76.12 -60.09 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.018 0.927 . . . . 0.0 111.237 158.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.49 -56.52 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -157.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -57.56 -31.28 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.984 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.4 -4.13 2.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.03 -44.62 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 -97.28 0.17 Allowed Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -130.86 163.78 26.66 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.527 1.155 . . . . 0.0 111.67 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.1 147.26 99.08 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.377 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -58.88 0.11 Allowed 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.128 2.552 . . . . 0.0 115.753 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.07 -69.3 0.62 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.814 1.188 . . . . 0.0 111.064 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.302 9.7 pt-20 46.13 42.55 9.96 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.23 82.52 0.22 Allowed Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.168 -0.796 . . . . 0.0 111.845 -162.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.86 94.4 5.82 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.489 0.662 . . . . 0.0 112.515 -164.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -173.37 94.29 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -127.91 91.17 3.22 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . 0.325 62.1 m 60.67 -102.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.662 1.185 . . . . 0.0 112.36 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.5 t -113.35 -67.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 160.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.0 84.66 0.17 Allowed Glycine 0 N--CA 1.479 1.559 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.3 145.81 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.495 0.718 . . . . 0.0 110.584 -174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 76.05 123.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.696 1.198 . . . . 0.0 113.349 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -77.0 133.98 38.97 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.689 0.757 . . . . 0.0 112.237 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -140.9 80.66 1.76 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -143.11 135.51 27.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -78.02 111.84 14.32 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t -75.76 138.06 40.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -77.67 107.57 10.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.432 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 79.8 mt -136.96 141.26 42.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.846 0.832 . . . . 0.0 109.977 -172.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.36 80.27 1.51 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -130.74 102.29 6.03 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -170.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.51 65.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 118.605 2.817 . . . . 0.0 118.605 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.63 -52.09 29.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.45 -35.33 58.54 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.33 12.46 1.21 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.94 -31.97 63.42 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 158.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.85 -38.84 66.93 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -49.6 -38.67 32.59 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -87.3 -37.63 17.0 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.58 94.28 3.65 Favored Pre-proline 0 CA--C 1.564 1.495 0 CA-C-N 119.861 1.21 . . . . 0.0 108.877 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.99 131.52 13.26 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.939 2.426 . . . . 0.0 114.02 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 153.9 29.02 Favored Pre-proline 0 CA--C 1.574 1.893 0 C-N-CA 123.897 0.879 . . . . 0.0 109.248 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.49 132.89 32.6 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.804 2.336 . . . . 0.0 113.304 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.27 158.33 15.77 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.292 0.637 . . . . 0.0 110.576 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 87' ' ' GLN . 20.9 mm -91.64 115.18 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 95' ' ' VAL . 50.4 m-85 -105.14 101.9 11.43 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -89.51 98.51 11.81 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.95 148.14 23.29 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.73 0.776 . . . . 0.0 112.014 171.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.98 103.5 6.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.6 tpp -71.26 134.95 47.2 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.62 0.724 . . . . 0.0 112.085 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -55.62 2.25 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.313 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -143.39 156.57 44.71 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.015 0.912 . . . . 0.0 110.333 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -158.02 131.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -121.28 130.85 53.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.257 1.023 . . . . 0.0 108.382 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.2 m -89.33 165.57 25.41 Favored Pre-proline 0 CA--C 1.571 1.771 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.78 106.36 1.09 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.479 2.786 . . . . 0.0 112.99 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 141.47 -57.5 0.58 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.19 -162.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 t -93.14 -29.62 15.65 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -73.26 147.17 44.85 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 120.222 1.374 . . . . 0.0 113.035 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -142.96 153.12 42.72 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.755 0.788 . . . . 0.0 110.972 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -95.08 133.85 38.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 N--CA 1.488 1.469 0 C-N-CA 123.146 0.578 . . . . 0.0 109.57 -179.445 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -98.67 99.23 10.33 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.024 1.284 . . . . 0.0 108.456 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 78' ' ' CYS . 16.9 mm -114.56 -38.26 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.001 -169.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.7 -43.94 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 124.702 1.201 . . . . 0.0 114.004 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.13 -41.05 99.25 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -72.29 -28.59 63.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 173.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.84 -42.24 81.73 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.514 1.506 . . . . 0.0 115.053 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -57.16 -44.16 83.21 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.36 -3.58 31.21 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.17 2.656 . . . . 0.0 118.17 166.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.37 -8.59 58.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.59 -40.5 2.46 Favored Glycine 0 CA--C 1.553 2.41 0 CA-C-N 120.192 1.36 . . . . 0.0 115.053 -164.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' CYS . 3.8 pt -77.19 166.62 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 125.655 1.582 . . . . 0.0 112.168 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -135.98 122.32 20.54 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 149.7 25.48 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -171.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -153.41 123.28 6.86 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.03 135.84 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.519 0.728 . . . . 0.0 110.643 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.42 -66.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.42 113.65 20.64 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.66 123.85 19.92 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.328 0.651 . . . . 0.0 111.157 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.06 -130.8 0.2 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 -162.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -122.57 -80.12 0.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.777 0.431 . . . . 0.0 111.087 -163.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 -128.37 3.2 Favored Glycine 0 CA--C 1.541 1.715 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -161.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.94 148.72 23.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.611 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.46 103.56 11.41 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 165.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.78 -173.39 1.19 Allowed 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.72 2.28 . . . . 0.0 114.451 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.81 -45.55 82.18 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 57.42 54.76 6.29 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -124.04 -166.91 1.56 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.41 1.084 . . . . 0.0 109.384 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.31 99.64 0.11 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.13 35.01 3.52 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-O 118.011 -1.438 . . . . 0.0 116.008 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -97.21 123.72 41.08 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.65 95.09 9.71 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.993 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.33 112.04 23.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.67 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -100.38 124.05 45.39 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -157.96 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.979 0.895 . . . . 0.0 111.347 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -98.54 160.86 14.0 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 0.0 111.436 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -143.14 143.93 32.01 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.284 0.633 . . . . 0.0 109.801 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -145.46 99.14 3.25 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -90.12 121.03 31.8 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.643 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.79 153.37 49.67 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.012 0.911 . . . . 0.0 109.85 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -70.45 133.84 47.22 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.539 0.736 . . . . 0.0 111.394 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.9 p -69.43 -61.91 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.28 -9.33 1.49 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.9 -57.66 9.12 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 120.733 1.606 . . . . 0.0 113.715 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -112.53 -36.94 5.08 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.819 0.848 . . . . 0.0 111.811 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.55 86.33 Favored Glycine 0 CA--C 1.556 2.62 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -161.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -91.31 146.1 24.1 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.924 1.362 . . . . 0.0 111.682 -172.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.24 115.73 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.57 -34.41 31.07 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.177 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.44 146.95 26.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.693 0.797 . . . . 0.0 109.973 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.17 120.46 4.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.514 0.726 . . . . 0.0 109.489 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -104.97 -52.65 2.81 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 123.847 0.859 . . . . 0.0 113.147 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.74 63.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.118 2.636 . . . . 0.0 118.118 170.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.7 82.93 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.6 -25.42 23.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 164.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.54 26.97 12.28 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -116.88 104.19 51.31 Favored Pre-proline 0 CA--C 1.567 1.632 0 CA-C-N 118.852 1.326 . . . . 0.0 109.151 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -79.16 149.6 22.31 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.152 2.568 . . . . 0.0 114.588 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -84.35 175.78 9.14 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.499 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.91 119.52 12.4 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.637 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.57 131.78 56.83 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.68 133.02 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.2 mm -77.4 97.6 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.657 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.63 18.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 117.752 1.861 . . . . 0.0 117.752 167.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 -68.15 0.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -91.21 -40.08 11.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.56 148.65 27.07 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.491 1.138 . . . . 0.0 113.026 -167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.22 -34.28 15.85 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -94.49 106.49 24.07 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-N 119.757 1.162 . . . . 0.0 110.039 -169.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.52 -15.95 17.22 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 123.608 2.872 . . . . 0.0 118.435 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 HG12 ' A' ' 95' ' ' VAL 0.269 10.9 p -67.28 -36.14 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -54.99 -37.01 66.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 164.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.08 -39.51 72.13 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 78' ' ' CYS . 26.0 m -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.236 1.414 . . . . 0.0 113.955 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -70.24 -31.43 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.35 -11.91 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 75' ' ' THR . 28.1 p -57.41 -24.79 57.63 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 168.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.4 p -80.92 -4.33 54.56 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 170.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mtp -117.34 131.56 56.77 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.648 1.113 . . . . 0.0 110.798 -162.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -104.8 174.5 5.85 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.319 1.048 . . . . 0.0 111.725 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.38 109.17 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.768 0.827 . . . . 0.0 111.92 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.56 9.83 59.74 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 118.868 2.307 . . . . 0.0 118.868 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.56 137.2 33.07 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.409 2.105 . . . . 0.0 110.049 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.24 116.12 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.97 128.9 31.28 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.411 0.684 . . . . 0.0 110.684 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.75 131.67 55.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.371 0.668 . . . . 0.0 110.371 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -171.47 150.69 2.87 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.16 155.31 28.73 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.41 ' HA ' HG22 ' A' ' 13' ' ' ILE . 63.5 m -125.11 138.58 54.17 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.344 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.24 143.96 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.076 0.55 . . . . 0.0 111.784 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.326 0.4 OUTLIER -59.67 -22.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -49.03 -31.43 7.62 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 160.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.66 -44.8 8.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.133 1.373 . . . . 0.0 111.302 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 150' ' ' PHE . 31.8 m -89.43 26.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.83 -40.88 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 125.061 1.345 . . . . 0.0 113.527 171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.79 12.76 28.89 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.58 -45.42 97.17 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 114.576 -2.631 . . . . 0.0 115.431 159.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.81 -10.7 26.03 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 CA-C-N 126.594 3.391 . . . . 0.0 117.686 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.209 1.004 . . . . 0.0 111.646 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 70' ' ' LEU . 47.3 t -84.66 -33.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 124.423 1.089 . . . . 0.0 113.763 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.25 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 160.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.72 26.31 0.24 Allowed 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 161.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -145.0 -46.47 0.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pp -55.83 -26.68 47.83 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 165.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -77.72 -50.9 11.47 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.988 0.915 . . . . 0.0 113.206 159.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.2 -59.39 2.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.07 0.948 . . . . 0.0 112.85 -161.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -52.56 -27.96 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.961 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.06 -1.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 168.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -41.1 -52.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 151.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.17 -120.89 2.12 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -145.85 98.36 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.323 7.7 m-20 55.52 152.0 0.06 OUTLIER Pre-proline 0 CA--C 1.576 1.943 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -63.34 -48.56 5.86 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.039 2.493 . . . . 0.0 115.693 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.68 -76.16 0.32 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.397 0.999 . . . . 0.0 110.196 168.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.263 0.9 OUTLIER 51.47 49.08 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.81 68.31 1.75 Allowed Glycine 0 CA--C 1.545 1.961 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . 0.251 9.2 pt20 -90.15 67.48 6.92 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 tmp_? -156.39 108.44 2.53 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -140.67 140.93 35.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.8 m -59.39 -51.4 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.98 -72.18 0.4 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.807 0.73 . . . . 0.0 111.212 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.01 77.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.563 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.49 95.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.64 -64.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.627 1.171 . . . . 0.0 109.303 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 3.4 mp0 74.1 103.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.265 1.426 . . . . 0.0 112.405 169.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.3 ttp -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.09 113.29 7.23 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.89 106.65 5.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.83 80.48 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 m -157.61 128.83 6.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.3 t -142.07 106.83 4.87 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.1 150.96 33.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.906 0.86 . . . . 0.0 110.584 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.39 -62.68 0.46 Allowed Glycine 0 N--CA 1.485 1.913 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.907 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.388 87.0 m-70 91.19 -58.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.291 . . 77.28 -29.57 0.17 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -84.08 -51.45 7.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.7 1.136 . . . . 0.0 112.592 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.05 -26.48 60.42 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 163.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.11 -9.7 58.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.66 64.48 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 162.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.24 -38.6 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -52.55 -38.14 59.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -87.86 -32.31 19.06 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.99 94.34 3.1 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 120.395 1.452 . . . . 0.0 109.28 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.98 142.03 41.62 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.34 2.693 . . . . 0.0 114.37 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -156.06 143.08 13.61 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.872 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.75 126.21 7.19 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 C-N-CA 122.958 2.438 . . . . 0.0 112.596 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -105.07 156.34 18.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.908 -168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.7 mm -90.05 115.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 124.465 1.106 . . . . 0.0 108.229 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 95' ' ' VAL . 41.9 m-85 -104.59 101.85 11.49 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.28 94.69 9.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.4 mmt -86.43 140.29 30.12 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.654 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.36 102.25 6.1 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.5 tpp -72.62 134.39 45.11 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.646 0.736 . . . . 0.0 111.813 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -55.72 2.35 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.993 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -144.28 152.46 40.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.549 1.139 . . . . 0.0 108.725 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.262 2.2 p -157.17 133.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 121.916 0.865 . . . . 0.0 109.323 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -119.19 154.3 33.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.981 1.313 . . . . 0.0 109.359 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.0 m -101.72 164.49 15.78 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.36 107.29 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.624 2.883 . . . . 0.0 112.985 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -59.12 0.55 Allowed Glycine 0 CA--C 1.539 1.534 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.896 -162.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.7 t -91.78 -24.71 19.32 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -72.52 135.68 45.7 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.215 1.371 . . . . 0.0 112.713 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -130.98 111.13 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -120.7 131.01 54.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 122.245 1.021 . . . . 0.0 112.689 -176.373 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.725 0.298 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.78 130.76 35.6 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.512 0.672 . . . . 0.0 111.021 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.15 -43.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.937 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.4 mm -47.34 -44.57 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.69 79.81 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.27 3.7 ppt_? -66.27 -28.57 68.81 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 174.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.49 -44.6 95.99 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.524 1.511 . . . . 0.0 114.375 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -56.9 -52.89 63.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.83 -2.12 13.87 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.75 -0.7 48.88 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.27 -40.9 2.29 Favored Glycine 0 CA--C 1.551 2.299 0 CA-C-N 120.519 1.509 . . . . 0.0 115.198 -165.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 pt -77.65 173.67 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 C-N-CA 125.899 1.68 . . . . 0.0 111.957 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -147.41 131.25 17.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.31 158.4 19.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -155.97 128.41 7.72 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 152.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.86 136.3 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.575 0.75 . . . . 0.0 110.46 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.68 -65.38 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.19 110.4 15.69 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.37 123.33 18.89 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.122 0.569 . . . . 0.0 111.647 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.22 -135.15 0.7 Allowed Glycine 0 CA--C 1.54 1.646 0 N-CA-C 117.445 1.738 . . . . 0.0 117.445 -163.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -97.67 -95.61 0.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.732 -161.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.06 -110.89 1.8 Allowed Glycine 0 N--CA 1.478 1.497 0 CA-C-N 118.232 0.469 . . . . 0.0 113.831 -165.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 149.65 24.29 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.949 0.881 . . . . 0.0 111.427 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.02 114.88 57.1 Favored Pre-proline 0 CA--C 1.569 1.684 0 CA-C-O 117.34 -1.314 . . . . 0.0 108.579 167.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.75 -168.56 0.41 Allowed 'Trans proline' 0 CA--C 1.567 2.172 0 C-N-CA 122.834 2.356 . . . . 0.0 114.439 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.96 -52.48 62.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.259 85.4 m-85 57.62 51.53 9.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -170.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.04 -164.86 1.42 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.478 1.111 . . . . 0.0 109.824 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.27 96.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 38.92 2.94 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.872 -176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 m -95.07 122.03 37.31 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.167 -2.161 . . . . 0.0 105.167 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.93 96.76 10.36 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.011 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.01 111.95 24.07 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.61 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.0 m -101.87 124.48 47.57 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 77' ' ' VAL . 42.8 p90 -160.2 167.76 26.91 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.687 -171.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -92.64 164.1 13.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -0.978 . . . . 0.0 112.61 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.28 143.85 30.44 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.127 0.971 . . . . 0.0 109.684 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -144.28 101.78 3.75 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 122.59 36.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.102 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.1 154.33 46.99 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -71.93 134.75 46.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.461 0.704 . . . . 0.0 111.084 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.1 m -66.54 -65.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -169.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.36 -2.2 1.64 Allowed 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.98 -57.53 5.35 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.004 1.729 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.2 -33.48 6.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.98 8.8 87.64 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.829 1.891 . . . . 0.0 117.829 -164.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -86.31 143.56 27.83 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.03 1.415 . . . . 0.0 112.162 -173.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.31 113.05 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.31 -33.67 32.42 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.021 -1.445 . . . . 0.0 114.4 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.51 145.4 27.89 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.781 0.832 . . . . 0.0 109.64 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -155.38 120.72 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -172.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 p -111.25 -48.39 3.1 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.61 64.98 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 165.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.37 94.35 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 165.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -73.73 -34.11 64.64 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.2 38.19 8.61 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 -166.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 118.49 5.78 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 118.72 1.26 . . . . 0.0 110.067 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.81 151.49 9.94 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.136 2.557 . . . . 0.0 113.956 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -83.82 176.51 8.87 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.7 173.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.03 120.51 13.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.463 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -115.26 135.16 54.45 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.32 133.19 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.9 mm -78.57 98.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.25 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.28 56.32 25.86 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 164.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -158.91 -65.15 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -90.75 -42.0 10.94 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.792 0.837 . . . . 0.0 113.185 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.72 149.87 32.63 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.761 1.164 . . . . 0.0 113.432 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -89.39 -37.54 14.77 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 107.44 27.21 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 124.514 1.126 . . . . 0.0 110.008 -169.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.86 -17.02 23.01 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 C-N-CA 123.709 2.939 . . . . 0.0 118.475 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.294 11.2 p -71.47 -36.99 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 117.607 -1.187 . . . . 0.0 114.198 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.91 -40.13 60.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 163.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.57 -42.11 83.11 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.2 m -71.51 -32.74 68.54 Favored 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 124.983 1.313 . . . . 0.0 114.372 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.0 mt -58.85 -55.02 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.855 1.207 . . . . 0.0 111.309 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 36' ' ' PHE . 28.0 m -77.56 -10.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 33.9 t -59.34 -23.02 62.16 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.7 p -103.36 44.49 1.01 Allowed 'General case' 0 CA--C 1.571 1.762 0 C-N-CA 124.025 0.93 . . . . 0.0 112.768 169.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.4 mtp -147.56 130.74 16.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.261 -0.9 . . . . 0.0 108.81 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -106.45 -180.0 4.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.102 0.961 . . . . 0.0 111.73 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.04 108.89 1.64 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.1 59.11 Favored Glycine 0 CA--C 1.553 2.468 0 N-CA-C 118.712 2.245 . . . . 0.0 118.712 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -96.49 140.06 31.67 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.914 1.857 . . . . 0.0 109.907 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.91 116.56 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.8 128.51 28.9 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 0.0 110.793 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.47 132.39 56.23 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.543 0.737 . . . . 0.0 110.518 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -169.97 154.13 5.04 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.9 157.24 25.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.93 139.54 47.39 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.385 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.98 149.62 49.51 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.193 0.597 . . . . 0.0 112.006 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -54.67 -29.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 118.0 2.592 . . . . 0.0 118.0 178.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -50.17 -29.87 10.15 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 163.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.9 -43.53 8.14 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 111.482 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -87.86 23.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.26 0.8 OUTLIER -65.21 -43.41 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.573 1.149 . . . . 0.0 113.296 174.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.1 15.77 19.87 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.27 -45.94 85.16 Favored Pre-proline 0 CA--C 1.57 1.712 0 CA-C-O 114.443 -2.694 . . . . 0.0 114.89 162.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -68.03 -6.53 17.35 Favored 'Trans proline' 0 CA--C 1.567 2.167 0 CA-C-N 126.557 3.377 . . . . 0.0 117.728 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.69 -42.12 12.87 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 119.253 0.933 . . . . 0.0 111.522 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.28 -34.76 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 124.562 1.145 . . . . 0.0 113.58 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.37 43.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 159.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 22.21 0.37 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -141.37 -43.27 0.37 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.097 1.359 . . . . 0.0 111.759 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -58.38 -24.1 58.93 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 168.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -78.37 -57.34 3.83 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.803 0.841 . . . . 0.0 111.978 160.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -87.1 -59.27 2.3 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.342 0.657 . . . . 0.0 112.754 -160.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -56.16 -32.5 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.78 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -13.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 171.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.08 -44.92 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.12 -83.44 0.06 OUTLIER Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -80.09 135.61 36.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -85.14 150.95 56.2 Favored Pre-proline 0 CA--C 1.571 1.788 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.536 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.11 -46.61 9.86 Favored 'Trans proline' 0 CA--C 1.56 1.783 0 C-N-CA 123.4 2.733 . . . . 0.0 117.381 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.43 -76.75 0.25 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.029 0.831 . . . . 0.0 109.16 173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 54.71 71.21 0.55 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 -79.36 1.92 Allowed Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.043 0.777 . . . . 0.0 115.043 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 65.24 74.1 0.39 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.907 1.283 . . . . 0.0 112.767 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . 0.294 11.5 ptt-85 -163.23 -79.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.588 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.38 17.7 p80 63.02 137.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.2 m -79.07 -75.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.475 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 71.9 m -101.12 -70.05 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.726 0.694 . . . . 0.0 110.054 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.67 84.16 0.17 Allowed Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.98 115.95 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.92 103.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.652 1.181 . . . . 0.0 113.139 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -149.32 113.46 5.19 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.8 tpt -138.21 103.38 4.91 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -89.2 106.29 18.34 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.815 0.446 . . . . 0.0 110.395 -170.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 67.63 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.967 1.307 . . . . 0.0 113.84 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -141.65 114.64 8.62 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m -134.78 98.38 4.02 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -111.71 74.99 0.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.339 0.59 . . . . 0.0 110.029 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.06 143.94 31.26 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.91 0.862 . . . . 0.0 109.451 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -172.05 95.95 0.11 Allowed Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.52 138.38 8.5 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.943 0.878 . . . . 0.0 111.331 -166.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.63 -16.78 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 165.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.47 -46.7 8.91 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.955 1.252 . . . . 0.0 113.337 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -70.46 -24.42 62.87 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.89 -12.77 59.35 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 164.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.88 -26.22 68.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 164.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.11 -35.82 80.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -55.12 -38.28 67.98 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -84.6 -33.64 23.31 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.99 93.52 2.96 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 120.265 1.393 . . . . 0.0 108.661 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.58 143.05 30.07 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 123.0 2.467 . . . . 0.0 113.572 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.1 142.47 30.38 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.167 -0.92 . . . . 0.0 109.787 -165.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.44 124.73 9.11 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 123.018 2.479 . . . . 0.0 112.029 176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.29 155.06 22.59 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -164.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -90.97 123.29 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 124.915 1.286 . . . . 0.0 107.755 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -113.34 101.66 9.61 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -89.25 97.98 11.51 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.18 148.36 23.68 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.046 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.42 103.23 5.85 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 22.7 ttm -76.92 141.84 40.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.098 0.952 . . . . 0.0 113.323 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -55.93 1.79 Allowed 'General case' 0 CA--C 1.56 1.329 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.907 178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 142.32 29.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.247 1.022 . . . . 0.0 108.373 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.7 133.75 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.992 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.89 147.18 51.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.962 0.905 . . . . 0.0 110.508 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.0 m -91.51 165.54 20.7 Favored Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.97 107.87 1.6 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.578 2.852 . . . . 0.0 113.237 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.44 -56.81 0.63 Allowed Glycine 0 N--CA 1.48 1.632 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.086 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.4 t -91.01 -27.24 18.77 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -73.38 141.52 47.0 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.183 1.356 . . . . 0.0 112.874 -176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? 67.42 101.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.26 1.024 . . . . 0.0 112.691 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -81.23 125.15 29.96 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.282 0.563 . . . . 0.0 110.788 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -173.724 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -106.14 111.6 24.29 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.939 0.79 . . . . 0.0 109.195 -174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.16 -45.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.134 0.973 . . . . 0.0 109.983 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 mm -47.41 -44.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 169.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.49 -39.97 81.11 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -69.02 -28.85 66.94 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.84 -41.75 59.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -56.72 -42.99 80.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.28 -8.14 53.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 118.33 2.715 . . . . 0.0 118.33 166.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.15 3.55 26.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 171.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.95 -38.02 3.24 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.6 1.545 . . . . 0.0 115.805 -168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 pt -81.57 160.35 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 125.988 1.715 . . . . 0.0 111.902 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -112.63 157.18 21.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.63 1.172 . . . . 0.0 109.944 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 132.86 26.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.728 0.811 . . . . 0.0 110.76 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -152.53 119.22 5.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.55 136.33 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 123.505 0.722 . . . . 0.0 111.014 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.03 -63.63 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.5 112.28 17.3 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.84 123.92 20.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.281 0.632 . . . . 0.0 111.493 169.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.17 -129.57 0.32 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 -165.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.252 69.0 ttt180 -96.04 -111.79 0.14 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.026 -164.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.59 173.34 47.52 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 118.987 0.812 . . . . 0.0 114.503 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -58.6 154.5 14.18 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.92 127.19 90.32 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.771 -166.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.38 -155.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.234 2.623 . . . . 0.0 113.703 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.78 -66.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 55.76 69.24 0.76 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.381 1.072 . . . . 0.0 113.768 -171.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -146.48 -166.66 2.54 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.175 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.48 95.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -173.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.09 35.19 3.49 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 117.803 -1.554 . . . . 0.0 115.78 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 m -96.26 127.02 41.88 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.43 93.91 8.41 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.49 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.67 113.84 26.02 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.422 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.1 m -108.28 121.96 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 77' ' ' VAL . 45.9 p90 -160.42 169.75 22.43 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.547 0.689 . . . . 0.0 110.766 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.69 161.86 13.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 112.353 168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.69 142.57 31.04 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.794 0.838 . . . . 0.0 109.796 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -144.21 97.62 3.08 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.4 p -88.83 120.92 30.67 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.34 151.24 47.36 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 121.597 0.713 . . . . 0.0 109.889 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -67.16 133.9 50.69 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.518 0.727 . . . . 0.0 111.582 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.6 p -69.44 -66.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -130.84 -15.53 3.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -52.83 -50.6 63.4 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.39 -34.27 2.5 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.717 0.807 . . . . 0.0 112.505 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.71 2.2 90.62 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -163.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -85.03 143.15 29.09 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.359 1.579 . . . . 0.0 112.084 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.23 115.09 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.36 -35.56 25.05 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.152 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.31 146.22 30.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.896 0.855 . . . . 0.0 109.551 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.94 121.3 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.561 0.745 . . . . 0.0 109.168 -170.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -109.96 -51.68 2.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.79 56.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 166.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.37 79.76 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -78.41 -32.44 48.71 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 169.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.98 55.35 Favored Glycine 0 CA--C 1.553 2.421 0 N-CA-C 117.174 1.629 . . . . 0.0 117.174 -158.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.14 105.04 55.78 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-N 119.654 1.727 . . . . 0.0 109.611 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.51 147.59 17.82 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 123.017 2.478 . . . . 0.0 113.936 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -84.51 174.81 9.73 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.262 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -140.48 122.67 15.8 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 136.15 53.3 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.95 130.87 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.0 mm -79.53 95.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.512 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.21 61.65 6.89 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 117.416 1.727 . . . . 0.0 117.416 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -158.92 -60.25 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.441 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 62.72 1.57 Allowed 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 119.13 0.877 . . . . 0.0 111.008 170.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.85 137.57 14.27 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.41 -0.806 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.02 -30.58 22.56 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -95.27 104.5 15.58 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 119.61 1.096 . . . . 0.0 110.317 -169.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.58 -17.62 20.53 Favored 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.631 2.887 . . . . 0.0 118.269 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG11 HG12 ' A' ' 95' ' ' VAL 0.276 8.4 p -66.84 -38.01 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -54.76 -37.08 65.53 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 163.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -73.37 -27.36 61.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.0 m -82.76 -48.12 11.18 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.539 1.536 . . . . 0.0 112.793 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -60.23 -39.17 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 26.0 m -71.35 -26.71 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -52.64 -30.76 33.35 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.2 p -78.95 -13.71 59.64 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 16.8 mtm -107.06 142.31 36.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.095 0.958 . . . . 0.0 111.856 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -108.1 -178.13 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.995 0.918 . . . . 0.0 111.255 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.71 112.11 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.099 0.96 . . . . 0.0 111.01 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 10.86 61.78 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 118.541 2.176 . . . . 0.0 118.541 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -97.19 131.91 43.46 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 120.6 2.2 . . . . 0.0 109.806 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.75 116.6 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.84 130.81 27.96 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.056 0.542 . . . . 0.0 110.76 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.46 131.54 55.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.372 0.669 . . . . 0.0 110.486 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -171.48 148.56 2.55 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -167.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.51 157.6 21.25 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.42 141.75 50.96 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.622 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.3 144.74 56.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.044 0.538 . . . . 0.0 111.667 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.337 0.2 OUTLIER -59.7 -24.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 117.514 2.412 . . . . 0.0 117.514 -175.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -28.64 9.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 163.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -92.97 -44.34 8.48 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 125.154 1.382 . . . . 0.0 110.94 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 HG11 ' A' ' 72' ' ' VAL . 24.9 m -90.65 24.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -67.9 -42.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.606 1.163 . . . . 0.0 113.825 175.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 14.43 22.85 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -56.46 -50.09 89.72 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 114.887 -2.482 . . . . 0.0 115.252 159.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.36 -18.7 65.9 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 CA-C-N 125.626 3.045 . . . . 0.0 117.388 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.46 -44.12 19.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.694 0.679 . . . . 0.0 112.107 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 70' ' ' LEU . 48.7 t -78.82 -29.41 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.48 -32.22 38.88 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 160.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.18 22.08 0.55 Allowed 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 165.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.1 m -140.0 -44.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.799 1.239 . . . . 0.0 111.825 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.77 -24.98 38.75 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.52 -54.81 5.54 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.737 0.815 . . . . 0.0 112.327 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -91.79 -62.27 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.307 0.643 . . . . 0.0 112.255 -159.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.6 mm -54.83 -28.66 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 169.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.26 -12.0 2.1 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.8 p -45.66 -43.82 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 161.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.55 -94.42 0.11 Allowed Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -120.14 169.37 10.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.053 0.93 . . . . 0.0 111.846 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.69 152.17 59.52 Favored Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 123.718 0.807 . . . . 0.0 111.736 168.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.53 -58.6 0.22 Allowed 'Trans proline' 0 CA--C 1.559 1.725 0 C-N-CA 123.385 2.723 . . . . 0.0 116.321 -172.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -80.93 -69.15 0.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.411 0.685 . . . . 0.0 110.716 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 49.34 53.81 12.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.94 78.47 0.25 Allowed Glycine 0 CA--C 1.546 2.019 0 CA-C-O 119.084 -0.842 . . . . 0.0 113.47 -165.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.8 92.2 8.18 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 117.683 0.741 . . . . 0.0 110.834 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -164.1 92.55 0.67 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -95.54 -63.61 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.992 -156.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 t 71.57 114.03 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.823 1.249 . . . . 0.0 112.694 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.346 21.8 t 76.02 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.762 1.225 . . . . 0.0 112.414 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.36 -179.08 51.8 Favored Glycine 0 CA--C 1.547 2.071 0 CA-C-O 121.704 0.613 . . . . 0.0 114.321 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.53 121.2 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.39 143.75 27.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.848 0.832 . . . . 0.0 111.626 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -71.29 145.09 49.74 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -167.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 45.0 ttp -81.66 124.61 29.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 166.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -100.97 126.86 47.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.915 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.79 144.31 27.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.956 0.884 . . . . 0.0 111.676 -170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -95.52 108.2 20.43 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -100.06 73.33 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.231 0.539 . . . . 0.0 110.662 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 137.54 43.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.79 -66.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.643 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.06 83.11 0.44 Allowed Glycine 0 N--CA 1.478 1.486 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -107.32 113.5 26.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.76 -17.16 63.41 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.03 -45.39 13.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -24.25 60.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 162.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.67 -19.67 61.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -53.85 -28.82 38.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 160.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.23 -39.59 78.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -54.82 -38.26 67.15 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -85.19 -34.27 22.09 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 169.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.79 95.43 3.45 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 120.292 1.405 . . . . 0.0 108.101 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -66.9 138.53 48.63 Favored 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.311 2.674 . . . . 0.0 114.709 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -140.72 135.95 16.03 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.604 -167.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 120.82 4.06 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.064 2.509 . . . . 0.0 111.969 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.83 153.94 20.16 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.023 -165.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.78 116.7 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 95' ' ' VAL . 47.9 m-85 -103.59 100.37 10.21 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.62 95.97 9.52 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -92.08 136.37 33.23 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.449 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.77 102.46 7.59 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.3 ttm -74.77 141.12 44.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -53.46 1.72 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.041 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -143.76 152.72 41.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.825 0.85 . . . . 0.0 110.252 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.271 1.7 p -155.45 129.41 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -120.1 146.88 45.52 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.587 1.155 . . . . 0.0 109.091 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.8 p -93.73 162.94 25.82 Favored Pre-proline 0 CA--C 1.571 1.762 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.57 108.15 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.498 2.799 . . . . 0.0 113.268 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.93 -59.22 0.57 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.832 -163.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 t -92.51 -22.75 19.38 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -71.88 158.31 36.29 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -169.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -90.93 126.94 36.21 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.389 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 143.18 27.01 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.285 0.634 . . . . 0.0 111.55 176.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 122.131 0.967 . . . . 0.0 109.791 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.952 0.406 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -77.16 134.96 38.52 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.244 0.618 . . . . 0.0 111.976 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.78 -47.19 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.708 0.803 . . . . 0.0 111.63 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -47.69 -43.01 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 168.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.48 74.88 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -76.89 -28.07 55.21 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 mt -74.76 -40.6 61.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.491 1.496 . . . . 0.0 114.651 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -55.19 -41.05 71.45 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.47 -1.26 36.64 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.04 -1.8 37.35 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.43 -44.95 1.52 Allowed Glycine 0 CA--C 1.548 2.121 0 CA-C-N 120.252 1.387 . . . . 0.0 114.024 -166.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 pt -68.63 166.69 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 C-N-CA 124.881 1.273 . . . . 0.0 111.664 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -112.85 179.03 4.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.633 0.73 . . . . 0.0 110.029 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -148.62 122.01 9.06 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -138.87 121.78 16.62 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.37 137.76 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.572 0.749 . . . . 0.0 111.57 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.34 -67.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.8 108.72 15.71 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.95 118.83 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.513 0.725 . . . . 0.0 111.317 170.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 -146.06 3.89 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -163.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -115.48 131.73 56.84 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.832 0.825 . . . . 0.0 109.82 -163.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.62 -135.89 18.03 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 114.736 -1.12 . . . . 0.0 115.356 168.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.62 146.6 26.95 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.745 0.818 . . . . 0.0 110.758 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -81.87 114.5 50.89 Favored Pre-proline 0 CA--C 1.57 1.741 0 CA-C-O 117.409 -1.282 . . . . 0.0 109.022 168.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.17 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 123.056 2.504 . . . . 0.0 114.136 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.83 -60.22 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.253 91.7 m-85 55.91 53.58 9.1 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -167.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.89 -177.66 4.01 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.641 1.176 . . . . 0.0 109.831 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.25 103.35 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 112.747 -169.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.8 34.98 2.68 Favored Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.581 -1.677 . . . . 0.0 115.505 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.1 m -107.09 124.67 50.01 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 120.513 2.156 . . . . 0.0 105.693 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.91 94.62 10.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.69 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.77 111.46 23.07 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.911 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 m -99.31 125.28 44.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' O ' ' SD ' ' A' ' 60' ' ' MET . 39.5 p90 -159.55 168.55 25.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.027 0.917 . . . . 0.0 110.818 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -93.69 161.42 14.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.678 0.791 . . . . 0.0 112.018 165.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -145.15 149.06 34.32 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.79 0.836 . . . . 0.0 109.466 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.89 96.31 2.2 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' CD1' ' A' ' 150' ' ' PHE . 64.4 p -85.79 119.14 25.79 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -135.37 155.21 50.96 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.985 0.898 . . . . 0.0 110.101 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -69.2 134.15 48.88 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.551 0.74 . . . . 0.0 111.53 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -57.35 4.22 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -139.77 -6.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.83 -51.65 68.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.707 1.594 . . . . 0.0 114.485 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -131.55 -38.83 1.15 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.572 0.749 . . . . 0.0 111.934 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.46 9.76 75.05 Favored Glycine 0 CA--C 1.557 2.711 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -153.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -81.98 139.46 34.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.433 1.617 . . . . 0.0 111.726 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.23 113.37 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -31.53 30.12 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-N 114.189 -1.368 . . . . 0.0 114.619 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.93 143.48 26.22 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 123.612 0.765 . . . . 0.0 109.431 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.64 123.7 5.77 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.467 0.707 . . . . 0.0 110.089 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -109.81 -51.97 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.847 0.859 . . . . 0.0 113.315 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -21.75 66.57 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.96 81.04 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 164.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -80.57 -25.59 38.46 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.78 25.4 53.25 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 117.54 1.776 . . . . 0.0 117.54 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -119.54 102.1 48.04 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 118.762 1.281 . . . . 0.0 108.612 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.82 147.73 21.86 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.052 2.501 . . . . 0.0 114.309 -174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.49 178.22 7.49 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.805 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -143.85 116.6 8.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.743 0.817 . . . . 0.0 108.822 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp -105.8 138.98 41.07 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.93 128.41 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.5 mm -76.71 114.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.11 57.18 10.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.487 2.555 . . . . 0.0 119.487 164.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -163.51 -67.23 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -170.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -103.39 -46.13 4.67 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.611 1.164 . . . . 0.0 112.781 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -76.38 143.56 40.61 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.268 1.033 . . . . 0.0 113.483 -163.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -89.15 -25.7 21.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.84 102.67 20.53 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 120.282 1.401 . . . . 0.0 109.505 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.54 -12.19 16.93 Favored 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.705 2.937 . . . . 0.0 118.576 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.257 7.8 p -67.5 -38.12 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 117.738 -1.125 . . . . 0.0 113.986 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -50.68 -40.26 53.25 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.25 -42.89 83.17 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -70.96 -40.09 72.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.905 1.282 . . . . 0.0 113.723 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.477 HD11 ' SG ' ' A' ' 90' ' ' CYS . 69.9 mt -48.57 -54.24 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.447 1.099 . . . . 0.0 112.483 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE1' ' A' ' 36' ' ' PHE . 34.3 m -82.7 -7.96 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.71 -35.22 74.07 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.252 1.1 t -103.77 61.8 0.75 Allowed 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 123.981 0.912 . . . . 0.0 109.484 164.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 27.0 mmm -147.17 118.59 7.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -101.56 169.78 8.62 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.597 0.759 . . . . 0.0 111.61 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.4 108.44 0.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.979 0.912 . . . . 0.0 112.432 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.43 10.54 56.86 Favored Glycine 0 CA--C 1.557 2.657 0 N-CA-C 118.668 2.227 . . . . 0.0 118.668 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.15 141.99 30.39 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.996 1.898 . . . . 0.0 109.89 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.68 119.43 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.02 131.93 31.43 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.194 0.598 . . . . 0.0 111.2 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.69 135.24 54.58 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.422 0.689 . . . . 0.0 110.881 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -172.64 156.89 3.69 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.528 1.156 . . . . 0.0 113.07 -169.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.17 155.41 21.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.397 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 76' ' ' ILE . 40.0 m -130.53 137.76 49.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.826 170.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.09 144.55 57.02 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.223 0.609 . . . . 0.0 111.703 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.47 -26.42 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.24 -27.47 6.05 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 161.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.33 -45.7 5.77 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.153 1.381 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.0 m -84.7 22.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -44.45 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.922 -1.111 . . . . 0.0 113.302 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.56 16.13 17.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.66 -48.89 94.33 Favored Pre-proline 0 CA--C 1.574 1.872 0 CA-C-O 114.836 -2.507 . . . . 0.0 115.002 161.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.78 -13.27 35.96 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.975 3.17 . . . . 0.0 117.44 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.28 -43.28 14.98 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.727 0.811 . . . . 0.0 112.077 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.1 -31.74 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.37 57.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -79.35 25.45 0.31 Allowed 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 162.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.6 m -144.91 -45.03 0.23 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.925 1.29 . . . . 0.0 111.72 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pp -55.05 -26.53 38.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 167.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.23 -53.86 6.27 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 123.951 0.9 . . . . 0.0 113.006 159.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -80.46 -54.56 5.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -162.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 mm -52.73 -38.15 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.0 2.79 0.67 Allowed 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.92 -46.11 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 160.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.85 56.22 0.05 OUTLIER Glycine 0 CA--C 1.542 1.732 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.844 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt 62.7 136.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.837 1.255 . . . . 0.0 113.321 -170.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 0.4 OUTLIER 56.59 165.6 0.06 OUTLIER Pre-proline 0 CA--C 1.584 2.267 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.74 -60.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.029 2.486 . . . . 0.0 114.237 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.23 116.65 4.39 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.91 1.284 . . . . 0.0 112.431 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 58.9 11.15 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 116.399 1.319 . . . . 0.0 116.399 -175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -92.71 125.95 37.56 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.601 0.7 . . . . 0.0 110.454 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -128.42 122.18 30.75 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.717 0.807 . . . . 0.0 109.391 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -96.55 137.52 35.5 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 18.0 t -74.04 167.69 21.03 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.24 120.2 14.7 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.347 0.659 . . . . 0.0 112.194 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.12 59.8 2.24 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 115.823 -0.626 . . . . 0.0 114.578 -170.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.5 t -143.04 123.19 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.14 150.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . 0.258 49.0 mt-30 64.34 49.16 2.59 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 26.7 ttt -176.83 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -134.19 140.22 46.36 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -59.12 -55.34 36.26 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.9 m80 75.51 131.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.598 1.159 . . . . 0.0 113.315 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 87.6 p -87.35 119.72 27.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.971 0.508 . . . . 0.0 109.805 167.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.1 m -76.16 -66.35 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.698 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.95 138.21 42.53 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.843 0.83 . . . . 0.0 108.897 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.92 85.78 0.06 OUTLIER Glycine 0 N--CA 1.476 1.309 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -93.49 150.27 20.57 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.254 0.622 . . . . 0.0 110.559 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.47 -11.26 16.48 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -87.08 -48.22 8.26 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.021 1.282 . . . . 0.0 113.144 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.73 -23.77 56.09 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 165.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.6 -15.79 60.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 165.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.68 -28.91 61.71 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 160.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -37.88 85.36 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -55.1 -37.53 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.17 -32.19 19.96 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.67 94.2 3.19 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 120.249 1.386 . . . . 0.0 108.325 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.18 137.15 9.37 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 122.809 2.339 . . . . 0.0 111.996 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -147.49 147.77 29.07 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.708 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.13 126.72 14.09 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.114 2.542 . . . . 0.0 114.231 -168.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 26.6 mt -103.2 154.04 19.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.579 -165.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.37 114.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' THR . 7.2 m-30 -108.35 98.52 8.04 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.55 107.8 18.75 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 56.5 mtt -113.46 148.17 36.44 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.955 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.38 102.63 5.82 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 45.9 tpp -72.19 130.77 41.63 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.03 0.919 . . . . 0.0 111.668 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -57.54 2.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.826 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.7 tmpt? -143.22 148.4 36.39 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.462 1.125 . . . . 0.0 108.521 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.27 131.58 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.03 139.4 51.79 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.925 0.89 . . . . 0.0 109.204 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 53.8 m -96.31 169.59 8.74 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.86 110.37 1.68 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.52 2.813 . . . . 0.0 114.194 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.37 -60.54 0.61 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.292 -164.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -92.53 -16.94 25.11 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -72.4 173.22 9.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.09 122.89 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.912 0.485 . . . . 0.0 109.922 169.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -78.4 132.04 37.19 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 111.688 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.704 0.764 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.7 113.66 19.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.84 -45.1 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.406 -164.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mm -52.09 -40.18 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 121.138 1.79 . . . . 0.0 113.914 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.7 77.85 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -80.23 -31.64 38.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.07 -32.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -55.14 -42.17 72.69 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 120.973 1.715 . . . . 0.0 115.524 164.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.5 6.22 18.15 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 166.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.86 -7.25 54.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.19 -47.97 1.0 Allowed Glycine 0 CA--C 1.549 2.18 0 CA-C-N 119.856 1.207 . . . . 0.0 113.215 -163.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -67.74 161.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.598 1.159 . . . . 0.0 111.815 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -137.87 116.71 12.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -106.25 138.1 43.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -142.24 122.22 13.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.36 137.11 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.68 0.792 . . . . 0.0 111.483 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.18 -65.04 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.484 172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.64 112.91 19.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.74 118.8 10.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.476 0.71 . . . . 0.0 111.087 169.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.41 -137.66 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 116.773 1.469 . . . . 0.0 116.773 -162.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -143.86 -171.03 3.46 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.729 0.811 . . . . 0.0 109.553 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.26 -24.54 9.36 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 120.596 2.999 . . . . 0.0 120.596 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.261 37.1 mt-10 78.52 139.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.584 1.554 . . . . 0.0 111.333 -174.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -76.49 118.28 70.41 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.443 -1.265 . . . . 0.0 111.164 -171.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.39 -154.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.567 2.171 0 C-N-CA 123.141 2.561 . . . . 0.0 113.568 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -68.63 -57.81 5.17 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 56.17 65.01 1.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.333 1.053 . . . . 0.0 113.814 -167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -139.55 -164.28 1.65 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.832 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.53 97.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.36 39.82 2.35 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 117.973 -1.46 . . . . 0.0 115.274 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -100.92 125.42 47.49 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.27 95.16 9.88 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.322 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.43 112.35 24.13 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.398 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -102.86 122.51 44.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' O ' ' SD ' ' A' ' 60' ' ' MET . 38.1 p90 -156.65 167.58 30.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.758 0.789 . . . . 0.0 110.644 -172.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -93.32 162.28 14.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 111.814 166.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -143.27 143.59 31.78 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.808 0.843 . . . . 0.0 109.376 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -145.65 98.17 3.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.8 p -90.55 120.38 31.59 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.23 152.66 48.81 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 121.857 0.837 . . . . 0.0 109.888 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -69.8 135.36 49.58 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.327 0.651 . . . . 0.0 111.362 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -68.1 -70.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -168.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.16 -4.37 3.08 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 171.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.59 -55.16 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 120.178 1.354 . . . . 0.0 113.77 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -110.6 -38.16 5.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.734 0.814 . . . . 0.0 111.623 170.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 8.54 87.32 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 117.841 1.897 . . . . 0.0 117.841 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -91.3 144.44 25.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.861 1.33 . . . . 0.0 111.46 -173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 p -84.08 116.07 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -84.63 -34.07 23.16 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.353 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.54 144.31 26.16 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.888 0.875 . . . . 0.0 109.097 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.5 126.06 5.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.685 . . . . 0.0 109.641 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.8 p -116.87 -47.76 2.69 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -23.29 66.76 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 164.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.13 93.66 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 164.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -72.73 -33.0 66.11 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.56 37.62 11.8 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.91 5.33 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 118.581 1.19 . . . . 0.0 109.898 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -85.72 153.76 10.19 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.1 2.533 . . . . 0.0 114.189 -174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.435 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.74 174.82 10.14 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.323 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.79 119.82 12.77 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.427 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -113.09 134.5 54.51 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -100.54 127.73 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.46 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.54 115.15 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.249 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.05 53.8 21.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 118.796 2.279 . . . . 0.0 118.796 165.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -73.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -164.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.23 -49.74 5.09 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.242 1.017 . . . . 0.0 112.815 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -76.26 146.56 38.89 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -159.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -88.96 -26.23 21.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -98.98 103.16 18.01 Favored Pre-proline 0 CA--C 1.567 1.601 0 CA-C-N 120.335 1.425 . . . . 0.0 109.284 -175.408 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.04 -14.66 20.97 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 123.575 2.85 . . . . 0.0 118.309 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 95' ' ' VAL 0.271 10.9 p -66.9 -39.36 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.216 -1.373 . . . . 0.0 113.846 173.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -51.66 -35.86 44.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 165.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.53 -41.85 59.91 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.9 m -67.11 -46.84 72.96 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.412 1.485 . . . . 0.0 113.433 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -63.93 -30.1 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 N-CA-C 115.068 1.506 . . . . 0.0 115.068 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.31 -8.79 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 16.3 p -58.38 -33.69 69.89 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.736 2.062 . . . . 0.0 116.116 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -81.1 -2.85 49.95 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.9 mtp -103.41 129.69 50.57 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.873 1.215 . . . . 0.0 110.919 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -106.69 175.05 5.63 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.497 1.119 . . . . 0.0 111.943 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.85 104.53 0.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.074 0.95 . . . . 0.0 112.375 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.16 12.72 51.35 Favored Glycine 0 CA--C 1.553 2.461 0 N-CA-C 118.577 2.191 . . . . 0.0 118.577 -171.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.0 135.84 36.04 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.37 2.085 . . . . 0.0 109.482 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.51 118.62 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.4 131.75 34.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.208 0.603 . . . . 0.0 111.264 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.87 133.44 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.338 0.655 . . . . 0.0 111.184 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -177.65 159.92 1.51 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.355 0.598 . . . . 0.0 112.129 -166.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.86 149.24 25.38 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 m -118.23 139.01 51.95 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.895 170.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.78 143.13 57.09 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.883 0.473 . . . . 0.0 111.701 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.87 -28.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -50.61 -27.93 7.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 163.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -97.32 -43.59 7.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.055 1.342 . . . . 0.0 111.135 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 150' ' ' PHE . 30.5 m -90.45 24.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -43.71 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.593 1.157 . . . . 0.0 113.088 173.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.75 14.43 25.12 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -58.09 -49.44 93.61 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 114.91 -2.472 . . . . 0.0 115.287 160.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.27 -15.25 47.01 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 CA-C-N 125.871 3.133 . . . . 0.0 117.563 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -83.06 -44.2 15.44 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.754 0.822 . . . . 0.0 111.889 171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 70' ' ' LEU . 55.4 t -81.78 -34.32 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.88 -33.02 48.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 163.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -78.19 20.07 0.41 Allowed 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 165.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.2 t -144.42 -44.0 0.25 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 120.952 -1.092 . . . . 0.0 113.239 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -50.73 -33.65 23.8 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 166.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.2 ttp-105 -82.71 -52.59 6.64 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.478 1.111 . . . . 0.0 113.187 165.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -88.2 -58.16 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.761 0.709 . . . . 0.0 112.594 -158.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.6 mm -57.01 -32.05 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.56 -6.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.24 -47.46 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 159.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.81 -113.52 0.31 Allowed Glycine 0 CA--C 1.539 1.565 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.31 163.85 21.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.544 1.164 . . . . 0.0 113.344 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.42 160.14 82.34 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 114.423 -1.262 . . . . 0.0 113.196 166.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.38 -53.13 1.57 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 123.622 2.881 . . . . 0.0 116.098 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.7 mt -88.92 -39.52 13.71 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 117.57 -1.205 . . . . 0.0 113.898 165.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.91 115.22 14.27 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.709 1.595 . . . . 0.0 110.215 -172.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.26 -45.8 1.11 Allowed Glycine 0 CA--C 1.547 2.078 0 CA-C-O 119.104 -0.831 . . . . 0.0 114.167 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -65.14 -69.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 118.218 1.009 . . . . 0.0 113.588 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 65.6 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.915 1.286 . . . . 0.0 111.62 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -113.69 -99.86 0.43 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.7 t -164.14 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 23.1 p -143.05 104.72 4.34 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.74 -172.23 54.29 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 121.841 0.689 . . . . 0.0 114.709 -173.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t 68.32 101.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 124.827 1.251 . . . . 0.0 110.091 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.4 120.22 9.92 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.628 0.728 . . . . 0.0 109.642 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -135.28 136.83 41.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.511 1.125 . . . . 0.0 109.532 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . 0.252 99.7 mmm 78.54 113.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.919 1.287 . . . . 0.0 111.745 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -110.15 116.52 31.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -90.72 94.06 9.52 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -164.96 122.75 1.62 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 m -64.83 -55.57 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 t 61.06 88.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.935 1.294 . . . . 0.0 113.287 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 mt -93.5 -101.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.139 -169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 139.35 105.22 0.64 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -136.7 115.14 11.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.73 -6.38 40.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.51 -48.91 7.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.694 1.134 . . . . 0.0 112.953 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -74.17 -25.14 59.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 165.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.09 -16.59 59.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.08 61.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 160.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.04 -36.86 80.6 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -55.11 -38.37 68.08 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -85.82 -33.65 21.28 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 93.31 3.3 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 120.176 1.353 . . . . 0.0 108.912 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.94 138.35 13.02 Favored 'Trans proline' 0 CA--C 1.558 1.696 0 C-N-CA 123.011 2.474 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.12 145.65 30.67 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.645 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.52 125.6 11.92 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.85 -173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.4 mt -103.59 156.18 17.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.683 -165.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.9 112.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.467 ' CE1' HG11 ' A' ' 95' ' ' VAL . 40.0 m-85 -101.86 102.92 13.58 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -88.87 96.54 10.74 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.3 138.05 31.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.721 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -126.37 102.97 7.39 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.5 tpp -73.42 136.37 44.28 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.389 0.614 . . . . 0.0 111.705 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -58.42 1.78 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.767 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 153.58 50.95 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.956 0.884 . . . . 0.0 109.812 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -156.55 130.29 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -120.55 145.52 47.24 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.27 1.028 . . . . 0.0 109.653 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.7 p -96.14 166.71 13.78 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -68.03 107.53 1.54 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.347 2.698 . . . . 0.0 113.585 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.87 -59.34 0.58 Allowed Glycine 0 CA--C 1.539 1.557 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.774 -164.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -89.36 -22.88 22.39 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -71.95 173.28 8.57 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 120.496 1.498 . . . . 0.0 114.423 -174.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -68.76 107.07 2.88 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.366 0.667 . . . . 0.0 110.714 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.78 103.68 10.91 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.019 -169.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -154.36 139.26 17.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 mt -77.75 -41.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.517 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -54.25 -37.39 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 121.066 1.757 . . . . 0.0 113.926 167.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.45 76.01 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.02 -31.74 64.65 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 165.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.5 mt -81.02 -33.76 33.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -53.55 -43.9 68.81 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.05 -0.63 28.71 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 118.025 2.602 . . . . 0.0 118.025 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.85 14.75 3.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.72 -41.51 2.84 Favored Glycine 0 CA--C 1.552 2.369 0 CA-C-N 120.285 1.402 . . . . 0.0 115.738 -171.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.31 168.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 C-N-CA 125.829 1.652 . . . . 0.0 112.0 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -141.74 118.96 11.39 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.44 136.62 39.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.691 0.796 . . . . 0.0 111.254 -176.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -145.18 119.96 9.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.35 136.87 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mt -82.93 -65.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.5 114.05 21.19 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.27 122.42 16.61 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.281 0.632 . . . . 0.0 110.803 167.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.3 -147.76 1.74 Allowed Glycine 0 CA--C 1.54 1.653 0 N-CA-C 118.179 2.032 . . . . 0.0 118.179 -162.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -115.98 133.46 56.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.777 0.799 . . . . 0.0 109.503 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.06 -119.47 6.04 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.512 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.92 152.35 36.23 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.665 0.786 . . . . 0.0 110.487 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -77.07 126.75 85.01 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.076 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -81.75 -150.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 123.293 2.662 . . . . 0.0 112.806 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.37 -59.6 3.85 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.254 54.9 m-85 56.43 53.41 8.71 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -129.31 -179.16 4.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.615 1.166 . . . . 0.0 110.254 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -54.38 103.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 42.55 2.67 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 118.123 -1.376 . . . . 0.0 114.978 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 m -110.05 126.52 54.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.84 97.99 9.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.638 170.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.08 115.62 27.71 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.854 0.835 . . . . 0.0 110.235 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -111.12 119.6 39.54 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' SD ' ' A' ' 60' ' ' MET . 43.7 p90 -159.77 167.01 29.26 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.806 0.812 . . . . 0.0 110.921 -168.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -93.31 163.56 13.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.464 -0.773 . . . . 0.0 112.444 166.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -146.43 144.64 29.83 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.083 0.953 . . . . 0.0 109.417 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -149.76 98.66 2.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.1 p -89.24 120.63 30.78 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.97 151.06 46.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.76 0.791 . . . . 0.0 109.92 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -69.1 135.23 50.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.559 0.743 . . . . 0.0 111.214 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 t -72.8 -63.93 1.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -168.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -132.72 -16.11 2.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.53 -54.06 50.0 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.418 1.463 . . . . 0.0 114.422 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -118.97 -31.93 4.61 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.678 0.791 . . . . 0.0 112.687 171.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 6.29 88.93 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -164.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -84.58 142.87 29.66 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.207 1.503 . . . . 0.0 112.405 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.49 117.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -34.53 18.98 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.714 -1.585 . . . . 0.0 114.5 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.31 146.64 29.78 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.423 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -158.72 124.14 4.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.23 0.612 . . . . 0.0 110.091 -169.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.2 p -111.17 -50.72 2.92 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -16.38 60.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 167.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.49 -41.9 77.4 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 162.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -78.33 -31.98 48.96 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.34 57.78 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 -158.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -114.3 102.77 55.05 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 119.556 1.678 . . . . 0.0 109.495 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -79.79 149.49 20.66 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.163 2.575 . . . . 0.0 114.58 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -85.81 175.25 8.78 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.227 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -143.06 119.21 10.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.647 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.66 133.38 52.18 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.23 125.07 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.2 mm -76.49 116.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.23 51.19 15.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 165.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -157.7 -57.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.678 0.791 . . . . 0.0 109.234 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -145.38 68.77 1.23 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 119.47 1.032 . . . . 0.0 110.979 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -151.92 137.56 17.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.696 0.798 . . . . 0.0 109.178 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -75.62 -38.9 58.61 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -85.92 115.57 62.3 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 124.471 1.108 . . . . 0.0 111.112 -169.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.23 -24.31 3.88 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 123.483 2.789 . . . . 0.0 117.8 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 95' ' ' VAL 0.267 1.4 p -71.16 -32.88 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.556 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 150' ' ' PHE . 14.7 m0 -52.18 -43.27 64.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.727 1.603 . . . . 0.0 114.533 168.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.88 -37.52 79.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.416 HG22 ' HZ1' ' A' ' 15' ' ' LYS . 40.3 m -71.38 -40.99 70.22 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.971 1.309 . . . . 0.0 113.439 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.6 mt -48.1 -55.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 125.352 1.461 . . . . 0.0 113.08 165.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.06 -7.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 46.0 t -56.08 -38.2 70.36 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.2 p -80.5 -8.84 59.72 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 171.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.3 mtp -99.91 128.84 45.96 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.416 1.086 . . . . 0.0 110.857 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.06 -178.51 3.77 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.843 0.857 . . . . 0.0 112.075 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 107.42 1.2 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.935 0.894 . . . . 0.0 111.212 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.61 8.89 58.09 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -94.22 132.31 38.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.711 2.255 . . . . 0.0 109.54 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.62 117.0 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.49 129.87 31.68 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.28 0.632 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.3 130.81 52.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.528 0.731 . . . . 0.0 110.835 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -174.16 160.97 3.48 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.001 0.905 . . . . 0.0 112.794 -166.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.67 149.57 23.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.285 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 57.3 m -126.41 142.81 51.4 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.869 167.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.96 144.94 56.45 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.405 0.621 . . . . 0.0 111.744 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.4 -30.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 118.658 2.836 . . . . 0.0 118.658 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -27.72 32.75 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 167.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -96.08 -43.59 7.7 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.034 1.334 . . . . 0.0 110.808 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 72' ' ' VAL . 31.1 m -88.68 20.54 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -40.92 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 C-N-CA 125.181 1.393 . . . . 0.0 114.258 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 15.7 22.32 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.31 -52.62 71.62 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 114.985 -2.436 . . . . 0.0 115.087 157.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.46 -12.53 28.18 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 CA-C-N 125.7 3.071 . . . . 0.0 117.636 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.18 -44.53 12.12 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 123.637 0.775 . . . . 0.0 111.822 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 70' ' ' LEU . 46.3 t -83.9 -29.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.01 -32.27 33.29 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 159.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.64 26.45 0.39 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 164.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.9 m -148.59 -41.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 113.089 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.8 -29.05 62.35 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 164.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -77.05 -52.99 8.36 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.76 0.824 . . . . 0.0 112.857 158.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -85.47 -60.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -159.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -56.12 -31.38 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 170.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.35 -11.14 13.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.41 -42.78 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.12 -70.0 0.1 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.517 -164.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -81.57 139.93 34.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.209 1.004 . . . . 0.0 113.393 -174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.09 151.49 71.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.579 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.0 -38.25 23.17 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 123.145 2.564 . . . . 0.0 116.997 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.49 -78.92 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.184 0.902 . . . . 0.0 108.796 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 65.04 -0.63 1.01 Allowed 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 118.803 2.89 . . . . 0.0 118.803 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 68.45 1.53 Allowed Glycine 0 CA--C 1.545 1.934 0 CA-C-N 119.989 1.268 . . . . 0.0 112.168 -161.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -91.1 113.57 25.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.113 0.565 . . . . 0.0 110.74 -169.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -90.2 115.08 27.16 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.2 m80 76.69 118.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.752 1.221 . . . . 0.0 111.66 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.3 -51.87 12.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 79.8 m -114.42 105.4 13.07 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.4 -93.76 0.13 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -89.23 98.54 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 168.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.35 111.78 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -91.2 147.79 22.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.533 0.733 . . . . 0.0 110.934 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -87.85 106.96 18.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.862 -161.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.15 161.46 14.26 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.497 0.719 . . . . 0.0 112.614 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . 0.253 7.8 t-80 73.62 95.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.085 1.354 . . . . 0.0 110.281 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t -133.38 -49.53 0.85 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.589 -168.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.6 p -155.76 138.0 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.246 1.385 . . . . 0.0 110.511 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.92 -84.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 118.794 -0.622 . . . . 0.0 109.645 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 170.58 -86.64 0.09 OUTLIER Glycine 0 CA--C 1.536 1.404 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 65.33 100.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.71 1.204 . . . . 0.0 112.434 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.86 -9.55 38.87 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.36 -48.11 7.89 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.695 1.134 . . . . 0.0 112.996 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -75.7 -24.34 56.23 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 165.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.45 -17.91 60.02 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 167.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.71 58.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 158.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.63 -38.18 80.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.16 -36.57 68.46 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.02 -34.76 22.26 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.78 93.32 3.26 Favored Pre-proline 0 CA--C 1.561 1.383 0 CA-C-N 120.198 1.363 . . . . 0.0 108.35 -174.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.1 141.45 29.53 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.954 2.436 . . . . 0.0 113.7 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -135.03 139.6 32.49 Favored Pre-proline 0 N--CA 1.492 1.627 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.166 -171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.53 115.99 4.2 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.134 2.556 . . . . 0.0 111.813 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.0 157.11 17.1 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.552 0.691 . . . . 0.0 112.142 -162.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 25.6 mm -87.28 111.08 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HE2' ' HE1' ' A' ' 73' ' ' TRP . 44.1 m-85 -98.97 97.31 8.49 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -87.64 101.92 14.12 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 54.6 mtt -106.29 141.97 36.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.87 101.42 6.08 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 18.2 ttm -76.52 136.14 39.32 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 -53.72 2.62 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.68 -2.054 . . . . 0.0 110.436 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -144.37 160.18 41.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.248 1.023 . . . . 0.0 110.971 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.21 127.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.45 130.95 54.54 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.994 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.6 m -87.59 166.95 22.49 Favored Pre-proline 0 CA--C 1.573 1.838 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.61 109.46 1.85 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.365 2.71 . . . . 0.0 113.208 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.8 -54.43 0.66 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.618 -163.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -94.73 -29.48 14.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -75.86 156.54 34.27 Favored 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 120.188 1.358 . . . . 0.0 113.259 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.16 115.41 18.36 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -116.36 133.9 55.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.514 -176.704 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.289 . . . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.27 122.63 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 111.385 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mm -90.67 -36.04 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.535 -174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mm -51.73 -44.15 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 CA-C-N 120.009 1.277 . . . . 0.0 113.771 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.69 76.59 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.255 7.8 ptp180 -75.92 -30.71 58.84 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 169.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.08 -43.02 68.57 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.624 1.556 . . . . 0.0 114.826 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -54.75 -43.14 72.44 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.26 -4.17 43.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 167.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.94 -8.17 57.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.74 -45.03 1.36 Allowed Glycine 0 CA--C 1.551 2.284 0 CA-C-N 120.058 1.299 . . . . 0.0 114.102 -164.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 pt -70.11 166.56 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 C-N-CA 124.942 1.297 . . . . 0.0 111.82 170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -140.28 115.36 9.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -90.33 135.74 33.49 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.778 0.831 . . . . 0.0 112.006 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -142.13 127.32 18.59 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.7 140.65 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.138 0.975 . . . . 0.0 111.332 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt -83.73 -66.6 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 114.33 22.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.18 120.7 13.2 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.47 0.708 . . . . 0.0 110.947 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.41 -138.1 0.8 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.918 1.527 . . . . 0.0 116.918 -165.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -125.83 135.57 52.13 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.687 0.756 . . . . 0.0 110.418 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.8 21.85 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 114.906 -1.043 . . . . 0.0 115.121 168.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -102.78 148.03 26.12 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.047 0.939 . . . . 0.0 110.036 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.21 123.48 84.71 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.931 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.27 -171.9 1.29 Allowed 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 123.191 2.594 . . . . 0.0 113.386 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -54.05 -53.53 51.81 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.3 51.03 13.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 -168.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -124.6 -175.34 3.24 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.418 1.087 . . . . 0.0 109.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -61.63 101.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.962 0.905 . . . . 0.0 112.915 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.91 39.18 1.6 Allowed Glycine 0 CA--C 1.547 2.081 0 CA-C-O 117.552 -1.693 . . . . 0.0 115.324 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -113.02 128.56 56.53 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 120.583 2.191 . . . . 0.0 106.396 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -89.29 93.26 9.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.538 0.735 . . . . 0.0 109.54 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.79 115.89 28.33 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.583 0.706 . . . . 0.0 110.743 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.5 m -108.81 122.3 46.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' SD ' ' A' ' 60' ' ' MET . 40.0 p90 -158.74 168.82 25.84 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.057 0.932 . . . . 0.0 110.682 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -94.29 160.73 14.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 111.809 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.19 143.54 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.504 0.721 . . . . 0.0 109.379 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.3 98.51 3.02 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 150' ' ' PHE . 70.4 p -87.02 119.83 27.64 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.37 153.08 51.94 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -69.42 136.34 51.46 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.47 0.708 . . . . 0.0 111.357 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 99.7 p -69.18 -61.3 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -138.65 -16.61 1.15 Allowed 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.14 -54.24 36.96 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.601 1.546 . . . . 0.0 114.368 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -100.93 -42.4 6.44 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 122.98 0.512 . . . . 0.0 110.858 163.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.56 13.83 83.1 Favored Glycine 0 CA--C 1.556 2.641 0 N-CA-C 117.756 1.862 . . . . 0.0 117.756 -159.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -95.23 148.64 22.18 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.679 1.239 . . . . 0.0 111.545 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.6 116.56 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.6 -35.15 22.92 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 114.152 -1.385 . . . . 0.0 114.197 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.71 144.66 28.47 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.77 0.828 . . . . 0.0 109.633 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -156.2 125.28 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.672 0.789 . . . . 0.0 109.855 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 m -111.57 -50.04 2.95 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -22.61 66.97 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.51 83.18 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -79.51 -25.07 41.86 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.85 25.29 56.41 Favored Glycine 0 CA--C 1.552 2.388 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -165.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 99.94 49.68 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-N 118.951 1.376 . . . . 0.0 108.613 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -78.69 142.91 18.38 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.02 2.48 . . . . 0.0 113.761 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.8 ppp? -83.38 173.93 11.12 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.674 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -138.09 122.39 18.2 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.76 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.3 134.32 51.94 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.369 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.84 126.68 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 170.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.6 mm -76.65 112.18 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.63 51.23 33.77 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 119.531 2.572 . . . . 0.0 119.531 165.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.29 -62.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -134.43 73.33 1.49 Allowed 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 119.155 0.889 . . . . 0.0 110.646 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -156.91 143.8 18.55 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.962 0.887 . . . . 0.0 110.262 169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -82.48 -41.0 20.32 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 72' ' ' VAL . 1.8 mt -80.05 123.46 83.47 Favored Pre-proline 0 CA--C 1.566 1.577 0 CA-C-N 119.623 1.101 . . . . 0.0 112.022 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.48 -21.38 4.35 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 123.325 2.683 . . . . 0.0 117.049 164.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 70' ' ' LEU 0.254 8.8 p -67.57 -42.2 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.548 1.522 . . . . 0.0 113.564 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.8 m0 -51.02 -34.92 31.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 167.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.85 -40.33 32.92 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 m -67.35 -46.45 73.36 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.636 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 pt -60.87 -42.17 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 73' ' ' TRP . 34.7 m -81.5 -10.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 38.3 t -53.1 -32.86 49.5 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.0 p -82.07 -8.62 59.67 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 91.6 mtp -105.86 127.71 53.29 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.243 -165.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -101.28 176.77 5.13 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.006 0.922 . . . . 0.0 111.791 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.77 107.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.832 0.853 . . . . 0.0 111.708 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.61 13.37 53.83 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 118.474 2.149 . . . . 0.0 118.474 -172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -96.28 134.26 39.61 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.012 1.906 . . . . 0.0 109.599 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.53 116.02 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.93 135.61 43.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.408 0.683 . . . . 0.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.29 130.6 46.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.831 0.452 . . . . 0.0 110.154 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -171.47 156.22 4.41 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 122.325 1.06 . . . . 0.0 113.327 -165.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -85.03 151.22 24.33 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.141 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 51.0 m -123.05 140.24 53.24 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.715 170.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.44 142.72 57.47 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.723 0.409 . . . . 0.0 111.474 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -59.95 -24.03 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -49.68 -31.02 10.16 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 163.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -92.1 -46.61 7.69 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 124.816 1.246 . . . . 0.0 111.361 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -86.17 17.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.59 -39.86 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 125.323 1.449 . . . . 0.0 114.019 170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.66 15.66 22.82 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 172.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -56.33 -51.6 79.64 Favored Pre-proline 0 CA--C 1.575 1.942 0 CA-C-O 115.232 -2.318 . . . . 0.0 114.68 157.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -66.49 -7.86 19.1 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 CA-C-N 125.388 2.96 . . . . 0.0 117.859 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.54 -42.74 11.89 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.8 0.84 . . . . 0.0 111.601 168.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.6 -40.59 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.944 1.298 . . . . 0.0 113.706 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.39 -30.89 42.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 164.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.09 10.73 2.18 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 167.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.2 m -138.37 -33.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.249 1.386 . . . . 0.0 114.117 170.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 -27.41 61.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 121.407 1.912 . . . . 0.0 116.125 166.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -83.39 -55.68 4.18 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.839 0.856 . . . . 0.0 112.449 162.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -80.92 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.603 0.761 . . . . 0.0 113.041 -160.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.9 mm -64.69 -31.25 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.68 -9.75 6.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 118.949 2.944 . . . . 0.0 118.949 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.66 -45.39 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.43 -115.69 0.6 Allowed Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.74 163.98 14.86 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.63 151.28 39.92 Favored Pre-proline 0 CA--C 1.57 1.736 0 C-N-CA 124.201 1.0 . . . . 0.0 111.975 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.03 -44.02 22.0 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.467 2.778 . . . . 0.0 117.041 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.1 mt -86.0 -48.93 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.091 0.86 . . . . 0.0 112.702 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.07 104.37 9.66 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 119.631 1.105 . . . . 0.0 110.913 -171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.41 77.67 0.85 Allowed Glycine 0 CA--C 1.542 1.768 0 CA-C-O 119.554 -0.581 . . . . 0.0 113.382 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -79.39 -53.35 6.99 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 77.64 134.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.591 1.157 . . . . 0.0 112.871 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . 0.262 83.7 m-70 78.58 107.38 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.792 1.237 . . . . 0.0 111.949 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.0 m -75.57 -60.27 2.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.829 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.92 110.2 13.91 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.28 112.48 4.04 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 115.858 1.103 . . . . 0.0 115.858 -160.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.48 80.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -169.45 165.64 10.45 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.916 0.865 . . . . 0.0 110.643 -165.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 141.22 58.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.711 -0.618 . . . . 0.0 111.904 163.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 87.5 mtp -62.51 -68.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -166.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.4 mtm-85 -138.42 85.99 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.151 0.887 . . . . 0.0 108.609 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 54.81 89.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.783 1.233 . . . . 0.0 114.317 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -108.19 73.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.63 0.728 . . . . 0.0 109.866 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 p -165.67 98.74 0.68 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.6 m -149.01 138.09 21.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.152 0.581 . . . . 0.0 110.471 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 77.1 mt -126.05 161.75 26.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.081 0.943 . . . . 0.0 111.296 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -120.55 -65.62 0.26 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 123.885 0.755 . . . . 0.0 111.994 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.391 92.9 m-70 90.03 -54.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . 0.274 . . 73.51 -17.86 0.41 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -170.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.81 -52.02 5.08 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.795 1.179 . . . . 0.0 111.918 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -73.27 -31.36 64.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 161.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.06 -11.15 60.45 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.68 -30.73 61.55 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 158.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -67.73 -40.14 84.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -51.29 -38.31 52.12 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.58 -32.21 18.24 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.7 94.84 3.32 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 120.363 1.438 . . . . 0.0 108.518 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.41 140.23 47.61 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.339 2.693 . . . . 0.0 115.022 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -142.14 134.56 13.7 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.766 -1.112 . . . . 0.0 110.34 -167.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.81 116.78 3.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.069 2.513 . . . . 0.0 112.055 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.1 mt -102.59 154.16 19.4 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.946 0.879 . . . . 0.0 112.783 -163.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.53 109.14 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.9 m-30 -103.21 98.19 8.16 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.44 98.64 10.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 18.8 mmt -91.56 139.16 30.97 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.56 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -127.06 101.54 6.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 46.8 tpp -74.23 133.12 42.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.789 0.804 . . . . 0.0 111.612 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 -54.51 2.44 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.491 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -144.98 157.6 44.08 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.897 0.879 . . . . 0.0 110.272 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.17 127.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -116.78 134.95 54.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.001 0.92 . . . . 0.0 109.426 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.9 p -88.5 164.7 31.39 Favored Pre-proline 0 CA--C 1.572 1.824 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.6 106.32 1.06 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.613 2.875 . . . . 0.0 113.285 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.88 -59.74 0.54 Allowed Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.765 -161.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.2 t -92.96 -26.56 17.51 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -74.03 140.72 45.61 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.461 1.482 . . . . 0.0 113.751 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.14 151.47 19.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.33 160.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -135.81 126.77 27.73 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -174.594 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.469 0.652 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.7 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.006 1.322 . . . . 0.0 112.047 -169.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.4 mt -84.64 -37.37 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.16 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.02 -43.35 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 124.686 1.194 . . . . 0.0 114.015 166.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.64 76.41 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.267 10.9 ptm180 -76.04 -30.11 58.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.12 -39.51 63.3 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -54.9 -42.42 72.13 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.67 -2.45 36.05 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 166.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.8 -3.2 43.24 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.35 -40.09 2.54 Favored Glycine 0 CA--C 1.55 2.234 0 CA-C-N 120.198 1.363 . . . . 0.0 115.007 -166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -72.96 165.55 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.069 1.348 . . . . 0.0 111.792 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -135.59 119.46 17.35 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -96.13 139.56 32.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.215 1.006 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -145.94 124.86 12.71 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -96.65 140.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.929 0.892 . . . . 0.0 110.765 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mt -86.03 -64.59 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.48 112.13 17.13 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.52 130.27 43.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.516 0.726 . . . . 0.0 111.573 169.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -154.77 1.75 Allowed Glycine 0 CA--C 1.541 1.701 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -67.71 -50.95 54.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 -162.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.9 -120.79 2.03 Favored Glycine 0 CA--C 1.544 1.9 0 C-N-CA 123.889 0.756 . . . . 0.0 112.693 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.42 146.38 40.68 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.982 0.913 . . . . 0.0 112.425 -170.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.44 121.37 66.55 Favored Pre-proline 0 CA--C 1.576 1.952 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.339 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.36 -150.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 123.29 2.66 . . . . 0.0 113.7 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.1 -68.62 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 57.67 56.19 5.04 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -126.1 -175.2 3.3 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.525 1.13 . . . . 0.0 110.133 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.99 101.99 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.31 40.2 2.85 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.063 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 m -105.26 123.38 47.74 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.57 96.14 10.52 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.016 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.22 113.04 24.59 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.736 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 91.9 m -101.51 125.31 48.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.0 p90 -158.74 167.86 28.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.367 -173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -92.22 163.8 13.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 112.566 168.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -144.91 142.96 30.31 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.65 96.74 2.95 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -92.32 119.68 32.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.04 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.24 157.52 46.69 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.503 1.144 . . . . 0.0 109.971 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.94 134.64 44.83 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.649 0.779 . . . . 0.0 111.042 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -70.19 -58.79 3.39 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -167.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -143.09 -3.9 0.94 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.39 -56.23 17.97 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.856 1.662 . . . . 0.0 113.662 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -120.18 -39.23 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.596 0.758 . . . . 0.0 111.797 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.83 12.3 77.61 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 -157.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -79.71 141.68 36.16 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.078 1.439 . . . . 0.0 111.919 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.26 118.42 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.9 -33.81 24.68 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 113.869 -1.514 . . . . 0.0 114.473 172.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.65 143.15 26.32 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.72 0.808 . . . . 0.0 109.5 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -150.81 120.29 6.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.77 0.828 . . . . 0.0 109.108 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -107.72 -51.17 2.94 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.769 0.828 . . . . 0.0 113.05 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -23.0 66.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 169.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.12 82.88 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -80.07 -28.74 39.14 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 167.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.58 38.87 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.056 1.582 . . . . 0.0 117.056 -165.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -120.41 99.5 47.96 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 118.776 1.288 . . . . 0.0 108.708 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.73 147.34 21.8 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.004 2.47 . . . . 0.0 114.336 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 2.0 ppp? -82.92 174.82 10.57 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.536 173.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -140.6 120.54 13.6 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.444 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.13 135.3 54.05 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.25 132.12 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 mm -78.05 100.98 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.651 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.72 56.04 24.46 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.219 2.048 . . . . 0.0 118.219 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.34 59.86 1.7 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.629 1.104 . . . . 0.0 112.701 169.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -147.54 141.65 26.05 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 122.104 0.954 . . . . 0.0 110.56 170.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -85.13 -33.82 22.29 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.54 103.66 19.87 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.745 1.157 . . . . 0.0 109.864 -171.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -14.45 17.95 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 123.698 2.932 . . . . 0.0 118.548 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 95' ' ' VAL 0.261 11.5 p -68.05 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 117.661 -1.162 . . . . 0.0 114.136 175.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -50.36 -38.53 42.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.82 -43.05 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -36.98 79.87 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.635 1.174 . . . . 0.0 113.645 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.48 -59.07 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 124.641 1.176 . . . . 0.0 111.741 164.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -81.08 -7.7 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 34.5 t -62.07 -31.13 71.53 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -90.6 16.98 8.06 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 168.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.1 mtp -121.92 151.63 40.51 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.42 1.488 . . . . 0.0 109.523 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.26 -175.73 4.09 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.918 0.887 . . . . 0.0 111.258 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.64 112.26 2.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.479 -1.388 . . . . 0.0 112.569 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 10.87 64.47 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -172.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -96.8 133.1 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 120.261 2.031 . . . . 0.0 109.915 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.43 117.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.97 133.86 32.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.352 0.596 . . . . 0.0 111.635 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -129.53 121.09 26.49 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -174.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -169.97 155.14 5.48 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.65 159.4 19.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 61.6 m -130.51 148.29 52.3 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.868 166.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.92 147.86 48.32 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.339 0.656 . . . . 0.0 112.075 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -55.79 -30.42 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -53.27 -26.7 19.3 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 165.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -94.66 -43.23 8.37 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.843 1.257 . . . . 0.0 111.376 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 HG11 ' A' ' 72' ' ' VAL . 26.3 m -91.17 23.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.253 0.8 OUTLIER -64.32 -44.44 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 124.494 1.118 . . . . 0.0 113.583 176.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.14 13.48 25.2 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 171.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.12 -47.79 98.22 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 115.097 -2.382 . . . . 0.0 116.068 163.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -62.31 -23.4 75.22 Favored 'Trans proline' 0 CA--C 1.563 1.932 0 CA-C-N 125.503 3.001 . . . . 0.0 116.871 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.9 -42.63 48.48 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 118.935 0.789 . . . . 0.0 112.6 174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.93 -30.83 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.11 -32.75 48.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 161.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.29 0.85 Allowed 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 164.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.8 m -148.23 -46.16 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.825 1.65 . . . . 0.0 110.842 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.35 -28.48 59.21 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 164.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -77.99 -52.78 8.27 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 159.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.22 -57.16 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.054 0.941 . . . . 0.0 113.191 -160.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.34 -40.28 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 C-N-CA 124.993 1.317 . . . . 0.0 113.967 170.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.35 7.4 0.45 Allowed 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 119.35 3.093 . . . . 0.0 119.35 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.36 -42.52 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 159.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.48 -94.92 0.1 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -128.87 124.76 36.08 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.319 0.9 OUTLIER 57.21 155.71 0.08 OUTLIER Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -175.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.63 -56.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 123.368 2.712 . . . . 0.0 114.58 -171.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.5 mt -59.63 -35.52 74.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 163.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -69.0 100.76 1.26 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.619 1.168 . . . . 0.0 110.403 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.04 87.23 0.13 Allowed Glycine 0 CA--C 1.544 1.901 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.463 -170.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.34 103.41 15.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -142.12 155.99 45.36 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.312 1.053 . . . . 0.0 109.317 -168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -70.97 122.78 20.62 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.099 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.48 -57.07 4.17 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -170.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 26.4 p -84.76 92.8 8.31 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.069 0.849 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.71 -149.65 40.23 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.476 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.97 122.22 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.56 113.05 5.0 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -95.71 73.83 3.15 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.008 0.908 . . . . 0.0 110.222 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 28.3 ttt -161.5 94.74 0.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.85 96.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.583 1.153 . . . . 0.0 110.741 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.39 -77.75 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.188 0.595 . . . . 0.0 110.549 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 63.38 86.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.678 1.191 . . . . 0.0 113.51 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 m -76.07 -56.55 4.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.718 168.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 t -70.81 -62.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.103 0.865 . . . . 0.0 112.874 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.34 3.9 tt 77.79 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.649 1.179 . . . . 0.0 111.552 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.67 -77.76 0.24 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 74.32 97.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.11 -14.02 61.07 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -86.46 -46.42 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -26.16 61.2 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 164.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.85 -17.93 61.0 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 168.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.5 61.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 160.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.86 -37.82 79.32 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.73 -38.25 69.52 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -84.27 -34.13 23.87 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 92.75 3.15 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-N 120.355 1.434 . . . . 0.0 108.924 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.4 139.77 23.66 Favored 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 123.036 2.491 . . . . 0.0 113.244 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -144.79 144.86 25.79 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.869 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.26 120.24 6.44 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 123.073 2.515 . . . . 0.0 112.398 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.6 mt -99.37 161.67 13.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.0 mm -86.69 140.98 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 169.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -131.35 100.13 5.07 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -87.95 95.81 10.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 21.1 mmt -89.88 143.61 26.64 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.925 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -133.78 103.95 6.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 26.6 ttm -79.91 140.26 36.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -55.49 1.91 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.103 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 tmpt? -142.29 149.34 39.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.297 1.046 . . . . 0.0 109.512 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.0 p -152.51 133.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.46 135.24 53.98 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.066 0.947 . . . . 0.0 108.958 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.9 m -91.51 167.84 14.69 Favored Pre-proline 0 CA--C 1.574 1.878 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.01 108.14 1.66 Allowed 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.57 2.847 . . . . 0.0 113.19 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 140.45 -58.12 0.59 Allowed Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.073 -162.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.9 t -92.36 -28.72 16.74 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -74.18 132.44 42.2 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 120.123 1.329 . . . . 0.0 112.2 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 62.76 96.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.247 1.019 . . . . 0.0 112.543 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -81.13 125.96 30.89 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.398 0.618 . . . . 0.0 110.916 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.293 1.044 . . . . 0.0 108.769 -174.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.82 107.31 0.06 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.643 1.177 . . . . 0.0 110.309 -167.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 mm -76.79 -43.59 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.107 0.563 . . . . 0.0 111.651 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.69 -44.75 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.55 83.46 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . 0.252 0.1 OUTLIER -71.42 -25.94 62.54 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 173.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.52 -39.22 58.7 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 120.782 1.628 . . . . 0.0 115.031 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -56.63 -40.65 75.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 169.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.64 -1.4 34.11 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 118.323 2.712 . . . . 0.0 118.323 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -0.41 38.36 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.131 1.901 . . . . 0.0 116.131 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.56 -40.57 2.4 Favored Glycine 0 CA--C 1.552 2.375 0 CA-C-N 120.303 1.41 . . . . 0.0 115.009 -167.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.07 167.96 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 125.553 1.541 . . . . 0.0 111.891 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -135.29 122.65 21.81 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 147.64 24.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -153.72 124.84 7.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.39 137.93 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.669 0.787 . . . . 0.0 110.753 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.78 -67.19 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.1 111.27 17.65 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.76 122.14 16.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.338 0.655 . . . . 0.0 111.136 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.86 -130.62 0.32 Allowed Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -164.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -133.64 -69.41 0.54 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.81 0.444 . . . . 0.0 112.145 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -179.74 17.04 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 117.351 1.7 . . . . 0.0 117.351 -166.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.42 122.65 28.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.987 -0.713 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.39 113.52 11.88 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 117.394 -1.289 . . . . 0.0 109.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.08 -143.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.094 2.529 . . . . 0.0 112.939 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.18 -59.75 4.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.6 m-85 52.05 43.33 30.5 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -160.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -121.51 -166.24 1.35 Allowed 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 125.143 1.377 . . . . 0.0 108.874 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.79 97.72 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.823 -1.173 . . . . 0.0 112.799 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 38.0 1.24 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-O 117.529 -1.706 . . . . 0.0 115.745 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -109.53 128.27 55.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.711 2.255 . . . . 0.0 106.491 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -90.52 94.92 9.91 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.436 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.74 118.25 31.43 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.339 0.59 . . . . 0.0 110.849 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -107.58 123.98 49.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' SD ' ' A' ' 60' ' ' MET . 42.7 p90 -161.46 168.09 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.848 0.832 . . . . 0.0 110.936 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -92.42 162.76 14.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 112.487 167.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.86 147.01 32.32 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.671 0.789 . . . . 0.0 109.587 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -151.05 98.99 2.64 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 150' ' ' PHE . 71.8 p -88.05 119.72 28.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.95 153.61 49.46 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.758 0.79 . . . . 0.0 110.208 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.92 136.6 52.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.613 0.765 . . . . 0.0 111.622 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.0 p -72.0 -66.21 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -170.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -132.66 -15.11 2.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -55.73 -49.08 74.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 -35.34 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.59 0.756 . . . . 0.0 112.243 168.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 8.22 85.79 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 -160.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -84.91 140.33 31.19 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.215 1.508 . . . . 0.0 112.175 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.97 115.79 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.71 -34.18 22.98 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.404 174.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.05 144.35 29.03 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.806 0.843 . . . . 0.0 109.389 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -158.51 122.08 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.588 -0.695 . . . . 0.0 110.944 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -107.71 -50.49 3.05 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.186 0.995 . . . . 0.0 113.441 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -18.95 64.25 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 170.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.91 65.59 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 166.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -16.08 26.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.09 25.23 Favored Glycine 0 CA--C 1.547 2.084 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.65 96.74 50.29 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.34 145.04 21.0 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.963 2.442 . . . . 0.0 113.899 -172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 36' ' ' PHE . 1.7 ppp? -85.2 174.8 9.37 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.934 176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -138.58 126.18 22.03 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.209 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.58 135.49 54.02 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.28 126.3 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.1 121.26 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 46.93 55.07 8.7 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 163.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -156.74 -51.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.537 -0.745 . . . . 0.0 110.34 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -135.02 -20.34 1.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 171.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.04 138.83 41.11 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.922 1.692 . . . . 0.0 112.208 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -79.71 -31.07 41.17 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 72' ' ' VAL . 3.5 mt -86.23 121.77 72.51 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 120.435 1.47 . . . . 0.0 111.039 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -81.71 -19.07 7.6 Favored 'Trans proline' 0 CA--C 1.571 2.368 0 C-N-CA 123.23 2.62 . . . . 0.0 116.949 163.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.552 HG12 HD22 ' A' ' 70' ' ' LEU . 6.0 p -69.05 -40.89 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 120.423 1.465 . . . . 0.0 113.814 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -50.57 -40.13 51.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.89 -40.06 69.13 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 m -68.92 -39.61 79.54 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.933 1.293 . . . . 0.0 113.518 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -53.42 -56.27 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 124.438 1.095 . . . . 0.0 112.16 167.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.49 -10.02 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.07 -27.93 55.5 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p -85.29 -0.22 54.05 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 171.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.09 128.62 56.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 120.065 1.302 . . . . 0.0 110.41 -161.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.44 173.6 6.23 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.11 0.964 . . . . 0.0 111.781 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -64.14 107.04 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.666 0.786 . . . . 0.0 111.446 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.87 11.66 54.5 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.625 2.21 . . . . 0.0 118.625 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.73 136.46 37.23 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 120.212 2.006 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.37 115.73 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.66 129.86 35.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.433 0.693 . . . . 0.0 110.666 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 132.86 54.15 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.444 0.698 . . . . 0.0 109.963 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -169.51 151.38 4.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.08 149.22 29.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.476 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.2 m -123.94 138.16 54.51 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.745 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.2 142.86 58.23 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.186 0.594 . . . . 0.0 111.493 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.338 0.1 OUTLIER -59.82 -23.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -172.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 -29.92 16.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 163.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -92.56 -45.72 7.97 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.988 1.315 . . . . 0.0 111.3 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.51 19.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -39.39 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 125.056 1.342 . . . . 0.0 114.067 171.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 17.02 18.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 171.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -57.26 -50.9 85.53 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-O 115.163 -2.351 . . . . 0.0 114.624 156.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -65.8 -4.3 9.69 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 CA-C-N 125.576 3.027 . . . . 0.0 117.862 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.61 -41.4 9.76 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.015 0.926 . . . . 0.0 112.003 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.06 -37.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 125.022 1.329 . . . . 0.0 113.558 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.11 -31.02 28.91 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 161.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -70.17 2.82 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 166.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 m -135.05 -37.84 0.79 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 120.481 1.491 . . . . 0.0 114.171 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -30.91 51.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 166.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -81.45 -55.82 4.44 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.618 0.767 . . . . 0.0 112.302 165.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -87.55 -59.37 2.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 119.043 0.838 . . . . 0.0 112.79 -160.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.73 -27.33 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.921 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.46 -16.94 4.26 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 118.883 2.92 . . . . 0.0 118.883 168.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -43.34 -47.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 161.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.06 -95.54 0.22 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.277 0.5 OUTLIER -146.58 174.21 11.63 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.597 0.713 . . . . 0.0 111.632 177.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -58.17 143.67 78.38 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.837 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.06 -58.78 0.67 Allowed 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.104 2.536 . . . . 0.0 115.999 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -77.98 -69.42 0.55 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.025 0.829 . . . . 0.0 110.807 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 53.12 42.2 32.18 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.3 81.18 0.09 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.697 -161.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -73.59 96.74 2.5 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.82 -162.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -168.22 113.01 0.64 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -87.13 97.32 10.68 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 124' ' ' VAL . 27.1 p -84.13 103.53 13.42 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . 0.261 20.4 p 49.24 61.73 2.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.31 77.98 0.67 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.674 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 121' ' ' CYS . 2.7 t -136.87 141.65 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.1 100.13 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.287 1.435 . . . . 0.0 111.533 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.08 -46.16 57.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 15.3 ptp -142.31 85.48 1.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.952 0.796 . . . . 0.0 109.101 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.8 109.37 16.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 170.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -125.34 149.66 47.89 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.825 0.821 . . . . 0.0 109.858 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -70.46 144.16 51.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.361 0.664 . . . . 0.0 112.274 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -69.61 113.33 6.78 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.247 0.619 . . . . 0.0 112.3 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.4 m -101.9 89.71 3.74 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.44 0.638 . . . . 0.0 109.307 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 133' ' ' LEU . 2.6 pt? -96.73 142.63 28.52 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.764 0.826 . . . . 0.0 111.799 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.78 92.22 0.08 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -135.88 155.31 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.202 1.001 . . . . 0.0 109.33 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -117.05 -16.48 10.47 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.08 -49.34 11.88 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.625 1.102 . . . . 0.0 113.48 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -24.97 47.59 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.36 -11.35 60.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 168.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.46 -29.94 51.33 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 159.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.01 -40.16 75.43 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -51.25 -38.67 53.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.1 -33.57 18.22 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.63 95.0 3.54 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-N 120.251 1.387 . . . . 0.0 108.293 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -69.37 139.35 41.36 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.3 2.667 . . . . 0.0 114.798 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -141.5 135.96 15.24 Favored Pre-proline 0 CA--C 1.567 1.598 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.842 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -81.54 114.76 2.75 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.086 2.524 . . . . 0.0 112.122 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -101.52 153.47 19.69 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.893 0.854 . . . . 0.0 112.736 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.05 111.7 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 40' ' ' THR . 5.6 m-30 -105.14 94.2 5.11 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -85.74 104.74 15.72 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 59.8 mtt -109.72 147.08 33.81 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.218 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.85 102.72 5.97 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 48.3 tpp -72.16 131.25 42.54 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.78 0.8 . . . . 0.0 111.533 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -56.89 2.36 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.734 172.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -141.38 159.94 41.16 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.6 1.191 . . . . 0.0 109.855 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 p -159.41 131.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.59 147.95 40.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.333 1.053 . . . . 0.0 110.204 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.6 m -93.62 163.71 23.42 Favored Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.94 105.96 0.89 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.469 2.78 . . . . 0.0 113.149 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 142.02 -58.94 0.55 Allowed Glycine 0 CA--C 1.539 1.54 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.01 -163.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 t -91.58 -26.97 18.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -72.13 143.99 48.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.278 1.399 . . . . 0.0 113.457 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -143.09 146.18 33.56 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.43 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.75 139.45 30.66 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 165.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.112 0.958 . . . . 0.0 109.29 -175.109 . . . . . . . . 0 0 . 1 stop_ save_